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SUMMARY 
Background: Sudden infant death syndrome (SIDS) is considered the second most frequent 
cause of infant mortality worldwide. Research specifically pertaining to SIDS is limited in the 
South African setting. Identifiable causes for sudden infant death remain challenging despite 
full medico-legal investigations inclusive of autopsy, scene visit and ancillary studies. Viral 
infections could contribute to some sudden unexpected death in infancy (SUDI) cases, 
especially since a multitude of respiratory viruses have been detected from autopsy 
specimens. The specific contribution of viruses in the events preceding death, including the 
subsequent involvement of the immature immune response in infants, still warrants 
deciphering. Infancy is characterised by marked vulnerability to infections due to immaturities 
of their immune systems that may only resolve as infants grow older when these sudden 
deaths rarely still occur. In South Africa there is a lack of a standard protocol for 
investigations into the causes of SIDS, including the lack of standard guidelines as to which 
specimens should be taken, which viruses should be investigated and which laboratory 
assays should be utilised. 
Objectives: In this prospective descriptive study we aimed to investigate the prevalence of 
viruses in SUDI and SIDS cases at Tygerberg Forensic Pathology Service (FPS) Mortuary 
over a one year period. The primary aim was to explore possible respiratory viral infections in 
SUDI and SIDS cases and to determine the usefulness of molecular techniques to detect 
viruses from SUDI cases. To determine the significance of viruses, we assessed signs of 
infection from lung histology. The secondary objectives included collecting demographic data 
to investigate possible risk factors for SUDI and to look for possible similarities between 
viruses confirmed in living hospitalised infants at Tygerberg, during the study period 
compared to viruses detected from SUDI cases. 
Methods: Between May 2012 and May 2013 samples were collected from 148 SUDI cases 
presenting at Tygerberg FPS Mortuary. As part of the mandatory routine investigations into 
SUDI, shell vial culture (SVC) results were collected from lung and liver tissue specimens 
and bacterial culture results were collected from left and right lung and heart swabs at 
autopsy. To investigate the possibility of viruses implicated in some of the infant deaths we 
used the Seeplex® RV15 Ace detection multiplex polymerase chain reaction (PCR) assay to 
establish the frequency of 13 ribonucleic acid (RNA) respiratory viruses (influenza A and B, 
human parainfluenza 1-4, human coronavirus [OC43, 229E/NL63], human rhinovirus A, B 
and C, respiratory syncytial virus A and B, human enterovirus and human metapneumovirus) 
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from RNA extracted from tracheal and lower left and right lung lobe swabs. Tissue from the 
lower left and right lung lobes were also assessed for histology signs of infection. 
Results: During our study we confirmed multiple known demographic risk factors for SIDS, 
such as the age peak around 1-3 months, the male predominance, bed-sharing, sleeping in 
the prone position, heavy wrapping in warm blankets, prenatal smoke exposure, and socio-
economic factors. With the Seeplex® RV15 Ace detection assay between one and three 
viruses were detected in 59.5% (88/148) of cases. Of the 88 cases that had viruses detected, 
75% (66/88) had one virus and 25% (22/88) had co-detections of two to three viruses. The 
most common viruses detected were HRV in 77% (68/88) of cases, RSV in 18% (16/88) of 
cases and HCoV in 14% (12/88) of cases. Many of the viruses we detected from our cases 
are included in the SVC test that forms part of the medico-legal laboratory investigation for all 
SUDI cases at Tygerberg FPS Mortuary. SVCs were positive in 9.5% (14/148) of all cases 
only. We showed that the SVC method is potentially missing most of the 13 respiratory 
viruses we investigated that could contribute to death in some of the SUDI cases. 
Conclusion: In some cases that had a Cause of Death Classification - SIDS, the PCR 
viruses detected cannot be ignored, especially when it is supported by histological evidence 
of infection. We thus propose that the use of PCR could alter a Cause of Death Classification 
from SIDS to Infection in some of these cases. Further research is needed to determine the 
significance of detecting viruses from SUDI cases wherein no significant histological 
evidence of infection was observed. This questions whether PCR may be too sensitive and is 
detecting past and latent viral infections that do not play any role in the cause of death. The 
histological picture also requires further characterisation to determine if it accurately predicts 
infections or lethal events and can truly support virology findings, especially in young infants 
whose immune systems are still maturing. Without determining the true prevalence of viruses 
in SUDI cases and the viral-specific immune response, the contribution of virus-specific 
infections to this syndrome will remain largely undetermined. 
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OPSOMMING 
Agtergrond: Wiegiedood (“SIDS/SUDI”) word beskou as die tweede mees algemene 
oorsaak van sterftes in kinders jonger as een jaar wêreldwyd. Toegewyde SIDS-spesifieke 
navorsing in die Suid-Afrikaanse samelewing is beperk. Dit bly steeds „n uitdaging om 
oorsake te probeer identifiseer vir hierdie onverwagte sterftes in kinders (SUDI) ten spyte 
van volledige medies-geregtelike ondersoeke, insluitende die lykskouing, ondersoek van die 
doodstoneel en aanvullende ondersoeke. Virusinfeksies kan aansienlik bydra tot sommige 
onverwagte sterftes in kinders, aangesien verskeie respiratoriese virusse alreeds aangetoon 
is in monsters verkry tydens outopsies. Die spesifieke rol wat virusse speel in die prosesse 
wat die dood voorafgaan, asook die bydraende rol van „n onder-ontwikkelde immuunrespons 
in babas, regverdig verdere ondersoek. Die eerste jaar van lewe word gekenmerk deur 
verhoogde vatbaarheid vir infeksies weens die ontwikkelende immuunstelsels soos wat 
babas ouer word, en die voorkoms van SUDI neem stelselmatig af met „n toename in 
ouderdom. In Suid-Afrika bestaan daar tans geen standaard protokol vir die ondersoek van 
wiegiedood nie en daar is ook nie standaard riglyne oor die tipe monsters wat geneem moet 
word, watter virusse ondersoek moet word en watter laboratorium toetse uitgevoer moet 
word nie. 
Doelstellings: In hierdie prospektiewe beskrywende studie is gepoog om die virusse wat in 
gevalle van wiegiedood of SUDI voorkom te ondersoek. Die studie is uitgevoer by die 
Tygerberg Geregtelike Patologie Dienste lykshuis oor 'n tydperk van een jaar. Molekulêre 
tegnieke om virusse aan te toon in hierdie gevalle is gebruik om spesifieke virusinfeksies te 
ondersoek. Die resultate is met histologiese tekens van infeksie in longweefsel gekorreleer. 
Demografiese data is verder versamel om moontlike risikofaktore vir wiegiedood te 
ondersoek. Dit is verder vergelyk met virusse wat met dieselfde diagnostiese tegnieke in 
babas geïdentifiseer is wat tydens die studieperiode in Tygerberg Hospitaal opgeneem was 
met lugweginfeksies. 
Metodes: Monsters van 148 SUDI gevalle wat by die Tygerberg lykshuis opgeneem is, is 
versamel tussen Mei 2012 en Mei 2013. As deel van die roetine ondersoeke in SUDI gevalle, 
was selkultuur resultate verkry van long en lewer weefsel, asook bakteriële kulture van 
deppers wat van beide longe en hart geneem was tydens die lykskouings. „n Seeplex® RV15 
Ace polimerase kettingreaksie (PKR) toets is gebruik om die teenwoordigheid van virusse te 
ondersoek wat moontlik by die babasterftes betrokke kon wees. Trageale- en longdeppers 
wat tydens die lykskouings versamel was, was getoets vir 13 ribonukleïensure (RNS) 
respiratoriese virusse (influenza A and B, human parainfluenza 1-4, human coronavirus 
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[OC43, 229E/NL63], human rhinovirus A, B and C, respiratory syncytial virus A and B, 
human enterovirus and human metapneumovirus). 
Resultate: Ons studie het verskeie bekende demografiese risikofaktore vir SUDI bevestig, 
byvoorbeeld „n ouderdomspiek tussen een en drie maande ouderdom, manlike 
predominansie, deel van „n bed met ander persone, slaap posisie op die maag, styf toedraai 
in warm komberse, blootstelling aan sigaretrook voor geboorte en sosio-ekonomiese faktore. 
Die Seeplex® RV15 Ace toets het tussen een en drie virusse geïdentifiseer in 59.5% (88/148) 
van die gevalle. Uit die 88 gevalle waarin virusse opgespoor was, was selgs een virus in 
75% (66/88) van gevalle gevind en twee en drie virusse in 25% (22/88). Die mees algemene 
virusse was HRV in 77% (68/88) van gevalle, RSV in 18% (16/88) van gevalle en HCoV in 
14% (12/88) van gevalle. Baie van die virusse wat tydens hierdie studie ondersoek was, was 
ingesluit in die roetine selkultuur toets wat deel vorm van die standaard medies-geregtelike 
laboratoriumondersoeke in alle SUDI gevalle by die Tygerberg lykshuis, alhoewel die 
selkulture positief was in slegs 9.5% (14/148) van gevalle. Ons het gevind dat baie 
respiratoriese virusse potensieel gemisdiagnoseer word wat „n rol kon speel in of bydra tot 
die dood van sommige SUDI gevalle. 
Gevolgtrekking: In sommige gevalle waarin SIDS geklassifiseer is as die oorsaak van dood, 
kan die virusse wat met PKR toetse opgespoor is nie geïgnoreer word nie, veral waar die 
bevinding ondersteun word deur histologiese bewyse van infeksie. Ons stel dus voor dat die 
gebruik van PKR toetse die oorsaak van dood klassifikasie kan verander van SIDS na 
Infeksie in sommige van hierdie gevalle. Verdere navorsing is nodig om die waarde van 
gelyktydige opsporing van virusse in SUDI gevalle te bepaal wanneer daar geen 
noemenswaardige histologiese bewyse van infeksie gevind word nie. Dit bevraagteken of die 
PKR toets dalk te sensitief is en gevolglik vorige en latente virusinfeksies identifiseer wat nie 
noodwendig 'n rol in die oorsaak van dood speel nie. Die diagnostiese en kliniese waarde 
van die histologiese beeld in terme van die rol van virusinfeksies as bydraende oorsaak van 
dood moet verder ondersoek word, veral in jong kinders wie se immuunstelsels nog nie 
volledig ontwikkel is nie. Indien die werklike voorkoms van virusse in SUDI gevalle en die 
virus-spesifieke immuunrespons nie bepaal word nie, sal die rol van virus-spesifieke 
infeksies in hierdie sindroom grootliks onbekend bly. 
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CHAPTER ONE 
INTRODUCTION 
The health status of a country can be measured by infant mortality rate (IMR) which is the 
number of deaths in infants younger than one year of age occurring for every 1 000 live 
births (Reidpath & Allotey, 2003; Goutas et al., 2011). Causes of deaths in infants are a 
reflection of the economic development of a population, their general living conditions, their 
social wellbeing, the quality of the living environment and the rate of morbidity in that 
population (Reidpath & Allotey, 2003). These factors can affect infant death rates depending 
on variables encompassing socio-demographics, such as race, gender, level of education, 
annual income per household, as well as geographical and environmental conditions. 
Autopsy findings have provided fundamental information regarding the nature and causes 
surrounding deaths in infants. Goutas et al. (2011) named the four leading causes of 
worldwide infant mortality to be congenital abnormalities, Sudden infant death syndrome 
(SIDS) or otherwise known as “Cot death”, prematurity and low birth weight. Despite a 
decline in infant mortality rates of about 46% over the last few decades, in many regions 
SIDS is still considered one of the most frequent causes of infant death during the post 
neonatal period (Spencer & Logan, 2004; Moon et al., 2007; Hauck & Tanabe, 2008; 
Athanasakis et al., 2011; Goutas et al., 2011). 
During 1974 to 1982, the SIDS incidence in Australia ranged from 1.7 to 2.1 per 1 000 live 
births (Williams et al., 1984). Early mortality data collected by Malteno et al. (1989) from 
1983 to 1984 found that approximately 3.8 SIDS cases occurred for every 1 000 live births in 
Cape Town, almost double that of the 1.7 to 2.1 found in Australia during the 1970s and 
1980s (Williams et al., 1984; Molteno et al., 1989). The exact incidence of SIDS in South 
Africa is uncertain (Saayman, 1992).  
SIDS was first defined in 1969 at the Second International Conference on Causes of Sudden 
Death in Infants as "the sudden death of any infant or young child, which is unexpected by 
history, and in which a thorough post-mortem examination fails to demonstrate an adequate 
cause for death” (Willinger et al., 1991; Beckwith, 2003). The definition was revised in 1989 
as “the sudden death of an infant under one year of age, which remains unexplained after a 
thorough case investigation, including performance of a complete autopsy, examination of 
the death scene, and review of the clinical history” (Willinger et al., 1991; Beckwith, 2003). 
The 1989 definition included an accompanying statement; “cases failing to meet the 
standards of this definition, including those without a post-mortem investigation, should not 
be diagnosed as SIDS” (Willinger et al., 1991; Beckwith, 2003). Prior to any medico-legal 
Stellenbosch University  http://scholar.sun.ac.za
2 
 
investigation, all sudden and unexpected infant deaths are categorised as sudden and 
unexpected death in infancy (SUDI), as is the case at the Western Cape Forensic Pathology 
Service (FPS) Mortuary at Tygerberg. Pulmonary infections are the most common diagnoses 
for a defined cause of death in SUDI cases in South Africa and many other centres in the 
world (Nicod, 2005; Weber et al., 2008a; Côté, 2010; du Toit-Prinsloo et al., 2013). 
All SUDI cases admitted to FPS Mortuaries in South Africa for examination and autopsy are 
investigated according to the auspices of the country‟s Inquests Act (58 of 1959). Despite a 
relatively well developed FPS, there exists no standardised national guidelines for the 
examination of these cases; neither at the seven large academic FPS Mortuaries, nor at a 
multitude of small, rural peripheral mortuaries (du Toit-Prinsloo et al., 2013). At the 
Tygerberg FPS Mortuary, all SUDI cases are investigated according to a standard facility 
protocol which includes autopsy, case note review, and laboratory investigations, including 
virology and microbiology, in an effort to identify possible causes of death. Toxicology and 
other tests are not performed routinely, but as indicated by case. Routine samples collected 
at autopsy at this facility for microbiology culture include sterile swabs from the left lower lung 
lobe, the right lower lung lobe and the heart. Virology samples include tissue from the lower 
left lung lobe, tissue from the liver and blood drawn from the base of the heart. 
From a virological perspective, every SUDI case is subjected to a routine viral screen by the 
National Health Laboratory Service (NHLS) using a centrifugation enhanced Shell Vial 
Culture (SVC) technique. Lung and liver tissue from these cases are screened for human 
adenovirus (HAdV), cytomegalovirus (CMV), respiratory syncytial virus (RSV), influenza A 
and B, human parainfluenza (HPIV) 1, 2 and 3 and Human metapneumovirus (HMPV) as the 
standard procedure to determine natural infectious deaths. The role and contribution of 
viruses in the sequence of events that may lead to SUDI, including the systemic response to 
such infections, are not well defined; even so, SVC screening for only nine viruses may be 
inadequate. Culture techniques, although still considered the gold standard for isolation of 
respiratory viruses, lack the degree of sensitivity of nucleic acid amplification tests (NAATs) 
(Lee et al., 2010).  
Viruses are common in infants and can lead to acute respiratory infections (ARI) and 
fatalities (O‟Callaghan-Gordo et al., 2011; Ghani et al., 2012; Kwofie et al., 2012). Numerous 
RNA and deoxyribonucleic acid (DNA) respiratory viruses have been isolated from SUDI 
cases and new respiratory viruses are continuously being discovered (Bajanowski et al., 
2003; Dettmeyer et al., 2004; Fernández-Rodríguez et al., 2006; Álvarez-Lafuente et al., 
2008; Prtak et al., 2010). This justifies the need for continual updated screening methods to 
ensure that viral respiratory infections contributing to such deaths are not missed. Exploring 
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alternative detection methods that will improve the accuracy of diagnosis and include a 
broader range of viral pathogens can provide crucial information in the search for answers. 
Questions that still remain include which viruses should routinely be investigated in SUDI 
cases and which techniques and types of specimens should be used. Routine viral screening 
focuses on RNA viruses at Tygerberg and because seven RNA viruses are included in the 
screen, and only two DNA viruses, we focused on the RNA viruses. Extensive international 
research has been conducted on various aspects of SUDI and the medico-legal 
investigations involved, but there is a limited amount of locally published literature available 
in South Africa (du Toit-Prinsloo et al., 2011; Douglas, 2012). 
The primary aim of our study was to investigate respiratory pathogens and likely infections in 
SUDI cases at the Tygerberg FPS Mortuary in South Africa. Using the Seeplex® RV15 Ace 
detection assay (a multiplex polymerase chain reaction [PCR] assay), 13 respiratory 
ribonucleic acid (RNA) viruses were investigated as possible causes for viral pneumonia in 
SUDI cases. These viruses included influenza A and B, HPIV 1-4, human coronavirus 
(HCoV) OC43/HKU1 and 229E/NL63, human rhinovirus (HRV) A, B and C, RSV virus A and 
B, human enterovirus and HMPV. The clinical significance of pathogens detected was 
interpreted against the histological manifestations of infection in the lungs. 
The background and literature review to follow will explore some of the important factors 
encompassing SUDI and SIDS investigations including respiratory pathogens and 
immunology that may play an important role in some of these cases. 
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2.1 Early History of SUDI and SIDS 
The occurrence of SIDS, where no cause of death can be ascertained, spans centuries. The 
first historical case alluding to SIDS appears in the Book of Kings in the Bible, during the 
ruling of Solomon, where it was presumed that a woman had lost her infant due to overlaying 
(bed-sharing). Until the late twentieth century, the practice of bed-sharing between infants 
and adults, where the infants allegedly suffocate in their sleep, were previously thought to be 
the leading cause of infant mortality of unknown cause (Byard & Krous, 2003). 
2.2 Definition of SUDI and SIDS 
In more recent years a definite distinction has been made between the terms SIDS and SUDI 
(Krous, 2010). Prior to any medico-legal investigation the term SUDI is used, which is a 
heterogeneous category of death for all sudden and unexpected infant deaths. The purpose 
of the medico-legal investigation is to provide sufficient evidence to explain the death of the 
infant. Upon completion of the autopsy, the term Borderline SIDS is used when pathology 
changes are detected in SUDI cases that are presumed non-lethal or non-specific and 
insufficient to result in death. If a SUDI case remains unexplained after a thorough medico-
legal investigation that includes reviewing the medical history of the deceased infant, the 
duration of gestation, delivery and postnatal development, the death scene investigation, the 
psychosocial history of the family and a complete autopsy, it is classified as SIDS 
(Bajanowski et al., 2007) (Figure 2.1).  
 
Figure 2.1: Categories for SUDI and SIDS 
Medico-legal 
investigation: 
Medical history, 
case files 
information, 
forensic autopsy 
and laboratory 
investigations 
Evidence insufficient 
for a conclusive 
diagnosis 
Evidence for a 
definite diagnosis 
SUDI with a definite 
diagnosis 
Natural cause of death: 
infectious, cardiac 
abnormalities etc. 
Evidence for a possible 
contribution, but 
insufficient to have 
caused death 
SIDS 
Borderline SIDS 
SUDI 
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Thus, SIDS is a subcategory of SUDI that is diagnosed when the evidence fails to uncover 
anything out of the ordinary and after all the processes encompassing the medico-legal 
investigation have exhausted other causes of death. This indicates that the accuracy of the 
diagnosis strongly relies on the thoroughness of the medico-legal investigations (Beckwith, 
2003; Bajanowski et al., 2007; Krous, 2010).  
The following categories were derived for SIDS cases meeting the requirements for the 
definition of SIDS including specific criteria (Krous et al., 2004): 
Category IA SIDS: 
 Age between 21 days and nine months 
 Normal clinical history and term pregnancy 
 No history of SIDS in the home and family environment 
 Death scene investigation does not reveal possible explanations for the mode of 
death 
 The autopsy does not reveal fatal pathological findings, but may reveal minor 
inflammatory infiltrates in the respiratory tract and although intrathoracic petechial 
haemorrhage is considered a supportive finding it is not considered to be obligatory 
or diagnostic in SIDS cases 
 There must be no indications of abuse and neglect including unexplained or 
unintentional trauma or injuries and signs of negligence 
 Substantial thymic stress should be absent and screening for microbiology, 
toxicology, vitreous chemistry, metabolic screening and radiology results should be 
negative 
Category IB SIDS: 
This category meets the criteria of Category IA, but excludes the death scene investigation 
and/or excludes one or more of the screening processes mentioned in Category IA. 
Category II SIDS: 
This category encompasses infant deaths that meet criteria of Categories IA and IB, but 
excludes one or more of the below mentioned: 
 Age range between 0-21 days and/or up to one year 
 History of SIDS in the home and family environment but excluding possible infanticide 
or genetic disorders 
Stellenbosch University  http://scholar.sun.ac.za
7 
 
 Neonatal or perinatal conditions such as prematurity that had resolved prior to death 
 Possible mechanical asphyxia or suffocation 
 Abnormal growth and development and inflammatory disorders insufficient to 
contribute to death 
Category Unclassified Sudden Infant Death: 
Infant deaths in his Category fail to meet the criteria for Categories IA, IB and II, but which 
excludes definite diagnoses of natural or unnatural causes of death. This Category also 
includes cases where no autopsies were performed. 
For the purpose of this thesis, SUDI will include all sudden and unexpected deaths, while 
SIDS will refer to cases where no diagnosis could be made after a complete and thorough 
medico-legal investigation and autopsy were performed, as per facility protocol. When 
literature is cited, the terms SUDI and SIDS will be used according to author definition and 
preference. 
2.3 Medico-legal investigation into SUDI and SIDS 
After many years of research the attempts to identify and confirm the cause of death for 
some of these cases are still unsuccessful, leaving SIDS a medical mystery in desperate 
need of elucidation (Koehler, 2010). Therefore medico-legal investigations into the causes of 
these deaths are warranted. 
Although investigations into causes of infant deaths at forensic mortuaries conform to 
regional protocols, some of which are aligned with international protocols (most notably those 
at selected academic centres), a national standardised SUDI protocol for South Africa has 
not been formulated or adopted. Most of the current regional protocols include a review of 
the clinical history and the circumstances surrounding the event, as well as an autopsy, but 
rarely investigation of the death scene. Unfortunately, the degree of detail with which SUDI 
cases are investigated and the quality of the information collected, especially in developing 
countries, is largely dependent on the availability of resources, equipment and trained 
personnel at institutes (Koehler, 2010; du Toit-Prinsloo et al., 2011). Therefore, investigations 
into the causes of SUDI and SIDS, including the limited information available pertaining to 
South Africa may currently, at best, be lacking.  
Upon completion of medico-legal investigations, those deaths classified as natural causes 
include unexpected congenital abnormalities or malfunctions of bodily organs, and any 
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infections that were not diagnosed, recorded, or regarded as significant, by a treating 
physician. 
Deaths defined as unnatural (Regulations Regarding the Rendering of Forensic Pathology 
Service, National Health Act [No. 61 of 2003] [N.R.929]) include amongst other factors 
physical injuries, trauma, abuse, homicide and any evidence of suffocation or aspiration of 
foreign material or gastric contents. 
If unnatural causes of death can be ruled out after autopsy and death scene investigation, 
valuable community and forensic resources can be saved and the potential miscarriage of 
justice can be avoided. Furthermore, if contagious or pathogenic organisms, that could cause 
or contribute to natural death, can be confirmed after the autopsy with appropriate specimen 
collection and laboratory investigations, it could have significant implications for the 
improvement of public health (Dempers et al., 2011). 
A retrospective pilot study that involved reviewing SUDI case files from 2000 to 2004 at the 
Tygerberg FPS Mortuary in the Western Cape and Pretoria FPS Mortuary in Gauteng 
revealed prominent discrepancies between the standard SUDI investigation protocols for 
these two large academic facilities. At Tygerberg a full macroscopic autopsy was performed 
for almost all the SUDI cases and a detailed histological analysis was conducted in about 
81% of the cases. At Pretoria a full macroscopic autopsy was performed in just over 60% of 
the cases and histology was done in only about 29% of the cases. Additionally, samples from 
about 60% of cases were screened for bacteria and viruses at Tygerberg, whereas Pretoria 
did not screen for bacteria and only performed viral screening in less than 3% of the cases 
(du Toit-Prinsloo et al., 2013). In a follow-up five-year multicentre study by du Toit-Prinsloo et 
al. (2013), Tygerberg conducted the most virology and microbiology investigations (57% of 
cases) compared to Pretoria‟s virology (31%) and microbiology (29%) investigations. Almost 
no virology and microbiology investigations were conducted at facilities in Durban, 
Bloemfontein and Johannesburg. Thus, Tygerberg appears to currently be the academic 
institute in South Africa where SUDI cases are most extensively investigated. Despite the 
thorough investigations at Tygerberg, another important component in SUDI investigations 
includes an examination of the death scene. The death scene investigation may, in some 
instances, reveal the cause of death and could also be crucial in the identification of 
hazardous environments for modification for future siblings of the same households 
(Dempers et al., 2011). Such examinations were not performed during the four year study 
period at either institute (du Toit-Prinsloo et al., 2011) and during the multicentre study, death 
scene investigations were only performed by pathologists in 0.5% of cases. The 
discrepancies between institutional protocols for macroscopic examinations and extent of 
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ancillary investigations such as virology and microbiology, may affect the final diagnostic 
categories for infant death classification (du Toit-Prinsloo et al., 2011; du Toit-Prinsloo et al., 
2013). 
Multidisciplinary approaches are required where standardised protocols are considered 
crucial to ensure consistency of data collected (Mitchell et al., 2000; Howatson, 2006; Prtak 
et al., 2010). Therefore, a single ancillary piece of evidence cannot be relied upon in isolation 
in SUDI investigations. Despite the lack of universal protocols there has been a definite trend 
internationally towards employing standard protocols to improve the quality of SUDI 
investigations and diagnoses, because SIDS had been used in the past as a “conventional 
diagnostic dustbin” (Mitchell et al., 2000).  This implies that the diagnosis of SIDS has been 
used inaccurately for a diverse range of natural and unnatural infant deaths, mainly due to 
the complexity of identifying and distinguishing between various diagnoses. Continued efforts 
are needed to define and improve national infant death investigations to streamline accurate 
assessment and inter-institutional comparison of SUDI data. This would not only contribute to 
identifying and confirming risk factors, but also to increase the understanding and insight into 
the pathophysiological mechanisms involved in these infant deaths (Weber et al., 2008a).  
A case study by Dempers et al. (2011) highlighted the importance of a complete autopsy to 
diagnose tuberculosis (TB) in an infant, which lead to the identification of TB in a close family 
member. This case also emphasised the difficulty of recognising TB in infants, because they 
do not present with the same clinical symptoms as adults. If a thorough autopsy had not 
been performed and histology analysis including a specific bacteriology stain (Ziehl-Neelsen 
stain) that revealed acid fast bacilli, the cause of death might have remained undetermined 
and TB would not have been diagnosed in another family member during that period. If a 
complete autopsy is not conducted with the aid of ancillary investigations, infections 
contributing to or responsible for death in infants may easily go unnoticed. The need for an 
autopsy further becomes necessary when the immature state of the immune system in 
infants is considered. Due to immune system still developing, clinical symptoms of infections 
could possibly be so minor that they are not recognised by parents and doctors (Dempers et 
al., 2011). 
2.4 Suggested guidelines in the literature for SUDI and SIDS autopsies 
Proposed guidelines for investigations into the causes of death include that SUDI autopsies 
should be performed according to a methodical protocol aided by distinct supplementary 
investigations and conducted by pathologists that are familiar with paediatric pathology. 
Ancillary investigations could include skeletal radiology, histology of the major organs, 
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microbiology and biochemical and metabolic analysis, but to include all of these tests may 
not always be practical in a resource-poor setting, such as South Africa.  
It has been suggested that microbiological sampling during an autopsy should include heart 
blood collection into sterile syringes, followed by bronchial swab collection once the trachea 
and bronchi have been cut open from the thorax. Prior to lung sample collection the surfaces 
should be wiped with ethanol or seared to limit the likelihood of acquiring post-mortem 
contaminants. Swabs should then be taken from the lungs after a sterile incision is made into 
the lung surface. Bacteriological sampling can further include lung fluid, tissue samples and 
colonic swabs (Howatson, 2006; Prtak et al., 2010).  
Virological sampling could include post-nasal swabs, nasopharyngeal aspirates, lung tissue 
and serum samples (Fernández-Rodríguez et al., 2006; Howatson, 2006).  
An additional examination modality was instituted in SUDI investigations at the Forensic 
Mortuary in Salt River in South Africa where a digital radiography system (LODOX Statscan®) 
was set up in 2007. They screened 192 SUDI cases using this system (Douglas, 2012). Lung 
disease was the most prevalent imaging pathological finding and this correlated well with 
their subsequent autopsy findings for those cases. In cases of natural infant death when no 
autopsies are performed, radiology may aid the diagnosis in combination with the medical 
history of the case, if the death was determined to be of an infectious nature. Radiology 
during post-mortems are generally used to reveal fractures and visualise foreign objects, 
such as bullets, but is surprisingly not widely used in South Africa for SUDI investigation, 
possibly due to limited funding and resources. There are also no guidelines regarding the 
documentation of radiological findings in SUDI cases (du Toit-Prinsloo et al., 2011; Douglas, 
2012). Thus SUDI investigations and determination of natural causes of death due to 
infections strongly rely on ancillary investigations, such as virological and microbiological 
culture and histological examination of body organs (Fernández-Rodríguez et al., 2006; 
Douglas, 2012). 
In a study conducted over a 10 year period (1996-2005) 546 SUDI cases from London, 
England were investigated to determine the role of specific autopsy investigations in 
concluding the final cause of death. After autopsy examinations the cause of death remained 
undetermined in 63% of the cases. The most common explained cause of death in the 
remaining cases was due to infections. Histology was the primary component towards 
determining the final diagnosis in 46% of the explained SUDI cases, other components 
included macroscopic examinations in 30% of the cases, microbiology investigations in 19% 
of the cases and in 5% of the cases the clinical history primarily determined the cause of 
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death (Weber et al., 2008a). Thus histological examination remains one of the most valuable 
supplementary autopsy investigations to identify a possible cause of death in SUDI (Weber 
et al., 2008a; Weber et al., 2012). Ansari et al. (2003) conducted a study in Botswana in the 
late 1990s where they emphasised the value of autopsy investigations, even in children 
dying from known infectious causes; thus non-SUDI cases. An investigative tool such as the 
autopsy can assist with a definite diagnosis. To emphasise the value of the autopsy, even 
outside the scope of the forensic pathology examinations for SIDS, a thorough anatomical 
autopsy can also allow the correlation between autopsy results and clinical information so 
that ante-mortem diagnosis and patient management can be improved (Ansari, et al., 2003). 
Another aspect that could affect the compilation of a feasible SUDI investigation protocol is 
the dilemma of the lack of agreement as to what is considered sufficient microbiological and 
virological investigations during SUDI autopsies (Weber & Sebire, 2010). The existing 
autopsy protocols also lack guidelines for interpretation of positive pathology results. In 
addition, variations occur when different pathologists interpret the findings as either 
significant to explain death, or insignificant; and therefore a final diagnosis of SIDS. In the 
case of microbiological findings the difficulty arises during the interpretation of positive results 
where it is required to distinguish between significant findings, supposedly insignificant 
positive findings and post-mortem contaminants. Weber & Sebire (2010) further suggested 
that methods are required to investigate the systemic responses to the pathogens isolated 
instead of simply relying on the isolation of pathogens. This would give a better idea of 
whether these pathogens were involved in the disease progression and whether pathogen 
detection correlated with pathological findings of infection or whether it was mere 
contaminants.  
Desmons et al. (2013) reported on a 22-month-old male SUDI case diagnosed with Varicella 
zoster virus (VZV) a few days prior to death. The infection was seen as being mild and 
symptoms were not considered alarming. The autopsy revealed skin lesions, but the organs 
were macroscopically normal and no cause or mechanism of death could be determined. 
Only after molecular analysis on frozen tissue samples, CMV and VZV were detected with 
the highest viral loads in the lungs, implicating the co-infection in the death. The CMV and 
VZV results correlated with histology signs of extensive necrotising inflammation. Their case 
study highlights the importance of a thorough histology and molecular virology investigation 
for determining a definite cause of death in a SUDI case. If such a diagnostic approach is not 
undertaken, the contribution of viral infections could be underestimated and underreported in 
SUDI cases (Desmons et al., 2013). 
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2.5 Viral pathogens in SUDI and SIDS cases 
The effect of viral infections contributing to, or causing SUDI, is not well defined and although 
often implicated in these cases, only a hand-full of possible viruses have received attention. 
Therefore, the role of infections still requires further investigation and should not be 
overlooked. Infectious organisms have been isolated in up to 49% of SUDI cases in the 
United Kingdom (Prtak et al., 2010). Weber et al. (2008a) found that a definite cause of death 
could be determined in 37% of SUDI cases in London, England after autopsies were 
performed. Of these, 58% were due to infections, of which 22% were caused by pneumonia. 
In a multicentre study in South Africa, about 77% of SUDI cases died from natural disease 
processes (pneumonia) with 26% dying from bronchopneumonia (du Toit-Prinsloo et al., 
2013). Blood-Siegfried (2000) pointed out that at least 70% of infants that have died of SIDS, 
where no cause of death could be found after investigations, had records of mild viral 
infections prior to their demise. Parents had also reported a visit to a healthcare provider, as 
well as symptoms of rhinitis, pharyngitis and a cough in their infants. This strongly suggests 
that infections play a role in a subset of SUDI cases. Once a severe or lethal viral or bacterial 
disease has been diagnosed in a SUDI case, the case cannot be categorised as SIDS, but 
rather as an infection and therefore a natural death (Blackwell & Weir, 1999). 
Over the past three decades, there has been consensus in the literature about the 
importance of viral infections in the epidemiology of SUDI and SIDS, especially when it 
occurs in combination with other risk factors. Several viruses have been detected in autopsy 
samples from cases of SUDI and SIDS (Table 2.1), but the significance of such findings has 
remained undetermined in the context of SUDI (Williams et al., 1984; Zink et al., 1987; 
Bajanowski et al., 2003; Dettmeyer et al., 2004; Álvarez-Lafuente et al., 2008). 
Williams et al. (1984) detected viruses in 26% of SIDS cases with a greater proportion in 
cases older than three months. They also detected viruses in 18% of their control cases that 
died due to accidents, which raised the question whether viral detection was associated with 
the events leading to SIDS or only an incidental finding. Patrick et al. (1989) identified a 
similar viral retrieval rate from cot death cases and controls. The absence of infection in 
some of their cot death cases created doubt regarding the importance of viral findings and 
they suggested that the standardisation of sample collection and viral retrieval processes 
could possibly yield more significant results. Patrick et al. (1989) found viruses in 19% 
(44/237) of cot death cases in Glasgow in 1979-1986, and broadly stated that viruses could 
be expected in about one-fifth of cot deaths. Cot death cases from their study that were older 
than 16 weeks (p<0.05) and with a post-mortem interval (PMI) of less than 24 hours (p<0.01) 
yielded significantly more positive viral results when using cell culture, immunofluorescence 
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and immune-enzyme assays. In 12 cases the same virus was detected from more than one 
sampling site and dual isolates were found in three cases (Patrick et al., 1989). 
Table 2.1: Viruses detected by immunological and molecular techniques from autopsy 
samples of sudden infant death cases 
Viruses isolated / Identified References 
Enterovirus  Urquhart & Grist, 1972; Uren et al., 1980; Williams et al., 1984; 
Grangeot-Keros et al., 1996; Dettmeyer et al., 2004; Weber et al., 
2010a 
Coxsackie virus Balduzzi & Greendyke, 1966; Patrick et al., 1989 
Echovirus Balduzzi & Greendyke, 1966; Patrick et al., 1989 
Polio virus Patrick et al., 1989 
Adenovirus Balduzzi & Greendyke, 1966; Urquhart & Grist, 1972; Uren et al., 
1980; Williams et al., 1984; Zink et al., 1987; Patrick et al., 1989; 
An et al., 1993; Dettmeyer et al., 2004; Weber et al., 2010a 
Epstein-Barr virus Dettmeyer et al., 2004; Álvarez-Lafuente et al., 2008 
Parvovirus B19 Dettmeyer et al., 2004 
Human herpes simplex virus Uren et al., 1980; Dettmeyer et al., 2004;  Álvarez-Lafuente et al., 
2008; Weber et al., 2010a 
Cytomegalovirus Uren et al., 1980; Zink et al., 1987; Patrick et al., 1989; Álvarez-
Lafuente et al., 2008; Weber et al., 2010a; Desmons et al., 2013 
Rhinovirus Urquhart & Grist, 1972; Uren et al., 1980; Williams et al., 1984 
Zink et al., 1987; Patrick et al., 1989 
Influenza virus Uren et al., 1980; Williams et al., 1984; Zink et al., 1987; Patrick 
et al., 1989; Bajanowski et al., 2003; Weber et al., 2010a 
Respiratory syncytial virus Uren et al., 1980; Williams et al., 1984; Patrick et al., 1989; An et 
al., 1993; Weber et al., 2010a 
Parainfluenza virus Uren et al., 1980; Zink et al., 1987; Patrick et al., 1989; An et al., 
1993  
Rotavirus Yolken & Murphy, 1982; Patrick et al., 1989 
Varicella Zoster Virus Desmons et al., 2013 
 
Some of the viruses isolated from SUDI cases (Table 2.1) were found in specimens from the 
myocardium, bowel, recto-sigmoid loop, suprarenal fat, liver tissue and post-nasal swabs 
(Patrick et al., 1989; Dettmeyer et al., 2004; Weber et al., 2010a). At the Tygerberg FPS 
Mortuary myocardial, post-nasal swabs, bowel, recto-sigmoid loop and suprarenal fat 
specimens are not considered for routine viral screening in SUDI cases, and SVC also does 
not screen for HRV, Epstein-Barr virus (EBV), parvovirus B19, herpes simplex virus (HSV), 
human enterovirus, coxsackie virus, echovirus or rotavirus. 
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One factor challenging the significance of positive viral identification from SUDI cases is the 
frequency of communal viruses in both SUDI and infants who died as a result of unnatural 
causes (Williams et al., 1984). Several of these viruses were also found to be similar to those 
circulating in living infants in the general population, some of which often cause self-limiting 
infections (Urquhart & Grist, 1972). 
If an infant has an underlying vulnerability, such as immunosuppression, then an infection 
with one or more of the viruses in Table 2.1 could well contribute to the infant‟s demise, 
especially if the infection goes unnoticed by parents, care-givers and physicians. 
Furthermore, the viral load required to contribute to, or result in, death is still undefined 
(Krous et al., 2009). Neither a single virus, nor combinations of specific viruses that have 
been detected from SUDI cases, have consistently been associated with such cases (Nelson 
et al., 1975; Samuels, 2003; Weber et al., 2010a). Nelson et al. (1975) concluded that if there 
was an association between respiratory viral infections and SIDS it seems to be a complex or 
even indirect association. Therefore, viral pathogens alone are considered a risk factor and 
may act as a trigger, but have not been recognised as a direct cause of SIDS (Álvarez-
Lafuente et al., 2008; Weber et al., 2010a).  
Dettmeyer et al. (2004) found human enterovirus in 14 cases and the DNA viruses at much 
lower prevalence with parvovirus B19 detected in seven cases, EBV in three cases and 
HAdV detected in two cases. Álvarez-Lafuente et al. (2008) investigated DNA viruses only 
and found human herpes virus (HHV)-6 in seven cases, EBV in six cases and CMV in five 
cases. Weber et al. (2010a) detected RNA viruses such as human enterovirus in five cases, 
RSV in four cases and influenza in one case. They also detected DNA viruses such as HSV 
in three cases, CMV in three cases and HAdV in one case. Gaaloul et al. (2012) only 
investigated human enterovirus in SIDS cases and found a prevalence of 12.5%. Both DNA 
and RNA viruses have been detected from SUDI and SIDS cases in the literature but the 
specific contribution of a group of RNA or DNA viruses to SUDI has not been establish 
because studies differed in the types of viruses and the amount of viruses investigated. 
2.6 Respiratory viral pathogenesis 
For a virus to survive and infect humans it needs to gain entry into the host by binding to host 
receptors on cellular membranes. When respiratory viruses are inhaled they generally gain 
entry through the nasopharyngeal epithelium, mucous membranes and airway epithelial cells 
(AEC) of the respiratory tract. They also encounter macrophages and dendritic cells (DC) 
which form part of the innate immune system, expressing pattern recognition receptors 
(PRR). Successful entry is followed by viral replication inside the nasopharyngeal epithelium, 
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mucous membranes and AECs that are completely dependent on the host‟s cellular 
machinery in the surrounding tissues. This induces the characteristic release of interferon 
(IFN)-  and IFN-  by AECs and other innate immune cells (Schwarze & Mackenzie, 2013). 
The innate immune system is the body‟s first response to infections and is continually 
surveying the external and internal environment for foreign antigens in order to rapidly mount 
a non-specific response (See & Wark, 2008). The PRRs on cells of the immune system 
detect viruses through recognition of pathogen-associated molecular patterns (PAMPS). The 
PRRs include Toll-like receptors (TLR) such as TLR-4 that binds to the fusion protein of 
RSV, intracellular adhesion molecule 1 (ICAM-1) which is a PRR for HRVs, retinoic acid-
induced gene 1 (RIG-1), and melanoma-differentiation associated gene 5 (MDA-5) 
(Rossmann, 1994; See & Wark, 2008; Schwarze & Mackenzie, 2013). After receptor binding 
viral entry occurs through fusion of the envelope with the membrane of the cell. For 
capsulated viruses, entry into the cell cytoplasm is not well characterised yet (Rossmann, 
1994). Upon detection of viruses by PRRs the DCs and macrophages of the innate immune 
response release interferons that impair viral replication (See & Wark, 2008). The production 
of interferons stimulates programmed cell death of infected AECs thus limiting further 
replication and subsequent infection of other cells (Schwarze & Mackenzie, 2013) and also 
activates natural killer (NK) cells (Schwarze & Mackenzie 2012). In asthmatics the epithelial 
cells in the respiratory tract release less interferon which limits programmed cell death in the 
infected cells and thus enhance viral replication. When AECs recognise viral pathogens a 
host of proinflammatory cytokines, chemokines and growth factors are released. During viral 
lung inflammation the AECs produce pro-inflammatory cytokines which include Tumour 
necrosis factors (TNF) and ILs that leads to the further recruitment of macrophages, DCs and 
neutrophils (Schwarze & Mackenzie 2012). NK cells are important effector cells forming part 
of the innate immune response to control viral infections. These cells lyse host cells infected 
with viruses and if extensive NK cells are activated it can contribute to virus-associated 
pathology (Jost & Altfeld 2013).  
The release of interferon and the ability of DCs and macrophages to act as antigen 
presenting cells (APC) serve as a link between the innate and the adaptive immune system 
by activating and recruiting naïve T cells (See & Wark, 2008). DCs can activate both effector 
and memory T cells to respond to viral infections and re-infections respectively (Schwarze & 
Mackenzie 2012). NK cells can also interact with DCs and produce cytokines and 
chemokines to regulate adaptive immune responses (Jost & Altfeld 2013). Although the 
adaptive immune system is not a rapid response it is very specific and effective. Cytotoxic 
CD8+ T cells are recruited to areas of acute inflammation during viral infection and secrete 
interferon but they can also function to dampen an exaggerated innate immune response to 
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decrease tissue damage (See & Wark, 2008). CD4+ T cells secrete cytokines during a viral 
infection and help to activate the production of antibodies by B cells that could neutralise 
foreign microorganisms or toxins (Gordon et al. 1999; Koziel 2005). Immunological adaptive 
memory is acquired after recovery from infection that allows the host to respond faster upon 
re-exposure to the same pathogen or a closely related one (Hikono et al. 2006) 
2.7 Introduction of respiratory pathogens investigated in this study 
The following sections will briefly introduce and characterise the thirteen respiratory viruses 
and subtypes that will be investigated during this study, namely influenza A and B, HPIV 1-4, 
HCoV (OC43, 229E/NL63), HRV A, B and C, RSV A and B, human enterovirus and HMPV. 
2.7.1 Human coronavirus (HCoV) 
The HCoVs are from the family Coronaviridae and the order Nidovirales. They are single-
stranded positive RNA viruses with their nucleic acids ranging from 27 000-33 000 base pairs 
(bps) in size. The HCoVs share common genes that encode for structural proteins that 
include the envelope, the membrane and the spike proteins. The HCoVs are divided into two 
groups; group one containing HCoV-229E and HCoV-NL63, and group two containing HCoV-
OC43 and HCoV-HKU1. Mutations in HCoV strains seem to occur frequently and if two 
viruses are present in the same cell genetic recombination can occur. The common 
symptoms observed in patients infected with HCoVs include coughing, fever, rhinorrhoea, 
bronchiolitis and croup (Kahn & McIntosh, 2005; Kuypers et al., 2007; Abdul-Rasool & 
Fielding, 2010). 
The first HCoV types, HCoV-OC43 and HCoV-229E, were already described in the 1960s 
(Kahn & McIntosh, 2005; Abdul-Rasool & Fielding, 2010). In 2003 a HCoV strain that caused 
severe acute respiratory syndrome (SARS) was identified. This SARS HCoV virus was 
distributed worldwide causing severe respiratory disease with a 10% mortality rate. As 
quickly as the outbreak occurred and the virus appeared, it disappeared again. No others 
had been detected in human populations since then. Several HCoV strains cause severe 
disease in animals, but only mild symptoms in humans, however, as was the case with the 
SARS epidemic, some animal coronaviruses (CoV) may be potentially life-threatening when 
introduced into the human population. The HCoV-NL63 viral strain was discovered in 2004 in 
The Netherlands when it was isolated from a seven-month-old girl who was suffering from 
symptoms that included coryza, conjunctivitis, fever and bronchiolitis. The following year 
HCoV-HKU1 was isolated from a man that was 71 years old who showed symptoms of 
respiratory disease, which included a fever and coughing (Kahn & McIntosh, 2005; Kuypers 
et al., 2007; Abdul-Rasool & Fielding, 2010). Recently the Middle East respiratory syndrome 
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coronavirus (MERS-CoV) was detected from a man with a fatal outcome who had shown 
signs of acute pneumonia and renal failure in Saudi Arabia. Both authors claimed that the 
clinical features seemed similar to that of the SARS-CoV outbreak (Zaki et al., 2012; Breban 
et al., 2013). MERS-CoV cases are being closely monitored and may have the potential to 
cause a human pandemic as was the case with SARS-CoV. The animal host for MERS-CoV 
is still unknown (Breban et al., 2013). 
Since the discovery and subsequent culture and characterisation of HCoVs, they have been 
found in a substantial proportion of children presenting with symptoms of a common cold. 
The HCoV strains can infect any age group, but the majority of these infections occur during 
childhood. Apart from SARS-CoV, the pathogenicity of HCoVs are generally low, causing 
upper respiratory tract infections (URTI), occasional pneumonia and can also contribute to 
asthma exacerbation in childhood. The only HCoV virus that has been thoroughly studied is 
SARS-coronavirus and this may be due in part to the notion that HCoVs only result in mild 
infections of the respiratory tract and has thus far not been considered as serious threats 
(Kahn & McIntosh, 2005; Kuypers et al., 2007; Abdul-Rasool & Fielding, 2010). 
2.7.2 Human enterovirus 
The human enteroviruses are non-enveloped icosahedral viruses from the picornaviridae 
family with positive single-stranded RNA and a genome size of about 7 500 bps. They cause 
illnesses that range from mild respiratory infections, such as the common cold, hand-, foot- 
and mouth disease, conjunctivitis, carditis, general neonatal infections, meningitis, 
encephalitis and paralysis (Hyypiä et al., 1997; Han et al., 2010). 
Originally, the human enteroviruses were grouped into polioviruses, coxsackie A and B 
viruses and echoviruses, but because genetic similarities between echoviruses and 
coxsackie viruses became apparent, the human enteroviruses have been grouped into five 
species, which include the poliovirus and human enterovirus groups A-D (Oberste et al., 
2004). 
The first isolation of human enterovirus 68 occurred in 1962 in California, Unites States of 
America (USA), where it was found in four children showing signs of respiratory disease. 
From that time onwards this virus was rarely isolated, but when it was isolated, it was always 
from respiratory specimens of patients that suffered from respiratory disease, including 
bronchiolitis and pneumonia. Unlike human enterovirus 68, most of the other human 
enterovirus strains are typically isolated from faecal specimens from patients with meningitis 
(Oberste et al., 2004). In 1971 human enterovirus 70 was isolated during a pandemic of 
acute haemorrhagic conjunctivitis (AHC). Human enterovirus 71 was isolated in 1969 from 
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the brain of a patient who had suffered from fatal encephalitis. Outbreaks of hand-, foot- and 
mouth disease were also associated with human enterovirus 71 in Sarawak, Malaysia, in 
1997. This strain led to serious myocardial dysfunction, paralysis and death in some of the 
paediatric patients. These deaths had a major impact on public health and resulted in the 
Government of Malaysia declaring hand-, foot- and mouth disease one of the notifiable 
diseases in 2007 (Yusof et al., 2011). 
2.7.3 Human metapneumovirus (HMPV)  
HMPV belongs to the paramyxoviridae family and is an enveloped virus characterised by 
negative-sense single-stranded RNA with a genome size of about 13 000 bps and is divided 
into two main genetic lineages, A and B. The genome of HMPV encodes for several proteins 
that include the attachment, nucleoprotein, fusion protein, matrix protein, phosphoprotein, 
small hydrophobic and the large polymerase proteins. Of these, the fusion protein is involved 
in immune protection and neutralising monoclonal antibodies against the fusion protein have 
been observed, whereas the attachment and small hydrophobic proteins seem to be only 
weakly immunogenic (de Graaf et al., 2008; Lo Pesti et al., 2011). 
HMPV was isolated from respiratory specimens of young children in The Netherlands during 
2001 and has since become recognised as a noteworthy cause of lower respiratory tract 
infection (LRTI), prevalent amongst infants. HMPV infection is not restricted to the paediatric 
populations and has been observed in the elderly and immunocompromised patients as well 
(Van den Hoogen et al., 2001; Williams et al., 2004; Lo Presti et al., 2011). Avian 
metapneumovirus (aMPV) was discovered during the 1970s when it was implicated in 
respiratory illnesses in birds. It was classified into subgroups A and B found in South Africa in 
1978, C in the United States of America (USA) and D in France. The aMPV subtype C that 
was isolated in 1996, was genetically related to HMPV. It was thus suggested that HMPV 
may have originated from birds and entered the human population through zoonosis (de 
Graaf et al., 2008; Lo Presti et al., 2011). 
Currently, HMPV is divided into subtypes A1, A2a, A2b, B1 and B2. There is no HMPV 
vaccine available yet, but research is on-going towards developing one. Cold-adapted 
vaccine strains of aMPV, which do not grow at normal body temperature, have been 
successful in preventing infections in poultry. Replication of HMPV in cell lines which 
normally support the growth of various respiratory viruses, such as human larynx carcinoma 
cell line (i.e. Hep-2), only weakly supports HMPV replication and this may be why this virus 
has only recently been identified. The recent identification was achieved through PCR tests 
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that employed random primers to increase the likelihood of detecting novel viral species (Van 
den Hoogen et al., 2001; Crowe, 2004; Lo Presti et al., 2011; Li et al., 2012). 
The symptoms of HMPV infection include fever, coughing and rhinorrhoea accompanied by 
vomiting. Infection with HMPV was related to clinical features that included bronchiolitis, 
croup, pneumonia, acute otitis media and asthma exacerbation. Recurrent infections with 
HMPV have also been observed in infants. In these infections the strains that were isolated 
during the first and subsequent episodes of infection were genetically distinct from each 
other, which may suggest some genetic variability (Van den Hoogen et al., 2001; Williams et 
al., 2004; Pesti et al., 2011). 
2.7.4 Human rhinovirus (HRV) 
The HRVs belong to the family picornaviridae and were first isolated in the 1950s. They are 
non-enveloped, single-stranded positive sense RNA viruses with a genome size of about 
7 200 bps. Over a hundred serotypes have been described and are mainly divided into HRV-
A and HRV-B after sequence analysis. More recently two other possible groups emerged, 
HRV-C and HRV-D. The high number of serotypes described can be accounted for by the 
error-prone polymerase that can result in mutations in the nucleotides of the HRV genome, 
driving viral adaptation and evolution (Tapparel et al., 2007; Cordey et al., 2010; Smuts et al., 
2011). 
HRV is found in low concentrations in saliva and was shown to be poorly transmitted during 
coughing and sneezing, which involves mainly oral secretions. For this reason, the main 
route of identified transmission was suggested to occur via contaminated nasal secretions 
and eyes. The virus can then be acquired through self-inoculation or from contaminated 
hands to the nose or eyes of susceptible persons. The virus initially enters through the nose 
and establishes infection in the ciliated epithelial cells of the upper respiratory tract (URT). In 
cases where the infection is self-limiting, after viral acquisition, the concentration of HRV 
increases in nasal concentrations, reaching a peak at about 48 hours, after which it starts to 
decrease. Yet, viral shedding can still occur for another three weeks after initial 
establishment of infection (Hendley et al., 1973; Gwaltney, 1995). 
HRVs are the frequent mild pathogens of the URT. These viruses are responsible for the 
common cold and other infections that include otitis media and sinusitis, but have also been 
associated with asthma exacerbations and severe LRTI in immunocompromised patients 
(Papadopoulos, 2004; Tapparel et al., 2007; Cordey et al., 2010). In hospital-admitted 
paediatric patients (<18 years) in California in 2007, 49% were infected with HRV genotypes 
A and C (Louie et al., 2009). Louie et al. (2009) reported the common symptoms to include 
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coughing in 71% of the patients, wheezing in 52% of the patients and fever in 48% of the 
patients. Although HRV was previously thought to be responsible for mild infections, the 
findings from Louie et al. (2009) suggested that HRV could also be associated with severe 
LRTI.  
2.7.5 Influenza A and B 
The human influenza viruses belong to the orthomyxoviridae family and can be further 
divided into three genera, namely influenza A, discovered during 1933, influenza B, 
discovered in 1940, and influenza C, discovered in 1950. The influenza viruses are 
enveloped, single-stranded negative-sense RNA viruses with influenza having a genome 
size of about 13 588 bps. The genome of influenza viruses codes for three membrane 
proteins that include the haemagglutinin (HA), neuraminidase (NA), the ion channel protein 
and a matrix protein (Chan et al., 2006; Gao et al., 2012). Several subtypes exist for 
influenza A. These are named according to the HA and NA proteins combined with H1, H2 
and H3 and N1 and N2 found to circulating in human populations within the last hundred 
years. Three known large influenza pandemics have occurred; the first in 1918, as a result of 
the H1N1 subtype, the second during 1957 as a result of the H2N2 subtype, and the third in 
1968 as a result of the H3N2 subtype (Zambon, 2001). 
Influenza A is a significant human pathogen responsible for annual epidemics during winter 
months and can also cause infections in birds, pigs and horses. Influenza B infections are 
mostly limited to humans where it causes significant disease, but epidemics rarely occur 
compared to influenza A. Influenza C is a less significant human pathogen and also generally 
restricted to humans, although groups B and C have both been isolated from mammalian 
species on occasions. Influenza infections can be asymptomatic or in more serious cases, 
characterised by a high fever, chills, coughing, headaches and a sore throat (Hilleman, 2002; 
Zambon, 2001; Petric et al., 2006). 
The RNA-dependent RNA polymerase of influenza A has a high replication error rate, which 
supports the rapid evolution of this virus. This also means that complete immunity to 
influenza virus infection cannot be achieved. Point mutations, especially in the HA surface 
glycoprotein, enable the virus to surpass the hosts immune defence of persons that had 
previously been exposed to influenza, which can result in annual re-infection. The 
ribonucleoprotein core of influenza A and B is divided into eight segments, whereas influenza 
C only has seven segments. The segmented ribonucleoprotein core permits re-assortment of 
genetic material and recombination amongst different influenza subtypes, giving rise to a 
substantial reservoir of novel influenza strains over time (Zambon, 2001; Gao et al., 2012). In 
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contrast to the majority of respiratory viruses, a vaccine exists for influenza, which serves as 
a preventative tool against severe infection. Even so, the influenza vaccine needs to be 
modified annually according to the circulating strains (Schwarze & Mackenzie, 2013). 
2.7.6 Human parainfluenza virus (HPIV) 1-4 
The HPIVs belong to the paramyxoviridae family and are divided into HPIV 1 (described in 
1956 together with HPIV 3), HPIV 2 (described in 1956), HPIV 3 and HPIV 4-A and HPIV 4-B 
(described during 1960-1964). They are small viruses ranging from 150-250 nm, 
characterised by an envelope, negative-sense single-stranded RNA molecule, and a genome 
size that is approximately 15 000 bps. The genome encodes for structural proteins that 
include the large nucleocapsid protein, the phosphoprotein, the nucleocapsid protein, the 
surface glycoproteins Haemagglutinin-neuraminidase (HN), the fusion protein and the 
membrane protein (Henrickson, 2003). Illnesses observed after HPIV isolation in children 
include mild colds, croup, bronchitis, bronchiolitis and less frequently, pneumonia. URTI 
include otitis media, pharyngitis and conjunctivitis (Gardner, 1969; Downham et al., 1974; 
Henrickson, 2003).  
The humoral immune response to infection with HPIVs include antibody production against 
the HN and fusion proteins of the virus, and to date there are no effective vaccines available 
(Henrickson, 2003). 
2.7.7 Respiratory syncytial virus (RSV) A and B  
RSV was first recognised as a cause of coryza in chimpanzees in 1965 and was 
subsequently detected in children suffering from respiratory illness (Simoes, 1999). Isolated 
RNA shows that the virions are single-stranded with 90% of the RNA having a negative 
polarity, and the genome size was determined to be close to 14 705.88 bps. RSVs are 
enveloped RNA viruses organised into the genus pneumovirus and the family paramyxovirus 
(Huang & Wertz, 1982; Domachowske & Rosenberg, 1999). 
Two of the transmembrane surface antigen determinants for RSV are the fusion and 
attachment glycoproteins. Despite the detection of neutralising antibodies against these 
glycoproteins during RSV infection, cellular immune response is required in order to 
effectively clear the virus and allow recovery from infection. Annual RSV infections with the 
same viral strains often occur within the first few years of life, suggesting that immunity may 
be incomplete during early life and only establishes after several infections where the 
immune response progressively strengthens with each re-infection. Even though multiple re-
infections are thought to occur throughout early life, severe infection is often only restricted to 
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the first two re-infections in childhood (Collins et al., 1995; Domachowske & Rosenberg, 
1999; Simoes, 1999). 
The most significant cause of LRTI in early childhood is RSV infection. The acquisition of 
RSV occurs form the nasopharynx and the eyes, followed by an incubation period of about 
five days, after which substantial viral replication occurs in the nasopharynx. RSV infection is 
characterised by rhinitis, coughing, fever and roughly a third of childhood cases develop 
acute otitis media. LRTI predominantly results in bronchiolitis and pneumonia, but may also 
develop into croup (Collins et al., 1995; Domachowske & Rosenberg, 1999; Simoes, 1999).  
Co-infection of some of the respiratory viruses outlined above is common, especially for 
HMPV and RSV (IJpma et al., 2004). Many respiratory viruses show definite seasonal 
variation, including RSV (Ghani et al., 2012; Kwofie et al., 2012), HMPV, influenza 
(O‟Callaghan-Gordo et al., 2011) and HPIV viruses, with peaks during winter and rainy 
months (IJpma et al., 2004; Smuts et al., 2011). HRV infections usually peak in autumn and 
spring (Smuts et al., 2011). Zink et al. (1987) and Grangeot-Keros et al. (1996) have 
discussed correlations between the increase of infections in colder climates and the 
incidence of SUDI and SIDS. Nelson et al. (1975) found a significant association between 
SIDS cases and infants hospitalised as a result of influenza in a study in Chicago from 
January 1970 to June 1976. 
Viral infections may act in combination with other factors, including the host‟s immune 
response to infection, the initiation of bacterial toxin production, as well as co-infection with 
other microorganisms, thereby contributing to SUDI. Viruses can also enhance cytokine 
activity, leading to the unregulated expression of inflammatory mediators. Inflammatory 
changes have regularly been observed in the URT and lower respiratory tract (LRT) in SUDI 
cases and clinical symptoms have often been reported in the days preceding death. The 
cytokine interleukin (IL)-6 has been detected in similar concentrations in cerebrospinal fluid 
(CSF) from SIDS cases, as well as those who died from serious diseases, such as meningitis 
and septicaemia. The combination of a viral infection and the subsequent activation of 
bacterial toxin production can increase pro-inflammatory reactions. To date no method exists 
for determining the degree of inflammation required for lethality. Despite this, severely 
elevated pro-inflammatory levels have been detected during lethal infections (Samuels, 
2003; Blackwell et al., 2005; Highet, 2008).  
2.8 Burden of respiratory disease and respiratory viruses in children 
Even though the specific role of viral infections in the context of SUDI is not well defined, the 
burden of disease resulting from respiratory illness is the largest cause of morbidity in the 
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world. ARIs are the leading causes of childhood morbidity and mortality worldwide and young 
children can have up to 5-8 respiratory infections annually. Although this rate should be 
comparable throughout the world, a much worse prognosis is found in rural Africa where 
patients suffer from poor health, malnutrition, high incidences of prematurity, anaemia and 
other co-morbidities, such as malaria and human immune deficiency virus (HIV) (Tregoning 
& Schwarze, 2010; O‟Callaghan-Gordo et al., 2011).  
In 2000, about 1.9 million deaths worldwide were attributed to ARI with 70% of these deaths 
occurring in Africa and Asia. In 2008 about 1.6 million children worldwide died of ARI and in 
developing countries the major causes of these deaths were due to viral pathogens, such as 
RSV, HPIV, influenza, HAdV, HCoV and human bocavirus (HBoV) (Kwofie et al., 2012). 
Infection of the respiratory tract was considered to be the third most frequent cause of death 
in African children younger than five years of age. Furthermore, in South Africa, about 80% 
of deaths during infancy and early childhood were shown to result from respiratory tract 
infections (IJpma et al., 2004).  
On a smaller scale Ansari et al. (2003) studied children from Botswana who died at 
Nyangabgwe Hospital from 1997 to 1998. They found 83% of the deaths amongst HIV-
positive and 67% amongst HIV-negative children at this hospital were attributed to 
respiratory infections. 
It was proposed by Weber & Sebire (2010) that infants succumbing to SUDI may have 
underlying genetic and biological vulnerabilities and immunodeficiencies. Even though the 
pathogenicity of respiratory viruses can be low in immunocompetent individuals and are often 
associated with a good prognosis, this postulated deficiency in the ability of the infant to deal 
with mundane infectious agents can predispose them to sudden and unexpected death in the 
presence of a mild viral infection, an unregulated immune response and/or other externally 
established risk factors (Weber & Sebire, 2010). 
HRV seems to be very common in young African children with acute wheezing. A recent 
study found HRV in 58.2% of children below five years of age, of whom 72% were younger 
than two years and a further 50% of these occurred in infants younger than 12 months. Co-
infections occurred with HMPV, HBoV and HCoV in 6.3%, 4.7% and 0.8% of infants 
respectively. In the infants that tested negative for HRV, 5.4%, 10.9% and 3.3% were 
positive for HMPV, HBoV and for HCoV respectively (Smuts et al., 2011). 
A prospective study during the winter months of 2002 identified HMPV as the sole pathogen 
in 5.8% of hospital-referred children with URTI and LRTI at Tygerberg Hospital, Cape Town, 
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South Africa. Other infections were due to RSV (15%), influenza B (15%) and influenza A 
(13%) (IJpma et al., 2004).  
In Ghana viruses detected in children under five years of age that were hospitalised with 
severe pneumonia in 2008 included RSV (14.1%), HAdV (10.2%), HPIV 1, 2 and 3 (3.1%) 
and influenza B (0.8%). There was one co-infection of RSV and HPIV 1 and another co-
infection of RSV with influenza B and HAdV. These viruses were isolated in 25.7% of the 
children and bacterial pathogens were only isolated in 9.4% of the children. From this study 
the majority of children infected were between the ages of six months to two years, and the 
majority of infections were of viral origin; 61.1 % were isolated in the rainy season, with RSV 
predominating (Kwofie et al., 2012). 
In Mozambique viruses isolated from 1999-2000 from infants younger than 12 months with 
ARIs included HRV (26%), HAdV (14%), HMPV (7%), HPIV (5%) and human enterovirus 
(3%). Co-infections with two viruses occurred in 9% of the cases and 2% had three viruses 
detected, with the majority of co-infections involving HAdV and HMPV. This study did not 
screen for RSV and the true frequency of viral infections might have been underestimated as 
a result (O‟Callaghan-Gordo et al., 2011). 
In Cape Town, South Africa, viruses isolated from infants between the ages of two months 
and one year who were admitted to the paediatric intensive care unit for ARI in 2009 included 
HRV (39%), RSV (27.7%), HAdV (15.4%), influenza A (13.3%), HPIV 1, 2 and 3 (11.8%), 
HMPV (6.2%) and influenza B (0.5%). The mortality rate of 11.4% was associated with HIV 
infection or exposure and nosocomial and influenza A infections. In this study the overall viral 
detection was 86%, with 13.5% having viral co-infection with two viruses and 0.5 % with 
three viruses (Ghani et al., 2012).  
In another study in Cape Town, South Africa, done by Zampoli et al. (2011), the isolated 
viruses included CMV (66%), RSV (13%) and HAdV (9%) in 202 children admitted to the Red 
Cross Children‟s Hospital suffering from severe pneumonia. Of these children, 62% were HIV 
infected. In 17% of the children co-infections occurred with two or more pathogens identified. 
In 43% of the children with severe pneumonia admitted to the Red Cross Children‟s Hospital, 
no pathogens could be detected, which indicates that better viral screening and detection 
methods are required to diagnose the causes of pneumonia. For this study, the in-hospital 
mortality rate was 25%. The majority of deaths occurred in HIV-infected children suffering 
from CMV-associated pneumonia, accompanied by high CMV viral loads. The cut-off viral 
load that can predict severe or fatal CMV disease still needs to be established (Zampoli et 
al., 2011). This high prevalence of CMV in South African children suffering from pneumonia 
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(66%) was similar to the CMV prevalence in lung autopsy samples from Zambia and 
Botswana (22.8% and 20.2% respectively) in the 1990s (Chintu et al., 2002; Ansari et al., 
2003). CMV infection generally results from opportunistic infections in patients that are 
immunocompromised, in which case, it may cause fatal lung disease. This virus has also 
been shown to cause pneumonia in infants believed to be immunocompetent. CMV is often 
detected alongside other causes of lung disease, therefore its individual role in fatal infection 
is questionable (Chintu et al., 2002).  
2.9 Diagnostic tests for respiratory infections  
Several important factors may help in the identification of different viral isolates in SUDI 
cases. These factors include the selection of viruses tested, viral load, and isolation and 
detection techniques used. Molecular PCR techniques use specific primer sequences and 
immunohistochemistry uses monoclonal antibodies that are extremely specific for the virus in 
question. Furthermore, Patrick et al. (1989) stated that many viruses may not be detected 
using current viral isolation methods and individuals immune systems may also respond 
differently to viral infection. For viral culture detection methods that highly rely on viral 
viability a long PMI may be important for viral viability. Weber et al. (2010a) speculated that 
long PMIs where degradation of viral particles occur, may also affect viral nucleic acid 
detection assays. Although the viability of viruses and the composition of nucleic acids may 
decline over time, no time-limit had been specified. According to Patrick et al. (1989) a 
prolonged PMI should not be a contraindication for viral investigations, because 18% of their 
viral positive cot death cases confirmed by culture methods and immunology assays had a 
PMI longer than 24 hours. Using non-culture methods for bacterial and viral detection 
assays, a PMI of four hours to four days still yielded significant bacterial and viral isolates in 
85% of SUDI cases (Rambaud et al., 1999). 
Prior to the 1900s viral growth was mainly achieved by propagation in embryonic eggs and 
experimental animals, but since then the achievement of growing human cells in vitro viral 
isolations have largely replaced in vivo laboratory diagnosis. Viruses grown in susceptible 
cell cultures can yield high viral concentrations. In addition, culture tubes facilitate 
manipulation and allow the addition of antibiotics to prevent contamination, which is not 
possible in animal hosts. Cell cultures were first used to culture the vaccinia virus in 1913 
and later smallpox and yellow fever in the 1930s. These in vitro cultures facilitated the 
development and production of vaccines (Leland & Ginocchio, 2007).  
Cell culture methods have always been designated as the “gold standard” for the detection of 
viable viruses, but with conventional cell culture techniques it can take eight to ten days for 
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sufficient viral growth, which limits the diagnostic value of such methods. On the other hand 
centrifugation-enhanced SVC greatly reduces the turn-around time to 1-2 days, which may 
further be decreased with the use of mixed cell lines, such as a combination of Hep-2 and 
Madin-Darby Canine Kidney (MDCK) cell lines (Leland & Ginocchio, 2007; Mahony, 2008). 
Faster, alternative techniques, such as NAATs were developed and can provide results in 
less than three hours (Loeffelholz & Chonmaitree, 2010). NAATs have higher positivity rates 
than SVC (Lee et al., 2010) and have superior diagnostic sensitivity and specificity for 
detection of respiratory viruses, to the point where interpretation of positive results becomes 
challenging. NAATs does not indicate viral viability and therefore challenges arise when 
viruses are detected in persons without any clinical symptoms of infection or once the 
persons have already completely recovered from illness. Prolonged shedding of HRV can 
occur up to three weeks after initial infection (Hendley et al., 1973; Gwaltney, 1995). These 
techniques also frequently detect multiple viruses in the same sample, which can complicate 
interpretation of results. Real-time PCR methods allow amplification and analysis of viral 
targets in one step and conventional multiplex PCR methods can detect larger range of 
viruses in a single reaction, but require an additional step for post-amplification detection 
(Pabbaraju et al., 2008; Gadsby et al., 2010; Loeffelholz & Chonmaitree, 2010; Gharabaghi 
et al., 2011). 
The detection of a virus in autopsy samples may not necessarily indicate a specific cause of 
death or an active infection, because CMV has been found to be present in numerous infants 
without any pathological manifestations. The contribution of a viral positive PCR result to 
events leading to death cannot be excluded, but require further evidence that an active 
infection was present through the detection of viral specific immune responses (Blood-
Siegfried, 2000; Álvarez-Lafuente et al., 2008). The sensitivity of NAATs and the latency of 
some viruses, such as CMV and other herpes viruses, means that positive tests need to be 
interpreted carefully by trained personnel and in parallel with histology and other results 
(Fernández-Rodríguez et al., 2006; Howatson, 2006). Techniques that have commonly been 
used in viral investigations from sudden infant death specimens include culture techniques 
(Balduzzi & Greendyke, 1966; Urquhart & Grist, 1972; Weber 2010a), immunofluorescence 
(Urquhart & Grist, 1972; Zink et al., 1987; Weber 2010a), immunohistochemistry (Dettmeyer 
et al., 2004), PCR and gel electrophoresis (Grangeot-Keros et al., 1996; Bajanowski et al., 
2003; Dettmeyer et al., 2004; Weber 2010a), in situ hybridization (An et al., 1993) and 
immunoglobulin (Ig) M and IgG immunoassays (Grangeot-Keros et al., 1996; Williams et al., 
1984; Zink et al., 1987). Specimens collected for viral investigations in sudden infant death 
studies included fresh, frozen and paraffin-embedded formalin-fixed samples from lung 
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tissue, serum, lumbar and CSF, colon, stool, suprarenal fat, myocardium, brain, thymus and 
nasal and tracheal swabs. Although formalin-fixed samples have been used to detect viruses 
Gazziero et al. (2009) found significant degradation of RNA and DNA in formalin-fixed cells 
compared to fresh cells and cells fixed in formalin-free media. Formalin fixation can thus 
cause fragmentation of RNA and DNA, reducing the nucleic acids suitable for molecular 
amplification (Gazziero et al., 2009; Desmond et al., 2013). CMV and VZV were only 
detected from frozen tissue and not formalin-fixed tissue in a SUDI case report by Desmond 
et al. (2013).  
2.10 Respiratory immune defence 
The principle defence mechanism of the host against respiratory infections is the physical 
and cellular components of the immune system and immune mechanisms of the respiratory 
tract. Breathing is a life-preserving function of the lungs and provides oxygen to the cells of 
the body, but during the breathing process, harmful microorganisms can also gain entry into 
the nasopharynx and the lungs (Nicod, 2005). 
In the URT a cough generates shearing forces that drives foreign material up and out of the 
bronchi and trachea, assisted by the beating of cilia on AEC lining the URT. The secretion of 
mucus-containing IgA allows the neutralisation of foreign pathogens and prevents the 
attachment of microorganisms to the epithelium. The AECs secrete chemokines, such as IL-
8 and IL-16, when stimulated by viral infections, cigarette smoke and other microorganisms, 
which are established risk factors for SUDI. The expression of these cytokines is followed by 
an increased expression of adhesion proteins during inflammation. Adhesion proteins slow 
down the immune cells in circulation by permitting adherence of neutrophils, monocytes, 
macrophages and lymphocytes to blood vessels and facilitate their migration from the blood 
stream to the area of inflammation. The recruited alveolar macrophages serve as a first line 
of defence in the lungs by neutralising foreign particles and recruiting more neutrophils and 
mononuclear cells to the site of infection and inflammation. The inflammatory response is 
enhanced by the secretion of IL-1 , IL-1  and TNF- , followed by secretion of adhesion 
molecules on epithelial surfaces, as well as chemokines, which form part of the innate 
immune response. During RSV bronchiolitis, necrosis and sloughing of AECs occur 
accompanied by increased mucus production, which reduces airflow (Hall, 2001). 
The respiratory mucosa houses DCs that are able to detect, capture and transport foreign 
microorganisms to the lymph nodes of the body, where the adaptive immune system can be 
stimulated. The DCs phagocytose epithelial cells that are infected with viruses. They then 
display viral particles on the outer membrane receptors to attract and stimulate naïve T 
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lymphocytes into effector T cells, present at the lymph nodes in the lungs. These effector T 
cells play an important role in viral clearance. Lymphocytes form 10% of the immune cells of 
the alveoli of the lungs, consisting of 50% cluster of differentiation (CD) 4+ T helper and 30% 
CD8+ cytotoxic T cells. A further 10-15% of the immune cells of the alveoli consist of NK cells 
and 5% consist of B lymphocytes. Both CD4+ and CD8+ T cells are vital role players in the 
adaptive immune defence against viral pathogens. The main Ig subtype produced by B cells 
in the alveoli is IgG, of which subtypes IgG1 and IgG2 are predominant (Nicod, 2005). 
2.11 Functional immaturity of the infant immune system 
Despite the respiratory immune defence mechanisms, the immune system of infants is 
functionally immature, compared to that of older children and adults. Before birth, the uterine 
cavity offers little antigen exposure, due to the sterility of that environment (Palmeira et al., 
2012). Infants are thus initially dependent on their innate immune mechanisms, maternal 
antibodies that were transferred across the placenta from the mother to the baby during 
pregnancy and the protective immune components of breastmilk for protection against 
pathogens (Cáceres et al., 2000; Jackson & Nazar, 2006; PrabhuDas et al., 2011). Some 
aspects of the infants‟ immune systems may be fully functional at birth, but the majority are 
not (Palmeira et al., 2012). 
Neutrophils function as part of the first line of defence during the innate immune response 
and their primary function is to phagocytose and subsequently kill and digest bacterial and 
fungal pathogens through the release of enzymes from cytoplasmic granules (Segal, 2005). 
Fewer neutrophils are present in infants, compared to older children and adults. Furthermore, 
neutrophils of infants respond suboptimally to chemo-attractants when compared to adult 
neutrophils, which means that recruitment of immune cells to sites of infection may be 
inefficient (Palmeira et al., 2012). Macrophages also forms part of the innate immune system 
and circulate as monocytes in the blood. Monocytes are recruited from the blood to tissue 
sites of infection, through chemo-attractants, during illness or cellular damage. At the site of 
tissue damage or infection, monocytes reside as resident macrophages to phagocytose and 
destroy invading pathogens, and clear the body of cells that have undergone normal 
apoptosis (Geissmann et al., 2010). Similar to neutrophils, the monocytes and macrophages 
in infants are also less sensitive to chemo-attractants, even though these cells are reported 
to be fully functional. As part of the innate immune system, infant monocytes generate lower 
levels of IFN-  and IFN- , than those of older children and adults. These two cytokines are 
key components of the regulation of both the innate and adaptive immune responses to viral 
infections through interference with viral entry and replication (Schroder et al., 2004; 
Palmeira et al., 2012).  
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In the cellular branch of the adaptive immune system, T cells are important regulatory cells to 
viruses and other intracellular pathogens and many of their functions are mediated by the 
expression and secretion of cytokines, such as IFN-  and IFN- . T cell populations in 
neonates are predominantly expressing the naïve phenotype and the expression of memory 
T cells only develops as the neonates grow older. As most cytokines are predominantly 
expressed by memory T cells, higher cytokine levels are found in older children compared to 
the infants that mainly express naïve T cells. The development of memory T cells with 
increasing age in the first to the second year of life is demonstrated by an increased 
expression of these effector T cell cytokines, IFN-  and IFN-  (Wiegering et al., 2009). 
Infants are capable of mounting a T cell response to infectious agents, but such responses 
may differ in quality and magnitude compared to adults. Furthermore, CD4+ T cell responses 
take longer to develop upon intracellular viral exposure and infection with CMV and HSV. 
Neonates have also been shown to have a smaller thymus if they were exposed to 
inadequate nutrition in utero. This could delay the development of T cells and affect their 
functioning, further enhancing the immaturity of the immune system in infancy (PrabhuDas et 
al., 2011). 
The humoral branch of the adaptive immune system, composed of B cells and antibodies, is 
also immature in terms of the onset, duration and quantity of the Igs produced in early 
infancy. The Igs are also of a different isotype, where infants have lower levels of IgG2 with 
lower affinities for antigens, compared to the Ig in adults. It has also been found that certain 
defects occur in the formation of the germinal centre in B cells in neonatal humans and mice. 
These defects seem to only resolve when infants are about four months old, which is just 
outside the 2-4 month peak window period for SUDI and SIDS. This is therefore another 
immaturity of the immune systems that leaves infants vulnerable during the SUDI and SIDS 
window period. With repeated exposure to foreign antigens in the infant‟s environment and 
once placental transferred IgG antibodies have declined, B cells start to produce antigen-
specific antibodies. With the maturation of the humoral immune system during late infancy, 
and as a result of repeated antigen stimulation, the infant‟s Ig levels begin to rise (Wiegering 
et al., 2009; Palmeira et al., 2012 ).  
2.12 The vulnerable period in infancy and SIDS peak 
Immaturities of the innate immune system, that direct functioning of adaptive immune 
responses, leave infants vulnerable in their first year of life, characterised by a greater 
susceptibility to developing infections (Palmeira et al., 2012; Reikie et al., 2012). Exposure to 
cigarette smoke, poor nutrition, a mild viral infection, excessive heat while sleeping in the 
prone position, an immature immune system due to a critical period in development and 
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other medical conditions all pose enough risk factors to fit the triple-risk model for SIDS 
(Filiano JJ & Kinney HC, 1994; Samuels, 2003; Bajanowski et al., 2007; Weber et al., 2010a; 
Weber & Sebire, 2010). According to this model the risk for SUDI is the highest when an 
underlying vulnerability in homeostatic control and an exogenous stressor coincide at a 
critical developmental period. One of the most likely environmental or exogenous triggers is 
viral infections and some of the proposed underlying vulnerabilities are immune deficiencies 
and poor control of over expression of inflammatory mediators (Samuels, 2003; Opdal & 
Rognum, 2004; Bajanowski et al., 2007; Weber et al., 2010a; Weber & Sebire, 2010). In 
addition, this critical developmental period could also coincide with the loss of protection of 
maternally derived antibodies (Balduzzi & Greendyke, 1966; du Toit-Prinsloo et al., 2011). 
While the immune system of the infant takes time to mature, a degree of humoral immune 
protection would have been provided from placental transfer of IgG from the mother during 
pregnancy (Cáceres et al., 2000). Mothers infected with HIV (Farquhar et al., 2005; Reikie et 
al., 2013) or with vaccine-induced immunity (Zhao et al., 2010) transfer lower levels of 
maternal IgG antibodies for specific vaccine preventable infections to their infants. 
Furthermore immune protection from placental transfer of IgG is short-lived and confers only 
limited protection against pathogens (Staines et al., 2010). Maternally derived IgG levels 
decrease as infants grow older. The decline in levels occur rapidly within the first six weeks 
after birth and markedly decline by six months, at which stage the maternal IgG would no 
longer offer protection. The maternally derived IgG levels become negligible as early as nine 
months of age, but usually towards 12 months, by which time infants are solely reliant on 
their own immature immune system for protection against pathogens (Gans et al., 1998; 
Nicoara et al., 1999; Thaithumyanon et al., 2000; Gans et al., 2004; Tapia et al., 2005). Since 
SIDS is documented to be higher in the 2-4 month age group, this could represent a critical 
developmental period that coincide with a loss of immune protection due to waning 
maternally-derived antibodies (Balduzzi & Greendyke, 1966; du Toit-Prinsloo et al., 2011). 
Human breastmilk provides nutrition to infants and contains immune system components 
protective against infections. It also contains large quantities of secretory IgA specific to 
infectious agents that the mother was exposed to, which can neutralise pathogens and 
prevent pathogen attachment to cells in the infant hosts. Other factors in breastmilk, such as 
lysozyme and lactoferrin, can limit microbial growth by disrupting bacterial cell walls and 
removing iron, which is essential for bacterial survival (Jackson & Nazar, 2006). IgM and IgG 
antibodies are also present, but at lower levels than to IgA. Breastmilk also contains 
cytokines, macrophages, neutrophils, T and B cells, offering cell-mediated immune protection 
in infancy (Jackson & Nazar, 2006; Chirico et al., 2008). 
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Due to the functionally immature immune system infants may respond differently to 
infections, compared to adults and older children, which can complicate diagnosis of 
infections. Signs of clinical progression of illness may not be so prominent during an 
examination of the clinical history of a suspected SUDI case (Dempers et al., 2011). All 
infants start off with a functionally immature immune system and can therefore not be 
regarded as an independent risk factor, because not all infants are predisposed to SIDS. Yet, 
the suggestion that certain clinical symptoms may be missed in some infants may be what 
sets healthy infants apart from those predisposed to SUDI, especially when a subset of 
infants have additional exposure to external modifiable risk factors. In these instances, and in 
line with the triple-risk model, the functionally immature immune system could play a 
contributory role by increasing infant vulnerability. 
2.13 Inflammation and possible contribution to infant demise 
The frequency of sudden unexpected death, although considered the predominant cause of 
death within the first year of life, declines drastically after the age of one year (Côté, 2010). 
By the ages of one to two years, when unexpected death in infants and children are rare, the 
majority of the immune responses and mechanisms have matured and are fully functional. 
Because sudden unexpected childhood deaths (SUCD) are rare after two years, it supports 
the theory that the immature immune system in infants may play a significant contributory 
role in SUDI and SIDS. 
It is important to thoroughly investigate all SUDI cases, because this can explain the cause of 
death in a noteworthy proportion of cases. The most common findings include infections, and 
to a lesser extent congenital abnormalities, such as metabolic disorders and cardiovascular 
diseases. A review of SUDI literature from 1966-2009 showed that 51% of the explained 
deaths were due to infections, followed by congenital malformations and unintentional 
injuries (Nicod, 2005; Côté, 2010). For the diagnosis of SIDS, specific criteria have to be met 
and most importantly, thorough investigations should not yield a cause of death, even though 
some cases may not display the typical pattern of SIDS (Blair et al., 2012). 
To establish a definite cause of death in SUDI cases can be quite challenging when only 
minor pathological signs are present and the boundaries between normal pathology and a 
subtle disease state can be indistinguishable. A positive virology test result from a SUDI case 
without histological evidence of inflammation becomes very difficult to interpret (Weber et al., 
2010a). The mere presence of viral pathogens in lung tissue from SUDI cases does not 
necessarily mean that it was the cause of death and other factors must also be considered in 
the final diagnosis. The significance of isolating potential pathogens from sites of the body 
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that are normally considered sterile also remains debatable, especially in the absence of 
immunopathology and inflammation. This was demonstrated by Krous et al. (2009), where 
cardiac inflammatory infiltrates had been detected from both SUDI and control cases. The 
mean numbers of necrotic cardiomyocytes and inflammatory infiltrates, including 
lymphocytes and macrophages, were found to be similar in 24 SUDI cases and 25 infants 
that suffocated. This questions whether such findings should not actually rather be 
considered normal autopsy findings in many infant deaths. The study also included a third 
group of four infants that died of myocarditis. Krous et al. (2009) argued that histological 
evidence of severe myocardial inflammation can easily be attributed to myocarditis, but at the 
other end of the spectrum when very mild myocardial inflammation is detected, the 
significance of the possible contribution to death remains questionable. The degree of 
myocardial inflammation, cellular necrosis and viral load that can be severe enough to cause 
death in infants, or be sufficient for a diagnosis attributable to viral infections, must still be 
determined. Krous et al. (2009) does not regard the presence of a small number of scattered 
inflammatory cells, in the absence of pathogenic agents, as significant to be lethal. Similarly, 
the absence of HAdV and human enterovirus which they were screening for from cases with 
evidence of lymphocytic infiltration into the myocardium did not necessarily mean that viral 
aetiology could completely be excluded, because other unrecognised or undetected viruses 
might have been involved. Present knowledge on the interaction between viruses and the 
immune system in the myocardium is restricted to experimental mouse models and require 
further investigation.  
Krous et al. (2003) found similar lymphocytic infiltration in the LRT (bronchi, bronchioles and 
the pulmonary interstitium) in SIDS and control cases (inflicted injuries, accidents, 
infanticides) in California from 1991 to 2000. In the URT (proximal and distal trachea) 
lymphocytic infiltration was significantly more severe in the control cases compared to SIDS 
cases. In their study histology signs of URT pathology observed were similar in SIDS and 
control cases (39% and 40% respectively). They concluded that microscopic signs of 
inflammation in SIDS are not necessarily lethal and can therefore not be a marker to indicate 
lethal infections. Clinically, bronchiolitis and pneumonitis severe enough to be lethal is 
normally preceded by clinical signs of illness including apnoea, lethargy, feeding difficulties 
and respiratory distress (Krous et al., 2003). 
Recent studies suggest the possibility of SUDI infants having primary immune abnormalities. 
This is in parallel with the hypothesis that infants succumbing to SUDI could have inherent 
vulnerabilities (Krous et al., 2009; Weber & Sebire, 2010). Primary immunodeficiencies from 
defects in the cellular and humoral immune response systems can lead to increased 
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susceptibility to infections. Examples of primary immunodeficiencies include X-Linked 
agammaglobulinaemia where B cell maturation is impaired and Ig production is reduced and 
Zap-70 deficiency where the concentration of CD8+ T cells is reduced and the CD4+ T cells 
are non-functional. Primary immunodeficiencies can lead to recurrent viral infections, and in 
the case of severe combined immunodeficiencies, the outcome may be fatal unless bone 
marrow transplantation occurs (Lim & Elenitoba-Johnson 2003). 
Defective control of inflammation, due to an underlying vulnerability in the host has been 
proposed as a relevant component in a subset of SUDI cases (Blood-Siegfried, 2000; 
Staines et al., 2010). The primary function of the immune system is to provide the host with a 
defence mechanism against infections, such as viral respiratory pathogens. The functions of 
a tightly regulated inflammatory response to infections include the migration of immune cells 
to the site of infection to prevent further pathogen replication, the creation of a barrier which 
can prevent the spreading of the invading pathogens and lastly the stimulation of stimulate 
tissue repair (Gotsch et al., 2007). 
The immune response to respiratory viruses often induces pro-inflammatory mediators. Due 
to the changes in cytokine levels favouring an exaggerated immune response, it has been 
proposed that the fatal outcome in SUDI cases may not necessarily be specific to a certain 
type of infection or pathogen, but may instead be a result of a failure in the immuno-
regulatory mechanisms in the infants. It was further suggested that a seemingly insignificant 
infection could trigger an inflammatory response exaggerated beyond normal, especially at a 
developmental stage when infants are less able to control such a response, which may lead 
to septic shock and the demise of such infants (Blood-Siegfried, 2000; Staines et al., 2010). 
Inflammation can also lead to the obstruction of bronchioles which can impair breathing and 
often, especially in the case of RSV infection, an exaggerated immune response occurs 
(Gotsch et al., 2007; Openshaw, 2005). One of the main anti-inflammatory cytokines is IL-10, 
which is considered an inhibitory cytokine that can dampen exaggerated inflammatory 
responses. A significantly lower IL-10 production was found in infants than in adults. Infants 
may thus be less able to compensate for inflammatory responses and may be more 
susceptible to the damaging effects that pro-inflammatory cytokines exert on organs in the 
host during infections (Schultz et al., 2004). Mutations that cause lower expression of anti-
inflammatory cytokines have been detected in some SUDI cases, together with increased 
pro-inflammatory cytokines, such as IL-6 and TNF-  (Staines et al., 2010). During the course 
of infection the levels of pro-inflammatory cytokines, such as IL-1, IL-6, TNF-  and IFN- , are 
increased. IL-1 has been shown to induce drowsiness and sleep apnoea, a possible 
mechanism contributing to SUDI in both humans and animals. Surprisingly, despite a 
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functionally immature immune system early in infancy, the production of pro-inflammatory 
cytokines can be detected from very early in life. The pro-inflammatory cytokine IL-6 is 
considered a marker for inflammation and tissue damage. It is the principal cytokine secreted 
during the acute-phase inflammatory responses to damage in tissues. This cytokine has 
been found in high levels in SUDI cases and infants who died of bacterial sepsis (Blood-
Siegfried, 2000; Gotsch et al., 2007), which highlights the similarities between SUDI cases 
and deaths due to infections and supports a possible contributory role of infections and the 
subsequent immune response to such infections in SUDI. 
Even though it is agreed that SIDS is a diagnosis by exclusion after a thorough medico-legal 
investigation and autopsy, a range of pathologic features have been found in such cases. 
Mild abnormalities that are categorised as non-specific findings include petechiae in the 
thymus, lungs and heart, congestion of the small veins and capillaries and intra-alveolar 
haemorrhage. These findings are considered non-specific because such minor microscopic 
discoveries cannot be considered to significantly contribute to or sufficiently explain the 
demise of the infant (Weber et al., 2008a). Other observed pathologic features include signs 
of mild inflammation, especially in the respiratory tract with increased IgG and IgM 
concentrations and T and B cell numbers in the lungs, which support the hypothesis of a 
prior respiratory tract infection possibly contributing to SUDI (Blood-Siegfried, 2000). 
2.14 Validity of positive bacterial findings in sudden infant death cases 
Prior to death, the internal organs of the body are considered sterile, but post-mortem, when 
the host‟s immune system ceases to function, epithelial barriers lose their integrity and 
bacteria migrate (Tuomisto et al., 2013). Some of the positive bacterial isolates that have 
been detected from SIDS cases include Staphylococcus species, Escherichia coli, 
Streptococcus species, Haemophilus influenza, Klebsiella species and Neisseria meningitidis 
(Rambaud et al., 1999; Weber et al., 2008b; Lobmaier et al., 2009; Pryce et al., 2011). 
It has been suggested that positive bacterial results obtained from autopsy samples can be 
acquired in four different ways with the first as a result of a true positive bacterial event, the 
second being agonal spreading of bacteria, the third being post-mortem migration and the 
fourth being contamination (Tuomisto et al., 2013). Firstly, a true positive event is defined 
when there is pure growth of a single species. It is suggested that such a species, if present 
during life, can therefore also be detected at death (Tuomisto et al., 2013). Periods of 
bacteraemia can often occur in life in the absence of any signs of damage and inflammation, 
but when the isolated species is a pure growth of a recognised pathogen (e.g. 
Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, Candida albicans, 
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Listeria monocytogenes, Neisseria meningitidis, Neisseria gonorrhoea, Haemophilus 
influenza and Cryptococcus neoformans, Enterobacter species, Enterococcus species, 
Klebsiella species, Proteus species, Salmonella species, Serratia marcescens, 
Streptococcus pneumonia, Streptococcus pyogenes, Streptococcus agalactiae, group A 
beta-haemolytic streptococcus and group B beta-haemolytic streptococcus), its presence at 
death should be seen as a contributory factor. More significance may be placed on a positive 
autopsy result if it can be corroborated with histological signs of disease (Morris et al., 2006). 
Secondly, agonal spreading of bacteria is hypothesised to occur during dying and 
resuscitation attempts when mucosal integrity is compromised under ischaemic and hypoxic 
stress (Morris et al., 2006; Tuomisto et al., 2013). Such positive results comprising of mixed 
growth of commensals and potential pathogens would not be considered a cause of death, 
but rather a consequence of it (Morris et al., 2006). Whether agonal spread is a true 
phenomenon is still uncertain and no evidence has yet shown that it occurs in practise 
(Morris et al., 2006; Tuomisto et al., 2013). Thirdly, post-mortem migration or translocation of 
bacteria occurs when species migrate into the blood from the gut after circulation has 
ceased. This occurs during the normal process of putrefaction (Tuomisto et al., 2013). In a 
review Morris et al. (2006) suggested that post-mortem translocation may be a rare event, 
especially when samples are collected soon after death and if bodies are refrigerated prior to 
autopsy. Fourthly, during specimen collection contaminants can be introduced into the 
organs or samples at autopsy from external sources. When mixed species are isolated from 
autopsy findings it generally indicates contamination of the specimens or post-mortem 
migration of species (Tuomisto et al., 2013). Krous et al. (2003) found organisms in 80% of 
SIDS cases and 89% of control cases (unnatural deaths) in California between 1991 and 
2000. Their results were not interpreted as pathogenic because of the high percentage of 
polymicrobial growth suggesting post-mortem contamination. 
In a SUDI systemic retrospective case review study in the UK Weber et al. (2010b) found 
that a PMI of five or more days resulted in a reduction of microorganisms isolated. They 
recommended that microbial sampling should be taken from all SUDI cases, even those with 
a PMI of five or more days. During their study they could not find an increased risk of normal 
bacterial translocation as the PMI increased. Therefore results may still be valid with longer 
PMIs. They also found a significant decrease in the number of positive single bacterial 
cultures and polymicrobial growth isolated from samples taken after a PMI of five or more 
days, compared to those from samples 24 hours after death (Weber et al., 2010b).  
From 33 autopsies performed on out-of-hospital adult male deaths from 2009-2010 in 
Tampere, Finland, liver specimens had a higher sterility rate compared to other sites (portal 
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vein blood and mesenteric lymph node specimens) up until five days post mortem. In 
contrast to Weber et al. (2010b) who did not find an association with an increased PMI and 
mixed or positive isolates after a PMI of five days, Tuomisto et al. (2013) found that both 
single and mixed bacterial isolates from liver specimens increased. 
2.15 Other risk factors for SUDI and SIDS 
Apart from viral infections, other risk factors for SUDI include but are not limited to socio-
demographics, sleeping position and -environment, genetics and the cardiovascular system, 
(Table 2.2) (Athanasakis et al., 2011).  
A poor socioeconomic status is considered a risk factor for SUDI and SIDS. This includes 
multiple social factors, such as resources, financial status, birth weight, parental smoking and 
sleeping position amongst others. These factors may act in combination with a range of other 
co-morbidities throughout life and contribute to morbidity and mortality in infants (Spencer & 
Logan, 2004). Other factors include low level of maternal education, multiple pregnancies, 
male gender, recent infection(s), lack of breastfeeding, and not using a pacifier (Byard & 
Krous, 2003; Samuels, 2003; Hunt, 2005; Vennemann et al., 2007; Highet, 2008; Adams et 
al., 2009; Weber et al., 2010a; Athanasakis et al., 2011; Blair et al., 2012).  
Poor antenatal care and substance abuse affect foetal development and growth, increasing 
the risk of prematurity and low birth weight, which are known risk factors for SUDI. After birth 
the sleep environment plays a crucial role in SUDI, where bed-sharing, heavy comforters, 
soft bedding, covering of the infant‟s head, wedging between objects, warm room 
temperatures, induction of sweating and fever, parental smoke in the sleeping environment 
and sleeping in the prone position, have all been identified as risk factors (Athanasakis et al., 
2011). The prone position has been suggested to increase the temperature in the nose, 
especially during viral infections, which could facilitate bacterial colonisation and toxin 
production (Blood-Siegfried, 2000). Cigarette smoke can enhance the susceptibility to viral 
infections and in animal models it enhances the lethality of toxins produced by bacteria 
(Blood-Siegfried, 2000).  
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Table 2.2: A few well-established risk factors for sudden infant death cases 
Risk factors References 
Male gender Bergman et al., 1972; Patrick et al., 1989; An et al., 1993; 
Vennemann et al., 2005; Vennemann et al., 2007; Brookfield et al., 
2011; du Toit-Prinsloo et al., 2011; Hutchison, et al., 2011; 
Trachtenberg et al., 2012; du Toit-Prinsloo et al., 2013 
Cold months of the year Bergman et al., 1972; An et al., 1993; Nunes et al,. 2001; 
Vennemann et al., 2005; du Toit-Prinsloo et al., 2011; du Toit-
Prinsloo et al., 2013 
Maternal and/or paternal 
smoking 
Nunes et al., 2001; Vennemann et al., 2005; Vennemann et al., 
2007; Ostfeld, et al., 2010; Brookfield et al., 2011 
Non-supine sleeping 
position 
Nunes et al., 2001; Paterson et al., 2006; Vennemann et al., 2007; 
Ostfeld, et al., 2010 Hutchison, et al., 2011; Trachtenberg et al., 
2012 
Bed-sharing Hutchison, et al., 2011; 
Age peak near the two-four 
month period 
Balduzzi & Greendyke, 1966; Bergman et al., 1972; Nunes et al., 
2001; Vennemann et al., 2005; du Toit-Prinsloo et al., 2011; 
Hutchison, et al., 2011; Trachtenberg et al., 2012; du Toit-Prinsloo 
et al., 2013 
 
Avoidance of specific risk factors, such as sleeping prone and exposure to cigarette smoke, 
resulted in a drastic decrease in the prevalence of SUDI, especially after the launch of the 
Back-to-Sleep campaign in 1994 (Willinger et al., 1994; Trachtenberg et al., 2012). 
Ultimately, SUDI is most likely the culmination of a variety of risk factors, mechanisms and 
pathophysiological responses (Byard & Krous, 2003; Randall et al., 2009).  
Table 2.2 highlights certain factors that regularly occur in SUDI and SIDS cases. Some of 
these factors are considered risks, despite the lack of comparison to age-matched control 
infants dying of known causes. Risk factors were included if it was present in more than half 
of the SUDI cases in these studies, irrespective of the population size or a suitable control 
group. If a control group was present, then the risk factors were included if the difference 
between the cases and controls were statistically significant, or much more prevalent. Most 
of these risk factors are well established in the literature (Nunes et al., 2001; Athanasakis et 
al., 2011). 
SUDI cases with none or one risk factor in isolation were found to be extremely rare (0.8%-
18%) in a population-based New Jersey study from 1996-2000. The majority of cases 
(78.3%) displayed between two and up to seven risk factors (Ostfeld, et al., 2010). 
Therefore, SUDI rarely occurs in the presence of risk factors that are generally not 
considered life-threatening, but rather require multiple risk factors to create the sequence of 
events that could lead to SUDI. 
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2.16 Developmental and genetic disorders 
Another leading hypothesis is that a developmental disorder of the brainstem may lead to 
impaired protective responses against life-threatening stressors while an infant is asleep, 
such as asphyxia, hypercarbia and hypoxia, including epileptic-seizure-induced hypoxaemia 
(Samuels, 2003; Randall et al., 2009). Proposed genetic risk factors include polymorphisms 
in the serotonin transporter (Hunt, 2005; Athanasakis et al., 2011) or immunoregulatory 
genes (Highet, 2008). Kinney et al. (2003) investigated serotonergic receptor binding and 
found that tritiated-lysergic acid diethylamide binding to 5-hydroxytryptamine (5-HT) 
receptors was significantly lower in SIDS cases compared to infants who died suddenly but 
in whom a cause of death was revealed after the autopsy. Paterson et al. (2006) used frozen 
medulla oblongata specimens from SIDS and control cases between 1997 and 2005 in 
California to investigate the 5-HT serotonergic neurons, which are involved with regulation of 
autonomic and respiratory systems. These neurons are situated in the brain stem and spinal 
cord and are responsible for regulation of homeostasis during sleep. Abnormal 5-HT receptor 
binding has previously been demonstrated in a subset of SIDS and it has been suggested 
that such abnormalities may be associated with SIDS through a failure to respond to 
homeostatic stressors while sleeping. Abnormalities included higher 5-HT neuron count and 
density in SIDS cases and a lower density in 5-HT binding sites. In addition, a significantly 
lower density in 5-HT binding sites were observed in male SIDS cases compared to female 
SIDS cases, which could contribute to the male predominance in SIDS cases. They 
concluded that some SIDS cases may thus have dysfunctions in their neuron firing, 
synthesis, release and also clearance of 5-HT, which can influence autonomic and 
respiratory responses (Paterson et al., 2006). They found that 87% of the SIDS cases had 5-
HT abnormalities and an exogenous stressor such as prone sleeping and bed-sharing. In 
another study in California between 2004 and 2008, SIDS cases had lower levels of 
serotonin and also confirmed reduced 5-HT receptor binding in SIDS cases compared to 
controls (Jhodie et al., 2010). In a Norwegian study between 1984 and 2007 SIDS cases had 
significantly higher expression of the IL-6 Receptor (IL-6R) compared to control cases 
(Rognum et al., 2009). The IL-6R is expressed by 5-HT neurons in the arcuate nucleus, 
which is where neurons aggregate in the hypothalamus. The SIDS group also had slightly 
elevated levels of IL-6 in the CSF compared to the control group. Rognum et al. (2009) 
showed a potential link between the 5-HT medullary system and cytokines. They concluded 
that possible interactions between IL-6 and the 5-HT medullary system could play a 
contributory role in impaired homeostatic responses towards hypercapnoea induced by 
infections or sleeping in the prone position in some SIDS cases. In support of the “triple-risk 
model” (Filiano & Kinney, 1994), Paterson et al. (2006), Rognum et al. (2009) and Jhodie et 
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al. (2010) showed links between external stressor risk factors, 5-HT abnormalities of the 
brain and the immune system. 
Ackerman et al. (2001) found mutations in the sodium channel gene (SCN5A) in 2% of the 
SIDS cases from 1997-1999 in Arkansas, USA. Both mutations detected in this gene cause a 
persistent inward sodium current similar to defects reported in patients with the long QT 
syndrome (LQTS), leading to increased cardiac events. URTIs could act as potential triggers 
that are typically characterised by manifestations that include irritation of the receptors in the 
URT, which can lead to apnoea or arrhythmia in infants with predisposing respiratory or 
cardiac malfunctions, such as malignant arrhythmia from LQTS (Vorontsov & Kelmanson, 
1990; Samuels, 2003). A cardiac channelopathy such as the LQTS may lead to lethal 
ventricular arrhythmias that affect both the rhythm and rate of the heartbeats (Schwartz et al., 
1998). Other cardiac channelopathies such as Brugada syndrome and catecholaminergic 
polymorphic ventricular tachycardia have also been observed in SIDS and could lead to 
sudden cardiac death (Van Norstrand & Ackerman, 2010). In addition, certain inborn 
metabolic errors have also been identified as risk factors for some SIDS cases, more 
specifically the deficiency in the medium-chain acyl coenzyme A dehydrogenase has been 
found in SIDS (Van Norstrand & Ackerman, 2010). 
2.17 Aims and objectives 
All SUDI cases in the Tygerberg FPS area, South Africa, are admitted to the Tygerberg FPS 
Mortuary and investigated according to the Inquests Act 58 of 1959. All the SUDI cases are 
subsequently screened for HAdV, CMV, RSV, influenza A and B, HPIV 1, 2 and 3 and HMPV 
as the standard procedure in an effort to identify the possible cause of death, but exploring 
alternative methods that will improve the accuracy of diagnosis and include a broader range 
of viruses seem justified.  
The specific aims and objectives of this study were: 
 To prospectively collect tracheal and lung swabs from SUDI cases through the Division of 
Forensic Pathology, Tygerberg FPS Mortuary, to assess respiratory tract pathology.  
 To collect SUDI cases presenting at Tygerberg FPS Mortuary and include one full year to 
assess possible seasonal peak incidences of SUDI and SIDS cases 
 To use the Seeplex® RV15 Ace detection PCR to establish the frequency of 13 RNA 
respiratory viruses (influenza A & B, HPIV 1-4, HCoV [OC43, 229E/NL63], HRV A/B/C, 
RSV A/B, human enterovirus and HMPV) from extracted RNA samples collected during 
the autopsy performed on SUDI cases 
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 To compare viruses detected with lung histology signs of infection 
 To collect demographic data to investigate possible risk factors for SUDI 
 To determine the viruses circulating in living hospital infants at Tygerberg, during the 
study period. 
Stellenbosch University  http://scholar.sun.ac.za
41 
 
CHAPTER THREE 
MATERIALS AND METHODS  
CHAPTER CONTENTS 
3.1  Study approach and design  
3.2  Ethical considerations 
3.3  Study population demographics 
3.4  Sample collection and processing 
3.5  Routine NHLS sample collection and processing 
3.5.1 Routine heart blood sample collection 
3.5.1.1  Routine heart blood sample testing (HIV) 
3.5.1.2  Routine heart blood sample testing (Chemistry) 
3.5.2  Routine swab autopsy sample collection 
3.5.2.1  Routine swab autopsy sample testing 
3.5.3  Routine lung and liver autopsy sample collection 
3.5.3.1  Tissue (lung and liver) autopsy sample testing 
3.6  Sample collection and storage for virological studies 
3.6.1  Tracheal swab sample collection 
3.6.2  Lung sample collection 
3.6.2.1  Histology of lung tissue sections 
3.6.2.2  Lung swab sample collection 
3.6.3  Lung and tracheal swab sample storage 
3.7  Histology preparation and analysis process 
3.7.1  Embedment (wax block preparations) 
3.7.2  Haematoxylin and Eosin Staining 
3.7.3  Histology analysis 
3.8  RNA extraction and complementary DNA synthesis for virological studies 
3.9  Multiplex polymerase chain reaction for virological studies 
3.10  Validation of the extraction and multiplex Seeplex® RV15 Ace Detection Assay 
3.11  Validity and interpretation of results 
3.12  Reviewing of case files and collection of routine laboratory results 
3.13  Data mining to collect virology results from hospitalised infants at Tygerberg 
3.14  Statistical analysis 
Stellenbosch University  http://scholar.sun.ac.za
42 
 
3.1 Study approach and design 
This was a prospective descriptive study designed at profiling respiratory viruses from cases 
presented as SUDI at Tygerberg FPS Mortuary in the Western Cape. Autopsy samples were 
collected from SUDI cases over a one year period from May 2012 to May 2013 and included 
four consecutive seasons; autumn, winter, spring and summer. The methodology 
subsections to follow consist of the ethical considerations for the study, and detailed 
descriptions of the sample collection, processing and detection methods used to investigate 
respiratory pathogens from SUDI cases collected. 
3.2 Ethical considerations 
The study was approved for one year by the Health Research Ethics Committee of 
Stellenbosch University on 7 March 2012 (protocol number N12/02/007) and renewed for a 
second year on 25 March 2013 (Addendum 1).  
The samples that were collected during the study period did not differ substantially from the 
current autopsy protocol used for SUDI investigations at Tygerberg FPS Mortuary. Therefore, 
a waiver of consent was granted for collection and subsequent laboratory testing of 
specimens. As the tissue was retained and tested with the aim of reporting the results to the 
Division of Forensic Pathology to assist in the process of determining the cause of death, 
consent was provided for by section 3(a) of the Inquests Act (58 of 1959) and the Criminal 
Procedure Acts (1977). The tests conducted on these specimens only included methods for 
testing for respiratory pathogens. All specimens were marked with the death register number 
only. No personal identifiers were available to laboratory personnel or the research team. 
The identity of the deceased and the link to the specimen was protected by a liaison officer in 
the Division of Forensic Pathology (Mrs Riley), as was the case with the routine specimens 
sent to the virology and microbiology laboratories. 
3.3 Study population demographics 
During the one year study period samples from 148 SUDI cases were collected from the 
Tygerberg Forensic Mortuary. All these cases were included in the study, provided that they 
were between the ages of at least three days and one year. All the cases that initially 
presented as SUDI, but were subsequently classified by the pathologists as unnatural 
causes of death, such as child abuse, homicide and poisoning either during the autopsy 
procedures or after further histological examinations of relevant organs and ancillary 
investigations, were excluded from the study. All known natural causes of infant death, where 
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life-threatening disease was noted by physicians prior to death, or where it included 
hospitalisation of the infants prior to the day of death, were also excluded from the study. 
Seasonal distribution of SUDI cases was based on a publication by Hussey et al. (1997) 
where the seasons in Cape Town were classified as follows: winter (June to August), spring 
(September to November), summer (December to February) and autumn (March to May). 
Eighty-nine (60.1%) of the cases were male and 59 (39.9%) female. Tracheal and lung 
swabs were collected from every SUDI case except the first case, where only tracheal swabs 
were collected.  
3.4 Sample collection and processing 
This section describes the type of autopsy specimens that were collected from SUDI cases 
both as part of routine mandatory microbiological and virological testing by the NHLS, 
Tygerberg Hospital, and those for additional viral investigations for this study. All specimens 
collected were labelled with the unique Western Cape (WC) Tygerberg (14) case number 
starting at 0000, followed by the year (e.g. WC14/0000/2012). 
3.5 Routine NHLS sample collection and processing 
To begin the autopsy a Y-shaped incision was made by a forensic pathologist or forensic 
pathology officer (FPO) assisting with the body dissection. Two incisions started behind the 
ears and met at the top of the sternum. The cut was then extended all the way down to the 
pubic bone. Next, the sternum and ribs were cut open to lift out the chest plate and expose 
the chest cavity. 
3.5.1 Routine heart blood sample collection 
For routine blood sampling, the pericardial sac was first opened. Thereafter the apex of the 
heart was partially lifted out of the chest cavity, using clean forceps so that blood could be 
drawn from the base of the heart at the right atrium and inferior vena cava. Blood was drawn 
using a 5 ml sterile syringe capped with a 15 gauge (g) needle into a red top chemistry glass 
tube. The blood tubes were sent with request forms for HIV testing or chemistry analysis to 
the NHLS laboratories at Tygerberg Hospital, depending on the pathologists‟ requests and 
the conditions surrounding the infant‟s death. 
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3.5.1.1 Routine heart blood sample testing (HIV) 
The majority of the HIV testing from the SUDI blood specimens was performed by a rapid 
third generation VISITECT® HIV1/2 test (Omega Diagnostics, UK; Davies Diagnostics (Pty) 
Ltd, Gauteng, South Africa) which is a point-of-care, qualitative immunoassay for the 
detection of antibodies to HIV-1/2 from human whole blood (specificity = 99.6% and 
sensitivity = 100%). Although this test is designed for non-haemolysed specimens free of 
contaminants, virtually all the autopsy blood specimens were notably haemolysed with 
platelet formation, but no other test was available at this centre. The test device consists of a 
membrane containing HIV-1/2 specific recombinant antigens and rabbit IgG. On the Test 
Line of the device are HIV-1/2 specific recombinant antigens and on the Control Line are 
goat anti-rabbit IgG. When serum and buffer are dispensed into the device, the HIV-1/2 
specific antigens form complexes with HIV antibodies in samples that are positive for HIV. 
This complex then travels down the membrane to the Test Line where the HIV-1/2 specific 
recombinant antigens are coated on the membrane causing the sample-HIV-1/2 specific 
antigen complexes to immobilise. A pink line can then be visualised at the Test Line. The 
rabbit IgG continues moving down the membrane to the Control Line, where it becomes 
immobilised by the goat anti-rabbit IgG coated onto the membrane at this region (Figure 3.1). 
Testing of the blood specimens were performed by the routine Medical Virology NHLS 
laboratory, Tygerberg Hospital. 
The process of the rapid third generation VISITECT® HIV-1/2 test was as follows: A drop 
(50 μl) of serum was dispensed into the sample well using a disposable plastic dropper 
supplied by the kit. Five drops of the diluent buffer was dispensed into the buffer well. After a 
15-30 minute incubation period the results were read. Negative tests showed only the pink 
line represented by the validation positive control at the Control Line, whereas a positive test 
result for HIV-1/2 showed the pink line represented by the positive control at the Control Line, 
including a second pink line by the Test Line (Figure 3.1). If the positive control line did not 
appear, the tests would have been regarded as invalid and repeated. 
If the blood was not severely haemolysed, as was the case with only a few of the specimens, 
an automated fourth generation HIV-1/2 Ag/Ab Combo (Alere DetermineTM, Japan; Abbott 
Molecular, Roodepoort, South Africa) test was performed on the AXSYM™ system (Abbott 
Laboratories, USA). The test is a microparticle enzyme immunoassay test for detection of 
antigen and antibodies to HIV-1 and HIV-2 (specificity = > 99% and sensitivity = 100%).  
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Figure 3.1: Examples of a positive and negative VISITECT
®
 HIV1/2 tests from three SUDI cases 
collected in 2013 
A: a test showing a line at the Control Line the farthest down the membrane and another line is 
present at the Test Line, closer to the sample well, indicating an HIV positive test result, confirming 
HIV1/2 specific antibodies in the test serum.  
B: two negative tests showing a red line each only at the Control Line. 
3.5.1.2 Routine heart blood sample testing (Chemistry) 
The chemistry analysis included detecting and reporting of urea and creatinine levels in the 
serum on an automated platform using the ADVIA® SIEMENS 1800 Clinical Chemistry 
system (Siemens Healthcare, Germany). Urea was measured using the ADVIA® Urea 
Nitrogen protocol based on the Roch-Ramel enzymatic reaction, using urease and glutamate 
dehydrogenase. Creatinine was measured using the Creatinine_2 method based on the 
reaction of picric acid with creatinine in an alkaline medium. The serum urea and creatinine 
tests are used for clinical investigation and diagnosis of metabolic and biochemical disorders, 
such as kidney and renal failure or dehydration. Unlike many chemical substances that are 
altered during post-mortem autolysis, both urea and creatinine levels are relatively stable up 
until about four days post-mortem, which makes the diagnosis of nitrogen retention possible. 
The testing of urea and creatinine were performed by the routine Chemical Pathology NHLS 
laboratory, Tygerberg Hospital. 
3.5.2 Routine swab autopsy sample collections 
For the heart swab collection at autopsy the surface of the heart was scorched with a red hot 
spatula heated in a direct flame. This was to avoid the subsequent culture of post-mortem 
flora or contaminants, and an incision was made into the organ with a sterile surgical blade. 
The swab specimen was then taken from the incision in the heart. The same process was 
followed for the lower lobes of both lungs. Request forms were completed for the routine 
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swab samples and sent to the routine Medical Microbiology NHLS laboratory, Tygerberg 
Hospital, for routine microbiological culture.  
3.5.2.1 Routine swab autopsy sample testing 
The media used for routine bacterial culture was prepared at the Media laboratory, NHLS, 
Green Point, South Africa, before transportation to Tygerberg Hospital. The Quality Control 
(QC) department, Media laboratory, NHLS, Green Point tested all the prepared media on a 
daily basis and the test results were verified by the QC department. The routine QC 
procedure includes viewing prepared media for contaminants or precipitation, confirming the 
appropriate volume and distribution of agar and the pH and colour of the media. Agar plates 
are then inoculated with American Type Culture Collection (ATCC) bacterial strains to 
identify lactose fermentation, haemolysis and antibiotic sensitivity. The media is then 
transported to the Medical Microbiology NHLS laboratory at Tygerberg Hospital.  
For this study, the material on each SUDI swab specimen was spread across a 4% blood 
agar plate, a MacConkey agar plate and a Chocolate agar plate permitting clinically relevant 
growth of Gram-positive, Gram-negative and non-selective bacteria respectively (MERCK, 
Germany). This was followed by an 18-24 hour incubation period at 35°C in the presence of 
carbon dioxide (CO2). 
3.5.3 Routine lung and liver autopsy sample collection 
For routine virological centrifugation-enhanced SVC a 5x5 mm section of the margin of the 
left lower lobe of the lung was placed in a red top chemistry tube using a clean forceps and a 
sterile blade. A small piece from the margin of the left lower lobe of the liver was placed in a 
separate red top chemistry tube. The specimens were transported to the Division of Forensic 
Pathology, where 1 ml of viral transport media (VTM) (Highveld Biological (Pty) Ltd, Gauteng, 
South Africa) was added to the tubes. The routine laboratory request forms were completed 
and the specimens were sent to the Division of Medical Virology, for routine SANAS (South 
African National Accreditation System) accredited virology SVC.  
3.5.3.1 Tissue (lung and liver) routine autopsy sample testing 
A Respiratory Panel 1 Viral Screening and Identification Kit (Light DiagnosticsTM Millipore, 
United Kingdom; Davies Diagnostics (Pty) Ltd, Gauteng, South Africa) was used for SVC of 
the lung tissue samples. It is an indirect immunofluorescence assay for detecting HAdV, 
influenza A and B, HPIV 1-3 and RSV in addition to CMV and HMPV. The liver samples were 
screened for CMV and HAdV. CMV was cultured on human fibroblasts (HF). HAdV was also 
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cultured on HFs and in a separate flask on a combination (combi) of Hep-2 and MDCK cells. 
The Hep-2/MDCK combi was also used to simultaneously culture the viruses included in the 
Respiratory Panel 1 Viral Screening and Identification Kit in addition to HMPV. 
3.6 Sample collection and storage for virological studies 
3.6.1 Tracheal swab sample collection 
The neck tissue was dissected by the pathologist or the assisting FPO to expose the trachea. 
An incision was then made in the trachea between the sternal notch and the thyroid gland 
using a sterile blade. The trachea was pulled upwards to expose the lumen and a flocked 
swab (FLOQSwabs™, Copan Flock technologies, Italy LasecSA, Cape Town, South Africa) 
was inserted and pushed downwards into the bronchi and rotated several times before 
retrieving the sample. The same process was repeated for a second swab to ensure 
sufficient sample collection from this site. The flocked swabs are designed with a solid plastic 
shaft coated at the end with Nylon® fibres. Unlike cotton swabs, flocked swabs do not have 
an internal core and thus volumes of specimen entrapment are virtually negligible allowing a 
better sample yield. The perpendicular arrangement of the swab fibres allows the sample to 
remain near the surface of the swab, facilitating sample recovery. After tracheal specimen 
collection both flocked swabs were placed in a single 16x100 mm tube containing 2 ml 
universal transport media - room temperature (UTM-RT) and three glass beads (COPAN 
Transystem® Innovating TogetherTM, Italy; LasecSA, Cape Town, South Africa). The UTM-RT 
system is designed to keep viral and bacterial samples stable at room temperature, but once 
the swabs are collected the screw cap tubes should be kept at 2-8°C during transit. The 
media is isotonic and contains antimicrobials to inhibit growth of certain bacteria and yeasts. 
The media also contains sucrose which enables the cryopreservation of the specimens 
during prolonged storage at –80°C. The UTM-RT tube was labelled with the case number 
and the type of specimen. Further processing of the UTM-RT tube and swabs required the 
samples to be vortexed to enable maximum sample recovery from the flocked swab, which 
was facilitated by three glass beads in each tube. 
3.6.2 Lung sample collection 
The lower lobes of both lungs were excised using clean scissors and scalpel blades and 
placed in dry plastic screw cap 90 ml specimen containers without any media (Bio-Smart 
Scientific, Cape Town). The containers were labelled with the case number and marked as 
left or right lung. Samples for virological studies were transported to the Division of Forensic 
Pathology on the 6th floor of the Clinical Building at Tygerberg Campus.  
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3.6.2.1 Histology of lung tissue sections 
The lower left and right lung lobes were handled with forceps (CJ Labs, Cape Town, South 
Africa), individually weighed and the information were recorded and sent to the pathologists. 
Next, the lungs were dissected through the middle to obtain a smooth flat interface, using a 
Tissue-Tek® Accu-Edge® trimming knife handle and disposable blades (Sakura Finetek 
Europe B.V., The Netherlands). From each of the lower left and right lung lobe tissue 
samples, a 1-3 mm thick slice was dissected across the broad lung surface and placed into 
separate histology cassettes and submerged in formalin (10% formalin, 90% tap water). The 
cassettes were labelled with the case number, and “2X L” (left lung) or “2Y R” (right lung), 
e.g. WC14/2222/2013, 2XL.  
3.6.2.2 Lung swab sample collection 
After cutting the tissue sections for histology, four flocked swab samples were taken from the 
freshly cut lower left and right lung lobe tissue. The swabs were rotated several times on the 
lung surface to ensure collection of small traces of lung tissue. The two swabs from the left 
lower lung lobes were placed in a single tube containing 2 ml UTM-RT and the same was 
done for the two swabs collected from the lower right lung lobe. The remainder of the lung 
tissue was placed back into the original screw cap tubes and stored at -80°C. 
3.6.3 Lung and tracheal swab sample storage 
The samples for virological studies were transported to a biosafety level 3 (BLS3) laboratory 
with restricted access, at the Division of Medical Virology, where the tissue samples were 
stored at -80°C. The UTM-RT tubes containing the tracheal and lung swabs were vortexed 
for one minute after which the lysate and swabs were divided into microcentrifuge tubes and 
stored at -80°C. 
3.7 Histology preparation and analysis process 
After at least 24 hours of fixation in 10% formalin to ensure tissue and morphology 
preservation, the histology cassettes containing the left and right lower lung lobe sections 
were removed from the formalin. The tissue sections were then manually processed for 
embedment in wax blocks and facing / trimming, cutting and subsequent haematoxylin and 
eosin (H&E) staining performed by Mr André Du Toit, medical technologist at the Division of 
Forensic Pathology.  
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3.7.1 Embedment (wax block preparations) 
The Tissue-TeK® VIPTM 5 Jr. Vacuum Infiltration Processor (Sakura Finetek Europe B.V., The 
Netherlands) was used to prepare the wax blocks. This is an automated tissue processor 
that employs pressure and vacuum cycles to facilitate penetration of the formalin, ethanol 
and xylene into tissue sections. The Tissue-TeK® VIPTM 5 Jr. can contain a maximum of 150 
cassettes and undergoes a series 14 one hour automated solution stations. The process 
starts with 10% formalin (BASF, The chemical company, Germany) and continues with an 
increasing series of ethanol (Illovo, Durban, South Africa) concentrations starting at 70%, 
80%, and 96% and then remaining cycles at an ethanol concentration of 100%. The 
increasing ethanol concentrations prevent precipitation of salts from the formalin and serves 
as a dehydrating solution to remove both water and residual formalin from the tissues in the 
cassettes. The last stations contain xylene (BASF, The Chemical Company, Germany), a 
clearing agent used to allow mixing of the tissue sections with wax, because ethanol and 
water are not soluble in paraffin wax. The Tissue-TeK® TEC embedding console system 
(Sakura Finetek Europe B.V. The Netherlands) was used to create wax blocks of the tissue. 
The Tissue-Tek® Base Moulds were filled with hot Tissue-Tek® paraffin wax (Sakura Finetek 
Europe B.V. The Netherlands). Forceps were used to correctly place the tissue into the hot 
wax in the embedding mould and left to set for 20 minutes. Once hardened, facing was 
performed during which the excess wax was trimmed from the block. This was followed by 
cutting on the Microm HM 335E microtome Rotary (Thermo Fisher Scientific, USA) to acquire 
a 4-5 μm sized tissue section that was placed in a water bath containing tissue adhesive at 
45°C. The water bath keeps the 5 μm tissue sections warm and straightens out any folds, 
after which the sections were mounted on glass microscope slides (Starfrost®, United 
Kingdom). The slides were then placed in an incubator to allow them to dry and facilitate 
attachment of tissue to slide. 
3.7.2 Haematoxylin and Eosin staining 
During the preparation for H&E staining the tissue had to be rehydrated by placing it in 
xylene for three cycles of five minutes each to ensure penetration of the H&E aqueous 
solutions. The slides were then placed in a series of decreasing ethanol concentrations 
starting at 100% then 96% and lastly 70% ethanol for five minutes each. The slides were 
then placed under running tap water to remove the excess ethanol prior to placing it in 
Mayers-Haematoxylin (MERCK, Germany). Haematoxylin is a basic dye that stains the 
nuclei of the cells a dark purple-blue to facilitate visualisation under a light microscope. The 
slides were rinsed again under running tap water and placed in Scott‟s solution, which is a 
blueing agent. Next the slides were placed in eosin (MERCK, Germany), followed by another 
Stellenbosch University  http://scholar.sun.ac.za
50 
 
rinse in running tap water. Eosin is an acidic dye that stains the cell cytoplasm in various 
shades of pink while staining red blood cells an orange-red colour to facilitate visualisation 
and identification. Following this, the slides were placed in increasing concentrations of 
ethanol to dehydrate the tissue again and lastly in xylene. Next, cover slips were mounted 
onto the slides using non-aqueous mounting medium (Personal communication. February 
2013. Mr André Du Toit, Chief Forensic Technologist at the Division of Forensic Pathology). 
3.7.3 Histology analysis 
Histological evaluations were conducted under the supervision of Dr Johan Dempers, the 
Principal Specialist Forensic Pathologist, at the Division of Forensic Pathology, Faculty of 
Medicine and Health Sciences, University of Stellenbosch and the findings were recorded. 
Findings were categorised into the following sections: 
 Oedema 
 Congestion  
 Interstitial Pneumonitis (IP) as defined by Krous et al. (2003): 
Grade 1:  “Very mild (barely present, often focal, and with no overall alteration of the 
alveolar septa)” 
Grade 2:  “Mild (relatively diffuse and mild thickening of alveolar septa)“ 
Grade 3:  “Moderate (diffuse involvement and associated with interstitial oedema)“ 
Grade 4:  “Severe (diffuse infiltration associated with significantly widened alveolar 
septa)” 
 Bronchopneumonia 
 Focal collapse 
 Pigment (iron / formalin) 
 Alveolar debris 
 Alveolar haemorrhage 
 Bronchus associated lymphoid tissue (BALT) 
 Bronchiolitis 
 Comments (any unusual observations) 
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3.8 RNA extraction and complementary DNA synthesis for virological studies 
RNA was extracted for the identification of thirteen respiratory RNA viruses and subtypes 
(Table 3.1). There were only two DNA viruses and because the prevalence of RNA and DNA 
viruses in SUDI and SIDS cases and their contribution are not defined yet, the DNA viruses 
were excluded. There were more RNA viruses in the Seeplex® RV15 Ace detection kit and 
because funds were limited focus was laid on the RNA viruses only. 
RNA was extracted from lung and tracheal swabs using the protocol for the purification of 
total RNA from animal and human cells from the Qiagen® RNeasy Plus Micro kit (Whitehead 
Scientific, Cape Town, South Africa) according the manufacturer‟s instructions. Minor 
modifications were introduced to the protocol to facilitate the swab samples. A negative 
control containing UTM-RT was included with every RNA swab extraction. 
In brief, the process was as follows: To lyse the samples, 350 μl Buffer RLT Plus and 5 μl 
carrier RNA (4 ng/μl) was added to each sample (swab in 200ul UTM). This was transferred 
to a QIAshredder spin column to disrupt and homogenise the sample. After homogenisation 
the lysate was transferred to a genomic DNA Eliminator spin column to remove genomic 
DNA. Then 350 μl of 70% ethanol was added and the lysate was transferred to an RNeasy 
MinElute spin column. Several wash steps were then performed, starting with 700 μl Buffer 
RW1, then 500 μl Buffer RPE and lastly 500 μl 80% ethanol to remove residual 
contaminants. Lastly the purified RNA was eluted twice into the same tube using two 
separate volumes of 14 μl RNase-free water. 
RNA viruses and subtypes are diagnosed using complementary DNA (cDNA), which is more 
stable than RNA. The RNA samples were therefore reverse-transcribed to cDNA using a 
RevertAid™ Premium Reverse Transcriptase enzyme (Fermentas, USA). Due to the 
discontinuation of this enzyme during the study period, a Maxima H Minus Reverse 
Transcriptase enzyme was used for some of the samples.  Random hexamers were used as 
primers (Fermentas, USA), and a deoxynucleotide triphosphate (dNTP) mix (Fermentas, 
USA), Thermo Scientific RiboLock™ RNase Inhibitor (Fermentas, USA), Qiagen® nuclease 
free water (Whitehead Scientific, Cape Town, South Africa) and 5X reverse transcriptase 
(RT) Buffer (Fermentas, USA) were also used for the cDNA synthesis process. A non-
template control (NTC) containing nuclease free water was included to control for cDNA 
synthesis reagent contamination. 
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Table 3.1: The panel of 15 viruses and subtypes included in the Seeplex
®
 RV15 Ace detection kit, 
however only the RNA viruses were investigated in this study (HAdV and HBoV are excluded). 
Virus Name Family Nucleic acid 
HRV Picornaviridae (+)ssRNA 
HCoV OC43 
HCoV 229E/NL63 
Coronaviridae (+)ssRNA 
Influenza A 
Influenza B 
Orthomyxoviridae (-)ssRNA 
PIV 1 
PIV 2 
PIV 3 
PIV 4 
Paramyxoviridae (-)ssRNA 
Human enterovirus Picornaviridae (+)ssRNA 
RSV A 
RSV B 
Paramyxoviridae (-)ssRNA 
HMPV Paramyxoviridae (-)ssRNA 
HAdV* Adenoviridae dsDNA 
HBoV* Parvoviridae ssDNA 
*HAdV and HBoV were not investigated in the study because they are deoxyribonucleic acid (DNA) 
viruses and because funding did not allow for testing of the DNA viruses. 
In brief, cDNA synthesis was done as follows: 8 μl of sample RNA was added to a 0.2 μl 
Quality Scientific Plastics (QSP®) PCR tube (Whitehead Scientific, Cape Town, South Africa) 
followed by the addition of a master mix, containing 1μl random hexamers, 1 μl dNTP mix 
and 4.5 μl nuclease free water (Whitehead Scientific, Cape Town) per sample. The samples 
were then incubated at 65°C for five minutes. A second master mix was added, consisting of 
4 μl of 5X RT Buffer, 0.5 μl RiboLock and 1 μl RevertAid™ Premium Reverse Transcriptase 
enzyme / Maxima H Minus Reverse Transcriptase enzyme per sample. cDNA synthesis was 
done on a Gene Amp® PCR system 9700 (Applied Biosystems, California). The reverse 
transcription was initiated with an incubation of ten minutes at 25°C, and continued with a 30 
minute incubation at 60°C and ending with a five minute incubation at 85°C.  
After DNA and RNA extraction and again after cDNA synthesis the nucleic acid concentration 
was measured on a NanoDrop spectrophotometer ND1000 (NanoDrop Technologies, USA)  
3.9 Multiplex polymerase chain reaction for virological studies 
After extraction and cDNA synthesis, the nucleic acid product from the swab samples were 
screened for 13 of the respiratory viruses contained in the Seeplex® RV15 Ace detection 
assay (Seegene, South Korea) according to the manufacturer‟s instructions. The two DNA 
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viruses contained in the kit (HAdV and HBoV) were not analysed. The kit is designed to 
qualitatively detect multiple respiratory viruses in a multiplex PCR assay. Each sample was 
simultaneously amplified in three separate reactions. 
The kit contained internal, negative and positive controls that were included every time the 
PCR was performed and procedures were followed according the manufacturers‟ 
instructions. The internal control (IC) was designed to identify inhibiting substances in the 
samples that could impede nucleic acid amplification. If the IC was not detected in any of the 
experiments, that assay‟s results would have been invalid and the procedures would have 
been repeated. The IC contains a DNA plasmid designed to ensure simultaneous 
amplification of the IC and respiratory viruses. The kit positive controls contain a mixture of 
the 15 respiratory viruses, including clones of the IC. The negative controls contain sterilised 
water and received all the other relevant reagents, to control for any form of contamination in 
the PCR process. According to the manufacturers the limit of detection for the RV15 Ace 
detection assay is 100 copies per 3 μl cDNA. 
In brief, a master mix, containing 4 μl 5X RV15 Ace PM, 10 μl, 2x Multiplex Master Mix and 
3 μl 8-Mop solution per sample was prepared for PCR amplification. Seventeen microliter of 
the master mix and 3 μl of the sample cDNA were added to each sample tube. The PCR 
reaction was conducted on the Gene Amp® PCR system 9700 (Applied Biosystems, 
California) with one cycle at 94°C for 15 minutes followed by 40 cycles at 94°C for 0.5 
minutes, 60°C for 1.5 minutes and 72°C for 1.5 minutes and ending with one cycle at 72°C 
for 10 minutes. 
For visualisation of the PCR products, a 2% gel was prepared by heating and dissolving 2 g 
Lonza SeaKem® LE agarose (Whitehead Scientific, Cape Town) and 100 ml Tris-acetate 
(TAE) 1x working concentration buffer. A stock of 50x TAE buffer was first prepared 
consisting of 242 g crystallised Tris (hydroxymethyl) aminomethane base (Boehringer 
Mannheim, USA), 57.1 ml AnalaR® acetic acid (BDH, South Africa) and 100 ml 0.5 m 
Ethylene diamine tetra acetic acid (EDTA) (Sigma-Aldrich®, USA) at a pH of 8.0 (Sambrook, 
et al., 1989). The warm gel was poured into 16 and up to 51 well gel moulds and allowed to 
set. Subsequently, 5 μl of the PCR product or molecular markers or 2 μl of the positive 
control supplied by the kit, were mixed with 1 μl GeneDirex® novel juice (Biocom Biotech, 
Cape Town) and loaded onto the 2% agarose gel. Novel juice aids visualisation of DNA 
bands on agarose gel once illuminated. The gels were run at 60 volts for 30-40 minutes 
using a BG Power6000 electrophoresis system (BayGene®, China) with gentle shaking on a 
lab rotator (Digisystem laboratory instruments Inc. Taiwan). The gels were analysed using an 
UVitec computer based gel documentation system (UVitec, United Kingdom) by first 
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adjusting the scale under white light and then visualising the PCR bands under the 
transilluminator. 
3.10 Validation of the extraction and multiplex Seeplex® RV15 Ace Detection Assay 
Validation of the extraction kits included slight modifications to the protocols to assist 
maximum sample recovery, including extraction and cDNA synthesis of confirmed positive 
respiratory samples from the diagnostic laboratory to ensure that the procedures were 
working. Validation of the multiplex Seeplex® RV15 Ace detection assay also included the 
use of confirmed positive respiratory samples from the diagnostic laboratory and QC 
samples from Quality Control for Molecular Diagnostics (QCMD, United Kingdom). The DNA 
and RNA were simultaneously extracted using the QIAamp® MinElute® Virus Spin kit for the 
validation processes (Whitehead Scientific, Cape Town, South Africa). 
In brief, the process was as follows: To lyse the samples, 25 μl QIAGEN® Protease was 
added to 1.5 ml microcentrifuge tubes, followed by the addition of 200 μl sample and 200 μl 
Buffer AL (containing 28 μg/ml of carrier RNA). Samples were then incubated at 56°C for 15 
minutes. The lysate was applied to a QIAamp MinElute column and centrifuge at 8 000 rpm 
for one minute. Several wash steps were then performed starting with 500 μl Buffer RW1, 
then 500 μl Buffer RW2 and lastly 500 μl ethanol (96–100%), in order to remove residual 
contaminants. The purified nucleic acids were eluted using 60 μl Buffer AVE. The viruses 
that were successfully detected from diagnostic respiratory samples and the QCMDs 
included the two DNA viruses, HAdV and HBoV, the RNA viruses, HRV, HCoV OC43/HKU1 
and 229E/NL63, influenza A, HPIV 1-3, RSV A and B and HMPV. Influenza B, HPIV 4 and 
human enterovirus could not be detected during the validation procedures. 
3.11 Validity and interpretation of results 
The Seeplex® RV15 Ace detection results were considered valid if: 
 The IC was detected for every sample and control 
 The NTC and negative controls were free of any viral products 
The positive results were interpreted according to the template provided in Table 3.2, 
although HAdV and HBoV were excluded from the results because only RNA extracts and 
the subsequent cDNA products were used for the viral screening. 
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Table 3.2: Interpretation of results according to amplified PCR product size compared to the molecular 
markers 
RV15 ACE Detection (A set) Size in agarose gel (base pairs) 
IC 850 
HAdV 534 
HCoV 229E/NL63 375 
HPIV 2 264 
HPIV 3 189 
HPIV 1 153 
RV15 ACE Detection (B set) Size in agarose gel (bp) 
IC 850 
HCoV OC43/HKU1 578 
HRV A/B/C 394 
RSV A 269 
Influenza A 206 
RSV B 155 
RV15 ACE Detection (C set) Size in agarose gel (bp) 
IC 850 
HBoV 579 
Influenza B 455 
HMPV 351 
HPIV 4 249 
Human enterovirus 194 
 
3.12 Reviewing of case files and collection of routine laboratory results 
Demographic and epidemiological data were recorded from the case files from all SUDI and 
SIDS cases included in the study and captured on a MS Office® Excel spreadsheet. 
Information collected included birth, death and autopsy dates, home address, sleeping 
position, type of blankets used, bed-sharing, illnesses in the days preceding death, alcohol 
use or smoking habits of the parents and the final concluding diagnosis and comments of the 
pathologists assigned to the cases.  
3.13 Data mining to collect virology results from hospitalised infants at Tygerberg 
Official data mining was done through the NHLS to acquire anonymous data from infants 
admitted to Tygerberg Hospitals during the study period. The data mining form is presented 
as Addendum 2. The gender and ages of hospitalised infants from May 2012 to May 2013 
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were retrieved, as well as the specimen types and test results of routine SVC and routine 
RV15 PCR. This data was used to compare to the SIDS and SUDI cases. 
3.14 Statistical analysis 
Statistical analysis was conducted using STATISTICA StatSoft® version 11 under the 
supervision Dr Justin Harvey from the Centre for Statistical Analysis at Tygerberg Campus 
(Stellenbosch University). For data that was not normally distributed, the Kruskal-Wallis and 
Pearson Chi-square tests were used. 
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4.1 Overview 
During this prospective descriptive study, SUDI cases were collected over a one year period 
from Tygerberg FPS Mortuary to investigate potential respiratory infections. A multiplex PCR 
was used to investigate the presence of 13 respiratory RNA viruses (influenza A and B, HPIV 
1-4, HCoV [OC43, 229E/NL63], HRV A, B and C, RSV A and B, human enterovirus and 
HMPV). We also captured routine bacterial and viral culture results as part of the routine 
screening according to the facility protocol. All cases were microscopically examined for 
histological signs of immune cell infiltrations. All available epidemiological data was also 
collected to investigate possible risk factors that may contribute to SUDI. 
4.2 Characteristics of study population 
A total of 148 SUDI cases were collected at Tygerberg FPS Mortuary during the one year 
study period. The male : female ratio of the study group was 1.5:1 (60.1% males and 39.9% 
females). 
The seasonal pattern and monthly distribution for the cases collected is shown in Figure 4.1 
where more than half of the SUDI cases presented at Tygerberg during the autumn and 
winter months. 
 
Figure 4.1: The seasonal distribution of the SUDI cases from May 2012 to May 2013. There was an 
increase of SUDI cases during autumn and winter. 
 Winter (Jun-Aug)  Spring (Sep-Nov)  Summer (Dec-Feb)  Autumn (Mar-May). 
Of the 148 SUDI cases the medico-legal investigations were only completed and the files 
signed out in 105 cases. The epidemiological data only includes information from these 105 
case files. The medico-legal investigations for the other 43 cases were still incomplete at the 
time of writing the thesis because the pathologists still needed to sign out those cases. 
39.9 %  
(n = 59) 
19.6 %  
(n = 29) 
16.9 %  
(n = 25) 
23.6 %  
(n = 35) 
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The median age of the cases was two months (mean 2.3 ± 2.32 months; range 3 days-12 
months). The majority of cases were between zero and three months old (84/105; 80%) and 
the largest peak was observed in the one to two months group (51.4%; 54/105) (Figure 4.2). 
Although the original inclusion criteria was an age between one week to one year, one three-
day-old infant, two of five days old and one six-day-old infant were included, because they 
fitted the profile of sudden and unexpected death. Of the 105 case files completed and 
signed out by pathologists, 104 files specified the date of death and the date of autopsy. The 
median PMI was three days (mean 3 ± 1.97 days; range 1-13 days). Up to 83.7% (87/104) of 
the autopsies were performed within 2-5 days of the infant‟s death. 
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Figure 4.2: Age distribution of the SUDI cases during the one year study period at Tygerberg FPS 
Mortuary. The highest prevalence was found in the zero to three month age group. 
The sleeping environment and parental information are shown in Figures 4.3 and 4.4. There 
were 32 (30.5%) SUDI cases that were put to sleep on their stomachs, 54 (51.4%) were 
wrapped in thick heavy blankets, 45 (42.9%) lived in informal settlements and the majority of 
the infants slept in a room with a closed window and shared a bed with up to four parents 
and/or siblings. Parents smoked and/or used alcohol in 41 (39.0%) and 39 (37.1%) SUDI 
cases respectively and the majority of cases had a single mother who was unemployed. The 
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median maternal age was 24 years but 13.3% were ≤ 20 years of age (mean 26.7 ± 7.30 
years; range 13-50 years). 
 
Figure 4.3: Factors relating to the sleeping environment. 
 
Figure 4.4: Parental information of the SUDI cases. 
4.3 Cause of Death Classification 
The final Cause of Death Classification was assigned by pathologists after the completion of 
the medico-legal investigation and autopsy for 101 cases only (Figure 4.5). To determine the 
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final cause of death classifications the pathologists had access to the routine virology and 
bacteriology results prior to signing out their SUDI cases, but the PCR viral results were not 
available to them. The data for the other 47 cases was not completed in the case files. Half 
of all the SUDI cases were assigned a Cause of Death Classification - Infection, 33.7% were 
classified as SIDS where evidence failed to reveal a cause of death and the remaining 15.8% 
died of other causes (congenital cardiac abnormalities in seven cases; aspiration of foreign 
material or gastric contents and starvation and dehydration in three cases each; unable to 
exclude accidental suffocation, prematurity and peritonitis as a complication of Meckel‟s 
diverticulum or malformation of gastrointestinal tract in one case each). 
 
Figure 4.5: The final Cause of Death Classification as determined by the pathologists after the 
medico-legal investigation. Pathologists were blinded to the PCR virology results, when they 
determined the final cause of death.  
 SIDS  Infection  Other. 
4.4 Respiratory pathogen detection 
Laboratory results were obtained for all 148 cases in the study. Bacterial and/or viral 
pathogens were detected in 86.5% (128/148) of all cases. Positive viral PCR and culture 
results, regardless of whether some of those cases were also positive for bacteria, were 
found in 62.2% (92/148) of cases. Positive bacterial results were found in 56.8% (84/148) of 
cases, regardless of whether some of those cases were also positive for viruses. In 44.5% 
(57/128) of the cases a single infectious agent was detected and co-detections of between 
two and six viruses and/or bacteria occurred in 55.5% (71/128) of cases. 
33.7 % (n = 34) 
50.5 % (n = 51) 
15.8 % (n = 16) 
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4.5 Viruses detected in the study 
4.5.1 Multiplex polymerase chain reaction for RNA viruses 
With the Seeplex® RV15 Ace detection assay between one and three viruses were detected 
in 59.5% (88/148) of cases. Of the 88 cases that had viruses detected, 75% (66/88) had one 
virus and 25% (22/88) had co-detections of two to three viruses (Table 4.1). Figure 4.6 
shows distribution of viruses detected from the 88 PCR positive SUDI cases. The most 
common viruses detected were HRV in 77% (68/88) of cases, RSV in 18% (16/88) of cases 
and HCoV in 14% (12/88) of cases. Most of the HRV, RSV and HCoV cases were positive 
from tracheal and lung samples. Histology signs of infection were observed in 64% (44/68) 
HRV-positive cases, 62.5% (10/16) RSV-positive cases, 58% (7/12) HCoV-positive cases, 
16.7% (1/6) human enterovirus-positive cases, 80% (4/5) HMPV-positive cases, 75% (3/4) 
PIV 3-positive cases and 25% (1/4) Influenza-positive cases. 
 
Figure 4.6 The distribution of viruses detected from the 88 PCR positive SUDI cases. HRV 
was by far the most frequently detected virus. 
The details of all PCR results are summarised in Addendum 3. In summary, HRV was 
detected most frequently in this study, followed by RSV A, HCoV OC43, human enterovirus, 
HMPV, HCoV 229E/NL63, HPIV 3, influenza A, RSV B and influenza B. In 62.5% the of 
positive cases, viruses were detected in all three specimens (tracheal swab, lower left lung 
swab and lower right lung swab), while 8% and 28.4% of cases produced positive results in 
two or one specimens respectively. Tracheal swab specimens were more frequently positive 
for viruses (86/88; 97.7%) than the lung swabs (63/88; 71.6%).  
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Table: 4.1: Prevalence of the respiratory viruses detected from the SUDI cases in the study 
using the Seeplex® RV15 Ace detection PCR assay. 
Virus  Prevalence 
in the 
study / (n) 
Positive 
in 
Trachea 
Positive 
in Lungs 
Positive in all 
three specimens 
Number of 
cases with 
one or 
more co-
detections 
Viruses co-
detected in 
one or more 
cases 
HRV 46% 
(68/148) 
68 45 38 19 RSV A 
RSV B 
HCoV OC43 
HCoV 
229E/NL63 
Human 
enterovirus 
HMPV 
PIV 3 
Influenza A 
RSV A and 
B 
9.5% 
(14/148) 
and 1.4% 
(2/148) 
Total: 
10.8% 
13 15 8 11 HRV 
HCoV OC43 
HCoV 
229E/NL63 
HMPV 
PIV3 
HCoV OC43 
and 
229E/NL63 
5.4% 
(8/148) 
and 2.7% 
(4/148) 
Total: 
8.1% 
10 7 3 9 HRV 
RSV A 
RSV B 
OC43  
HCoV 
229E/NL63 
PIV3 
Human 
enterovirus 
4.1% 
(6/148) 
6 5 3 4 HRV 
HMPV 3.4% 
(5/148) 
5 4 3 2 HRV 
RSV A 
PIV3 2.7% 
(4/148) 
1 4 1 4 HRV 
RSV A 
HCoV OC43 
Influenza A 
and B 
2.0% 
(3/148) 
and 0.7% 
(1/148) 
Total: 
2.7% 
4 2 1 1 HRV 
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The most PCR-positive cases occurred in autumn with an equal percentage of cases in 
winter and spring and a decline in summer (Table 4.2). Influenza PCR-positive SUDI cases 
only occurred in winter and HMPV PCR-positive cases occurred in winter and spring. No 
clear seasonal pattern was observed for any of the other viruses. There were more HRV 
PCR-positive cases in spring and summer compared to autumn and winter. Both RSV and 
HCoV had the most PCR-positive cases occurring in autumn and winter. 
Table 4.2: The seasonal pattern for the respiratory RNA viruses detected in the study. 
Virus Name Autumn: 
80% of the cases 
were PCR-positive 
(28/35) 
Winter: 
79.7% of the cases 
were PCR-positive 
(47/59) 
Spring: 
79.3% of the cases 
were PCR-positive 
(23/29) 
Summer: 
64% of the cases 
were PCR-positive 
(16/25) 
HRV 53.6% (15/28) 53.2% (25/47) 73.9% (17/23) 68.6% (11/16) 
RSV A and 
B 
21.6% (6/28) 
17% (8/47) 0 12.5% (2/16) 
HCoV OC43 
and 
229E/NL63 
21.6% (6/28) 
8.5% (4/47) 4.3% (1/23) 6.3% (1/16) 
human 
enterovirus  
3.6% (1/28) 
4.3% (2/47) 8.7% (2/23) 6.3% (1/16) 
HMPV 0 6.4% (3/47) 8.7% (2/23) 0 
PIV 3 0 2.1% (1/47) 8.7% (2/23) 6.3% (1/16) 
Influenza A 
and B 
0 
8.5% (4/47) 0 0 
 
4.5.2 Unexpected Multiplex PCR results 
HAdV was detected in 3.4% (5/148) of cases; in the trachea in four cases and the trachea 
and both lungs in the 5th case. HAdV was detected as the sole virus in two cases and co-
detected with viruses such as HRV, RSV B, HCoV and HPIV 3 in three cases (data excluded 
from Tables and Addendum three because we focused on the 13 RNA viruses only and not 
the DNA viruses).  
4.6 Routine viral culture results 
SVCs were positive in 9.5% (14/148) of all cases. CMV was detected in 13 cases, of which 
one was in the liver tissue, two in the liver and lung tissue and ten in the lung tissue only. 
HAdV was detected in one case from the liver. Examples of SVC negative and positive 
results are shown in Figure 4.7. Histology signs of infection were noted in 78.6% (11/14) of 
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cases with a positive SVC result. Three cases wherein CMV was detected did not show any 
histological evidence of infection. 
A B 
 
C D 
 
E 
 
Figure 4.7: Images of negative and positive SVC results 
A: an example of a negative SVC result from combi Hep-2 and MDCK cells. 
B: an example of a HAdV positive SVC result from combi Hep-2 and MDCK cells.  
C: an example of a negative SVC from HF cells.  
D: an example of a HAdV positive SVC result from HF cells. 
E: an example of a CMV positive SVC result from HF cells.  
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4.7 Routine bacterial culture results 
Bacterial culture results were positive in 56.8% (84/148) of cases. Of these, 83.3% (70/84) 
had one species detected, 15.5% (13/84) had two species detected and 1.2% (1/84) had four 
species detected. An equal number of cases (32/148; 21.6%) had either detection of post-
mortem flora or no growth on the culture plates. Histology signs of infection were observed in 
60.7% (51/84) of the SUDI cases that were bacterial culture-positive. Of the bacterial culture-
positive cases, 57.1% (48/84) also produced PCR-positive viral results and 58.3% (28/48) 
had histological evidence of infection. More lung specimens were positive for bacteria. The 
least likely specimen type to produce bacterial growth and post-mortem contaminants was 
the heart swab. The lung specimens more often cultured post-mortem flora and bacterial 
isolates (Table 4.3). 
The percentages of bacterial species detected during routine bacterial culture from SUDI 
cases are shown in Table 4.4. Klebsiella pneumonia and Escherichia coli were the most 
frequently detected pathogens. 
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Table 4.3: The routine bacterial culture results according to sample site. 
 Heart Swab (n) Left Lung Swab (n) Right Lung Swab (n) 
Bacterial species 25 57 46 
Post-mortem Flora 15 63 70 
No Growth 108 28 32 
 
Table 4.4: The prevalence of bacterial species found during routine culture 
Bacterial species Prevalence in the study / (n) 
Klebsiella pneumoniae 16.9% (25/148) 
Escherichia coli 16.2% (24/148) 
Staphylococcus aureus 5.4% (8/148) 
Beta-Haemolytic Streptococci 4.7% (7/148) 
Klebsiella oxytoca 4.1% (6/148) 
Raoultella planticola 2.7% (4/148) 
Haemophilus influenzae 2.0% (3/148) 
Candida albicans 2.0% (3/148) 
Streptococcus pneumoniae 1.4% (2/148) 
Enterococcus faecalis 1.4% (2/148) 
Enterobacter cloacae 1.4% (2/148) 
Enterobacter aerogenes 0.7% (1/148) 
Raoultella ornithinolytica 0.7% (1/148) 
Enterococcus species 0.7% (1/148) 
Pseudomonas species 0.7% (1/148) 
Serratia liquefaciens 0.7% (1/148) 
Lactococcus garvieae 0.7% (1/148) 
Leuconostoc citreum 0.7% (1/148) 
Salmonella 0.7% (1/148) 
Enterobacter species 0.7% (1/148) 
Acinetobacter species 0.7% (1/148) 
Staphylococcus epidermidis 0.7% (1/148) 
Coagulase negative Staphylococcus 0.7% (1/148) 
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4.8 Histology results 
Microscopic signs of infection from the left and right lower lung lobes were detected in 59.5% 
(88/148) of cases. Signs of possible infection included IP, bronchopneumonia, bronchiolitis 
and possible viral infections characterised by findings such as neutrophil and lymphocyte 
infiltrations and viral inclusion bodies ( Figure 4.8). In 40.5% (60/148) of the cases non-
specific changes were observed in the lungs that were generally not considered to be 
indicative of infections ( Figure 4.9). Examples of lung histology from the SUDI cases are 
shown in Figures 4.10 – 4.13. 
 
Figure 4.8: Specific histology findings for the 148 SUDI cases. 
 
Figure 4.9: Non-specific histology findings for the 148 SUDI cases. 
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Figure 4.10: Example of a SUDI case with pulmonary bronchopneumonia 
A: fibrin present in the lungs. 
B: confluent pneumonia with neutrophil infiltrations. 
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Figure 4.11: Example of a SUDI case with histology signs classified as pulmonary bronchitis. 
Lymphocyte infiltrations are present in the lungs. 
A 
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Figure 4.12: Example of one SUDI case classified as having normal lung histology 
A: healthy alveolar structures in the lungs of a SUDI case. 
B: signs of congestion in the blood vessels. 
C: congestion. 
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Figure 4.13: Examples of two SUDI cases classified as pulmonary IP 
A and B: a case with grade 3-4 IP. 
C: a case with grade 1 IP. 
D: signs of intra alveolar haemorrhage in the same case shown in C. 
Of the cases that were positive for signs of infection on histology, 89.8% (79/88) had one or 
more infectious agents detected with PCR and culture. In contrast, 81% (49/60) of the cases 
with negative histology had one or more infectious agents detected with PCR and culture. 
4.9 Routine blood results  
Of the cases that had blood sent for HIV testing, 29.6% (40/135) were reactive as recorded 
by the laboratory, indicating the presence of HIV-1/2 antibodies in these serum samples. 
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4.10 Medical history 
A medical history was recorded in all cases and in 26.7% (28/105) of cases, parents reported 
some clinical symptoms prior to the infant‟s death. The main symptoms recorded included 
fever, caughing or a runny nose. 
4.11 Statistical analysis and comparisons 
4.11.1 Cause of Death Classification and pathogen detection 
In a 2-way summary table comparing Cause of Death Classification and respiratory viruses 
detected by PCR alone, an association was found between positive PCR results and a 
Cause of Death Classification - Infection (Pearson Chi-square, p = 0.0096) (Table 4.5).  
Pathologists were blinded to the viral PCR results when assigning a Cause of Death 
Classification. The same number of cases classified as SIDS was PCR positive and PCR 
negative and details are presented in Table 4.6.  
Cases with a final Cause of Death Classification - Other had the lowest PCR-positive 
detection rate at 37.5% as shown in Table 4.4. Details of the six PCR-positive SUDI cases 
with a Cause of Death Classification - Other are shown in Table 4.7. 
When both PCR and culture results were compared to the Cause of Death Classification in a 
2-way summary table, an association was found again between the Cause of Death 
Classification and respiratory pathogens detected (Pearson Chi-square, p = 0.0226). In all 
three Cause of Death Classification groups (Infection, SIDS and Other) more cases had one 
or more pathogens detected compared to cases with no pathogens detected (Table 4.8). 
Table 4.5: 2-way summary table comparing Cause of Death Classification and respiratory viruses 
detected by PCR. 
PCR Viruses detected  Cause of Death 
Classified - Infection 
Cause of Death 
Classified - SIDS 
Cause of Death 
Classified - Other 
No 25.5% (n = 13) 50% (n = 17) 62.5% (n = 10)  
Yes 74.5% (n = 38)* 50% (n = 17) 37.5% (n = 6) 
* - p = 0.0096 
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Table 4.6: Details about the 17 PCR-positive SUDI cases classified as SIDS 
Case 
No. 
PCR results Histology signs of 
infection 
Medical 
History  
Cause of 
Death 
Classification 
Routine Culture 
Results 
 
009 HRV 
RSV B  
HCoV 
OC43/HKU1 
Query RSV Stomach 
virus and 
cold 
SIDS  
023 HCoV 
OC43/HKU1 
Focal collapse, 
alveolar debris 
None SIDS  
029 HRV Congestion, IP grade 
4, alveolar  
haemorrhage 
None SIDS  
039 HRV 
RSV A 
IP grade 1, focal 
collapse 
Coughing 
and fever 
SIDS Escherichia coli 
Pseudomonas spp 
Serratia liquefaciens 
Lactococcus garvieae 
045 HRV Oedema, focal 
collapse, 
pigment/formalin 
None SIDS Staphylococcus 
aureus 
Klebsiella 
pneumoniae 
051 HRV Unremarkable None SIDS Leuconostoc citreum 
053 Influenza B Oedema, focal 
collapse, congestion 
Flu-like 
symptoms 
SIDS Klebsiella 
pneumoniae 
062 HRV Unremarkable Coughing SIDS Klebsiella 
pneumoniae 
069 HRV IP grade 1, focal 
collapse, alveolar  
haemorrhage 
None SIDS Klebsiella oxytoca 
072 RSV A Congestion, IP grade 
2, focal collapse, 
bronchiolitis, alveolar 
haemorrhage 
No SIDS Escherichia coli 
083 HRV Oedema, IP grade 2, 
alveolar debris 
No SIDS HAdV 
085 HRV Oedema, congestion Throat 
infection, 
seven days 
antibiotics 
SIDS Haemophilus 
influenzae 
102 HRV Oedema No SIDS Klebsiella 
pneumoniae 
104 PIV 3 
HCoV 
OC43/HKU1 
Oedema, 
bronchopneumonia, 
Alveolar debris, 
bronchiolitis 
Lethargic at 
crèche 
SIDS  
139 HRV Oedema, IP grade 2 Slight cold 
symptoms 
SIDS  
145 HRV  
HCoV 
229E/NL 63 
Oedema, IP grade 2 No SIDS  
147 HCoV 
229E/NL 63 
Oedema, IP grade 3, 
alveolar debris 
No SIDS  
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Table 4.7: Details about the six PCR-positive SUDI cases with a Cause of Death Classification - Other 
Case 
No. 
PCR 
results 
Histology signs of 
infection 
Medical 
History  
Cause of Death 
Classification - Other 
Routine 
Culture 
results 
005 RSV A Oedema, congestion, 
focal collapse, pigment 
iron/formalin, alveolar 
debris 
Yes Congenital cardiac 
abnormalities 
 
013 RSV A 
HCoV 
OC43/HKU1 
Congestion, pigment 
iron/formalin, alveolar 
haemorrhage 
None Aspiration of foreign 
material 
 
015 RSV A Focal collapse, alveolar 
debris 
Was not 
breathing 
right 
Congenital endocardial 
fibroelastosis and the 
consequences thereof 
 
043 HRV Oedema, congestion, IP 
grade 1, focal collapse, 
pigment iron/formalin 
None Not determined by 
autopsy alone, but 
accidental suffocation 
could not be excluded 
 
064 HRV Oedema, congestion, 
alveolar debris, alveolar 
haemorrhage, viral 
inclusion bodies query 
RSV 
None Pulmonary embolism: 
natural 
 
073 HRV Oedema, IP grade 2, 
alveolar debris, alveolar 
haemorrhage, viral 
inclusion bodies query 
RSV/HAdV, foreign 
material in airways 
None Aspiration of stomach 
contents and the 
consequences thereof 
Klebsiella 
pneumoniae 
 
 
Table 4.8: 2-way summary table comparing death classification and respiratory pathogens detected 
by PCR and culture. 
PCR and culture 
pathogens 
Cause of Death 
Classification- Infection 
Cause of Death 
Classification - SIDS 
Cause of Death 
Classification - Other 
No 3.9% (n = 2) 23.5% (n = 8) 18.8% (n = 3)  
Yes 96.1% (n = 49)* 76.5% (n = 26) 81.3% (n = 13) 
* - p = 0.0226 
4.11.2 Polymerase chain reaction viruses, and seasonality and gender 
Although more viruses were detected in the SUDI cases during autumn and winter (Figure 
4.14), the association between seasonality and positive PCR results was not significant 
(Pearson Chi-square, p = 0.975). There was also no significant association between PCR 
positive cases and gender, but 64% of the males were PCR positive compared to 55% of the 
females (Figure 4.15) (Pearson Chi-square, p = 0.263). 
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Figure 4.14: The SUDI cases that were PCR-positive and PCR-negative across the four seasons. 
 
Figure 4.15: Gender according to PCR-positive and PCR-negative SUDI cases. 
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4.11.3 Histology signs of infection and pathogen detection 
Although more SUDI cases that were PCR-positive had histology signs of infection compared 
to PCR-negative cases, no significant association was found between histology signs of 
infection and detection of PCR viruses (Pearson Chi-square, p = 0.8177). 
We further found no association between histology signs of infection and the detection of 
PCR and culture pathogens (Pearson Chi-square, p = 0.264), or the detection of bacteria 
alone (Pearson Chi-square, p = 0.909). 
4.11.4 Cause of Death Classification and age in months 
Infants in the Cause of Death Classification - Infection group were significantly older with a 
median age of two months (mean 2.75 ± 2.25) compared to infants in the Cause of Death 
Classification - Other group with a median age of one month (mean 1.31 ± 1.35) (Kruskal-
Wallis Test: p = 0.015), but not compared to the Cause of Death Classification - SIDS group 
with a median age of 1.5 months (mean 2.32 ± 2.25) (Kruskal-Wallis Test: p = 0.40) (Figure 
4.16). Although infants in the Cause of Death Classification - SIDS group seemed to have a 
higher mean age in months compared to infants in the Cause of Death Classification - Other 
group, the difference did not reach statistical significance (Kruskal-Wallis Test: p = 0.36). 
4.11.5 Pathogen detection and age in months 
The SUDI cases that were positive for viruses using PCR only were significantly older with a 
median age of two months (mean 2.73 ± 2.17) than infants who were PCR-negative with a 
median age of one month (mean 1.88 ± 2.48) (Kruskal-Wallis Test: p = 0.003) (Figure 4.17).  
No statistical significance was found between the ages of cases that were culture positive 
with a median age of two months (mean 2.61 ± 2.58), compared to cases that had a flora 
result and/or a culture negative result with a median age of two months (mean 2.11 ± SD 
1.91) (Kruskal-Wallis Test: p = 0.39).  
Cases that were positive using the routine SVC method were significantly older with a 
median age of 2.5 months (mean 3.13 ± 2.03) compared to SVC-negative cases that had a 
median age of two months (mean 2.34 ± 2.34) (Kruskal-Wallis Test: p = 0.0021) (Figure 
4.18). 
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Figure 4.16: A box and whisker plot showing the median age in months for SUDI cases in the three 
Cause of Death Classification groups. Infants in the Infection group were significantly older than those 
in the Other group (p = 0.015), but was similar to the SIDS group. The median value is represented by 
the middle box. The outer box represents the interquartile range (IQR) spanning the middle 50% of the 
data set. The whiskers indicate the minimum and maximum age values. 
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Figure 4.17: The box and whisker plot shows the median age of SUDI cases that were PCR-positive 
(Yes) and those that were PCR-negative (No) for respiratory viruses. Cases with viruses detected 
were significantly older than those cases that were PCR-negative (p = 0.003). The median value is 
represented by the middle box. The outer box represents the IQR spanning the middle 50% of the 
data set. The whiskers indicate the minimum and maximum age values. 
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Figure 4.18: The box and whisker plot shows the median age of SUDI cases that were routine SVC-
positive (Yes) and those that were SVC-negative. SVC-positive SUDI cases were significantly older 
than cases where no viruses were cultured (p = 0.0021). The median value is represented by the 
middle box. The outer box represents the IQR spanning the middle 50% of the data set. The whiskers 
indicate the minimum and maximum age values. 
4.11.6 Post-mortem interval and pathogen detection 
There was no difference between the median PMI (4 days) and PCR-positive cases (mean 
5.10 ± 3.25) compared to PCR-negative cases (mean 4.56 ± 3.36) (Kruskal-Wallis Test: p = 
0.19). 
No association could be found between the median PMI of 3.5 days in SUDI cases with 
bacterial culture positive results (mean 4.42 ± 3.23) or the median PMI of four days for those 
with no growth or mixed growth and post-mortem flora / contaminants (mean 5.57 ± 3.31) 
(Kruskal-Wallis Test: p = 0.84). 
Cases where viruses were cultured using routine SVC had a significantly higher median PMI 
of 4.5 days (mean 5.5 ± 3.07) compared to the median PMI of three days for cases with no 
viruses cultured (mean 3.5 ± 1.79) (Kruskal-Wallis Test: p = 0.025) (Figure 4.19). 
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Figure 4.19: The box and whisker plot shows the median PMI for SUDI cases that were SVC-positive 
(Yes) and those that were SVC-negative. Cases that were SVC-positive had a higher PMI compared 
to cases that were SVC-negative (p = 0.025). The median value is represented by the middle box. The 
outer box represents the IQR spanning the middle 50% of the data set. The whiskers indicate the 
minimum and maximum age values. 
Cases with sterile autopsy samples with no bacterial culture growth had a similar median 
PMI of three days (mean 4.09 ± 2.52) compared to the median PMI of 3.5 days in cases with 
bacterial growth (mean 4.42 ± 3.23) and the median PMI of three days for cases with post-
mortem flora cultured (mean 3.35 ± 1.69). 
4.11.7 Demographics and potential SIDS risk factor investigations 
The median number of people sharing the same bed with infants (n=2) was the same for all 
three Cause of Death Classification groups; Infection (mean 2.0 ± 0.84), SIDS (mean 
1.83 ± 0.76), as well as Other (mean 1.67 ± SD 0.65). 
The median number of people per household (n=4) did also not differ between the Cause of 
Death Classification groups; Infection (mean 4.5 ± 2.38), SIDS (mean 4.6 ± 2.16), and Other 
(mean 4.75 ± 2.60) (Kruskal-Wallis Test: p = 1.000). 
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The mothers of all cases had a similar median age, regardless of the Cause of Death 
Classification assigned to the infant; Infection, 26 years (mean 26 ± 7.47), SIDS, 25 years 
(mean 27 ± 7.74), and Other, 23 years (mean 25 ± 5.51) (Kruskal-Wallis Test: p = 1.000). 
No significant associations were found when comparing Cause of Death Classification to 
factors such as sleeping position, the use of thick or thin blankets, gender, type of housing, 
maternal employment status and seasonality. The only significant difference was found for 
positioning of the window (open/closed) (p = 0.0506) and the maternal marital status 
(p = 0.001) (Table 4.9). 
4.12 Viruses confirmed in living infants admitted to Tygerberg hospital 
For comparison purposes, routine SVC and PCR results from 553 infants (53% males and 
47% females) that were admitted to Tygerberg Hospital from May 2012-May 2013 were 
retrieved. Of these, 88 were tested using SVC with 21.6% (19/88) found to be positive for 1-2 
viruses (Table 4.10) and 465 were tested by PCR with 50.5% (235/465) found to be positive 
for 1-3 viruses (Table 4.11). HRV and HCoV are not included in the routine SVC test. The 
Virology laboratory, NHLS, Tygerberg Hospital recommends PCR for routine analysis of 
infant specimens, due to higher detection rates of viral pathogens, but physicians still 
requested SVC in some of these cases. 
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Table 4.9: Comparison of Cause of Death Classification with various epidemiology factors 
Sleeping 
position 
Cause of Death 
Classification - 
Infection 
Cause of Death 
Classification - 
SIDS 
Cause of Death 
Classification - 
Other 
Pearson Chi-
square 
Side 71.4% (n = 35) 51.6% (n = 16) 53.3% (n = 8)  p = 0.221 
Stomach 26.5% (n = 13) 41.9% (n = 13) 33.3% (n = 5)  
Back 2.1% (n = 1) 6.5% (n = 2) 13.3% (n = 2)  
Type of blanket used 
Thin light 
blanket 
36.2% (n = 17) 51.6% (n = 16) 53.3% (n = 8)  p = 0.297 
Thick heavy 
blanket 
63.8% (n = 30) 48.4% (n = 15) 46.7% (n = 7)  
Gender     
Male 56.9% (n = 29) 61.8% (n = 21) 50.0% (n = 8)  p = 0.370 
Female 43.1% (n = 22) 38.2% (n = 13) 50.0% (n = 8)  
Window     
Closed 71.4% (n = 35) 51.6% (n = 16) 53.3% (n = 8)  p = 0.0506 
Open 26.5% (n = 13) 41.9% (n = 13) 33.3% (n = 5)  
No window 2.1% (n = 1) 6.5% (n = 2) 13.3% (n = 2)  
Housing     
Informal 58.8% (n = 20) 51.9% (n = 14) 44.4% (n = 4)  p = 0.705 
Formal 41.2% (n = 14) 48.1% (n = 13) 55.6% (n = 5)  
Maternal Employment status 
Unemployed 81.4% (n = 35) 80.0% (n = 24) 60.0% (n = 9)  p = 0.213 
Employed 18.6% (n = 8) 20.0% (n = 6) 40.0% (n = 6)  
Maternal marital status 
Single 93.8% (n = 45) 64.5% (n = 20) 60.0% (n = 9)  p = 0.001 
Married 6.2% (n = 3) 35.5% (n = 11) 40.0% (n = 6)  
Seasons     
Autumn 23.5% (n = 12) 20.6% (n = 7) 25.0% (n = 4)  p = 0.936 
Winter 35.3% (n = 18) 41.2% (n = 14) 50.0% (n = 8)  
Spring 23.5% (n = 12) 23.5% (n = 8) 12.5% (n = 2)   
Summer 17.7% (n = 9) 14.7% (n = 5) 12.5% (n = 2)  
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Table 4.10: Viruses detected using SVC from 19 infants at Tygerberg hospital from May 2012-May 
2013. 
Virus name Number of infants (n) Prevalence in  
19 positive cases 
Prevalence in  
88 cases tested 
RSV 11 57.9% 12.5% 
CMV 3 15.8% 3.4% 
Influenza A 2 10.5% 2.27% 
PIV 3 2 10.5% 2.27% 
PIV 1 1 5.3% 0.9% 
HAdV 1 5.3% 0.9% 
 
Table 4.11: Viruses detected using PCR from 235 infants admitted at Tygerberg hospital from May 
2012-May 2013. 
Virus name Number of infants (n) Prevalence in 235 
positive cases 
Prevalence in 465 
cases tested  
HRV 93 39.6% 20% 
RSV A 85 36.2% 18.3% 
HBoV 85 36.2% 18.3% 
HAdV 23 9.8% 4.9% 
Influenza A 8 3.4% 1.7% 
RSV B 8 3.4% 1.7% 
PIV 4 8 3.4% 1.7% 
HMPV 7 3.0% 1.5% 
Human enterovirus 6 2.6% 1.3% 
HCoV OC43/HKU1 4 1.7% 0.9% 
PIV 1 3 1.3% 0.6% 
PIV 2 2 0.9% 0.4% 
HCoV 229E/NL63 1 0.4% 0.2% 
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5.1 Overview 
Attempts at identifying a cause of death for SUDI cases are still partially unsuccessful, 
leaving some cases classified as SIDS, with the cause of death remaining a medical mystery 
(Koehler, 2010). SIDS cases still make up a large proportion of SUDI cases, despite many 
current regional protocols including a review of the clinical history and the circumstances 
surrounding the event, as well as an autopsy, laboratory investigations and occasional 
investigation of the death scene (du Toit-Prinsloo et al., 2011; du Toit-Prinsloo et al., 2013). 
In this prospective descriptive study we aimed to investigate the prevalence of 13 respiratory 
RNA viruses (influenza A and B, HPIV 1-4, HCoV [OC43, 229E/NL63], HRV A, B and C, 
RSV A and B, human enterovirus and HMPV) in SUDI and SIDS cases at Tygerberg FPS 
Mortuary over a one year period. Many of these viruses have been detected from infants that 
died suddenly and unexpectedly and from living infants with ARIs and pneumonia (Weber et 
al., 2010a; Kwofie et al., 2012). We wanted to explore possible viral infections in SUDI and 
SIDS cases and aimed to determine the usefulness of PCR in detecting viruses from SUDI 
cases that may contribute to death. The virology results were interpreted alongside a clinical 
history of the presence or absence of infection prior to death and histology signs of 
respiratory infection. We also collected routine laboratory results and epidemiology data. In 
keeping with the study objectives, we showed that more than half of the SUDI cases had 
positive PCR results for viruses and half of the cases in the final Cause of Death 
Classification - SIDS group were positive for viruses. In this setting at Tygerberg, a high 
percentage of viruses were detected by PCR from SUDI and SIDS cases. Many of these 
viruses remain mostly undetected by the current routine SVC method used in the SUDI 
laboratory investigation protocol at this facility. Using PCR we detected viruses that might 
have contributed to infant death in a portion of cases, especially where histology signs of 
infection were observed. Incorporating this PCR method into the facility protocol could 
potentially alter the final diagnostic categories for SUDI cases at Tygerberg, or at the least, 
highlight the possibility of viruses contributing to fatal events. In the discussion sections to 
follow, we will cover demographic risk factors and further lay emphasis on the respiratory 
viruses detected from PCR-positive cases, and specifically more detail on the cases with a 
final Cause of Death Classification - SIDS where viruses were detected. 
5.2 Characteristics of the study population 
Out of the 148 SUDI cases we collected, 60.1% were males. Our percentage of males was 
very similar to Trachtenberg et al. (2012) who found 60.6% of SIDS cases to be male (1996-
2008) and slightly higher than du Toit-Prinsloo et al. (2013) who found 56% of SUDI cases to 
be male (2005-2009). The male gender has long been established as a risk factor for SIDS 
Stellenbosch University  http://scholar.sun.ac.za
88 
 
(Vennemann et al., 2005). In our study no significant association was found between the 
male gender and cases with a final Cause of Death Classification of Infection, SIDS or Other. 
More males in our study were virus-positive (55/89; 61.8%) compared to females (31/59; 
52.5%), but there was no significant association between the male gender and respiratory 
viruses. The male predominance seems to span over infections, prematurity and infant 
mortality in general and is therefore not limited to SIDS. The cause for male predominance in 
SIDS is still unclear, but it has been suggested to have a biological origin (Drevenstedt et al., 
2008). Moscovis et al. (2013) found that adult male peripheral blood mononuclear cells 
produced less pro-inflammatory cytokines compared to females. They suggested that a 
reduced pro-inflammatory response could limit damage during pathogenic stimulation, but 
could also lead to a higher susceptibility to initial invasion of pathogens. They also found that 
the pro-inflammatory response was reduced further upon exposure to a surrogate for 
cigarette smoke (Moscovis et al., 2013). In SIDS cases specifically, Paterson et al. (2006) 
found more males with medullary abnormalities than females, which could reduce the ability 
to respond to homeostatic stressors while sleeping. Thus, the male predominance may stem 
from inherent vulnerabilities, which seems to be multifactorial, as is the case with SIDS. 
The median age of three months for the SUDI cases in our study was consistent with two to 
four month peak age for SIDS reported in the literature (Balduzzi & Greendyke, 1966). The 
peak age for the infants in our study was between zero to three months, and although the 
one to two month age peak was the second largest in our study, our findings were still close 
to the two to four month age peak found by Trachtenberg et al. (2012) and the three to four 
month age peak found by du Toit-Prinsloo et al. (2013). The first few months of life are 
considered a particularly vulnerable period for infants because their immune protective 
responses to pathogens are still developing, their maternally transferred IgG antibodies have 
begun to wane and all vaccinations have not yet been completed (Gans et al., 2004; 
Palmeira et al., 2012; Reikie et al., 2012; Reikie et al., 2013). The number of SUDI and 
SUCD cases are negligible by the age of one to two years when the immune system of 
infants should be fully functional (Wiegering et al., 2009; Côté, 2010; Palmeira et al., 2012), 
which suggests that immature immune responses play a contributory role in infant 
susceptibility to SIDS in early life. SUDI cases with a Cause of Death Classification - 
Infections were significantly older than those in the Cause of Death Classification – Other 
group, but still fell within the vulnerable period before vaccinations have been completed and 
when maternal antibodies have already drastically declined (Reikie et al., 2013). The median 
age for our SIDS cases also falls within the vulnerable period although they were not 
significantly older than the mean age of infants in the Other group.  
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The median age of two months for our SUDI cases who were PCR-positive were significantly 
higher than the median age of one month for PCR-negative cases. Patrick et al. (1989) also 
found that older infants (>16 weeks / four months) had significantly more viruses compared 
to younger infants with the least viruses detected in the zero to two months age group, but 
explanations for this were not offered in their article. Williams et al. (1984) also detected 
significantly more viruses from SIDS cases older than three months (39%), compared to 
cases younger than three months (14%). They suggested that some respiratory viruses, and 
specifically RSV, may play an important role in sudden death in infants older than three 
months, but that this still could not explain the cause of death. More recent studies do not 
specifically compare older to younger infants in terms of viruses detected from SUDI or SIDS 
cases (Weber et al., 2010a; du Toit-Prinsloo et al., 2013). We did not measure antibody 
levels for the infants or their mothers, but despite early infant vulnerability, maternal IgG offer 
partial protection in very young infants. We could only speculate that maternal antibodies 
circulating in young infants may protect them from infections and could possibly explain why 
PCR-negative cases were more prevalent in younger cases. In addition, breastmilk contains 
high levels of certain immune factors that could protect young infants against infections, but 
the levels of immune components in breastmilk decrease over time. This may also explain 
why younger infants could possibly show less infections compared to older infants. 
Sadeharju et al. (2007) found that infants in Finland (1995-1996) that were breastfed 
exclusively for more than two weeks had higher maternal enterovirus specific IgA antibodies 
in breastmilk and decreased enterovirus infections throughout their first year of life compared 
to infants that were breastfed for less than two weeks. After three months the enterovirus 
specific IgA levels in breastmilk samples declined. Ladomenou et al. (2010) found reduced 
episodes of ARIs and common infections, including hospital admissions in infants exclusively 
breastfed for at least six months compared to non-breastfed or partial breastfed infants in 
Crete (2004-2005). Gordon et al. (1999) also found human breastmilk to contain IgA 
antibodies specific for bacterial toxins which could neutralise these toxins and possibly 
contribute to protection against SIDS in breastfed infants. Breastfeeding has been shown to 
decrease the risk of SIDS where Vennemann et al. (2009) suggested that breastfeeding for 
the first six months should be incorporated into the risk-reduction messages. During our 
study we did not collect data regarding breastfeeding because it was not included in the case 
files. We were therefore also unable to determine if infants were exclusively breastfed or also 
given formulas. It is clear that breastfeeding is pivotal for infant immune maturity and this 
data should be incorporated in future research studies. 
In our study the infants with a final Cause of Death Classification - infection seem to more 
closely resemble infants with a Cause of Death Classification - SIDS, in terms of age and 
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PCR-positive cases, compared to infants in the Cause of Death Classification - Other group. 
The latter group was the only group where more than half of the cases were PCR-negative. 
Another possible explanation why infants in this specific group were so much younger could 
be because they died of explained causes that included cardiac abnormalities, aspiration of 
foreign material or gastric contents, starvation and dehydration and prematurity amongst 
others and thus did not fit the general profile of SUDI or SIDS. 
It has been confirmed in the literature that SIDS cases rise in winter months when the 
number of infections also increase (Grangeot-Keros et al., 1996). A very early study from 
Nelson et al. (1975) found a significant rise in SIDS cases during influenza outbreaks over a 
42 month study period. They also found a significant association between a rise in 
temperatures and SIDS, but infections with influenza A was independent of temperature. We 
found a high percentage of SUDI cases in the winter and autumn months. Weber et al. 
(2008a) found no relationship between the seasons and the frequency of SUDI cases. In 
agreement with our findings, Vennemann et al. (2005) and du Toit-Prinsloo et al. (2013) also 
found more cases in the colder months of the year. In our study, more cases were PCR-
positive than PCR-negative for viral pathogens throughout all four seasons and we therefore 
could not demonstrate a significant association between the detection of viruses and the 
colder seasons. It is possible that our study period was not long enough to identify possible 
trends. We were able to observe that Influenza PCR-positive SUDI cases only occurred in 
winter and HMPV PCR-positive cases occurred in winter and spring but no clear seasonal 
pattern could be determined because the numbers were so small. 
5.3 Demographics 
Different factors in the infant‟s sleeping environment have been considered risks for SUDI 
and SIDS, including the sleeping position, heavy comforters, warm room temperatures and 
bed-sharing (Athanasakis et al., 2011; Hutchison, et al., 2011). In our study only a third of the 
cases for which data was provided were put to sleep on their stomachs. It is now several 
years since the National Institute of Child Health and Development introduced the “Back-to-
sleep” campaign in the USA, recommending that infants be placed on their backs to sleep 
rather than the stomach or so-called prone sleeping position (Trachtenberg et al., 2012). The 
prone sleeping position has also been associated with increased density of bacterial 
colonisation in the nasopharyngeal tract in infants (Goldwater, 2004). It was also 
hypothesised that infants could ingest bacteria that are present on their sleeping surfaces 
and that an increased temperature could enhance bacterial toxin production when sleeping in 
the prone position (Goldwater, 2004). 
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More than half of the infants in our study were found with thick heavy blankets and slept in 
rooms with closed windows. In the literature, warm home environments and overheating due 
to excessively wrapping infants in bedding and warm clothing are considered risk factors for 
SIDS (Sullivan et al., 2001). The majority of our cases had single parents in their mid 20s 
who were unemployed and lived in informal settlements. SIDS has been associated with 
young mothers below the age of 20, including populations with a poor socio-economic status 
and single and unemployed parents (Sullivan et al., 2001). Many of our cases also shared a 
bed with between one to four other adults and children. Parents overlaying their infants have 
long been considered a risk factor for SIDS. Bed-sharing could also lead to overheating and 
re-breathing of CO2 from others in the same bed (Sullivan et al., 2001). Parental alcohol 
usage and smoking were recorded in many of our cases, both of which are known risk 
factors for SIDS. O'Leary et al. (2013) found a high risk of SIDS when mothers used alcohol 
during or one year after pregnancy, but it also increased the risk of non-SIDS infant deaths. 
Exposure to alcohol in utero can have negative effects on the brainstem development which 
in turn could affect homeostatic control. Zhang & Wang (2012) found a significant association 
between both pre- and postnatal smoking and SIDS. Exposure to cigarette smoke could 
adversely affect the neurotransmitter systems required for homeostatic control. The cases 
within our study population were thus exposed to multiple known demographic risk factors. 
5.4 Polymerase chain reaction viruses detected and histology signs of infection 
Using the Seeplex® RV15 Ace detection assay on cDNA from tracheal and lung swab 
samples, we detected between one and three viruses in the majority of cases. More than half 
of our PCR-positive cases suggest a viral aetiology, confirmed by the Cause of Death 
Classification – Infection and histological signs of infection. Conversely, we found viruses in 
several cases in the Cause of Death Classification – Other group. Weber et al. (2010a) 
suggested that if viral detection occurs in the absence of clinical or morphological signs of 
infection, it may indicate asymptomatic carriage or an incidental finding with no contribution 
to the cause of death. They stated that the majority of pathologists would be in agreement 
that a positive viral result could only be deemed significant if it is supported by significant 
signs of inflammation. They further admitted that it is a challenge even in the presence of 
inflammation, to distinguish between a virus that may be incidental or have a contributory 
role and those viruses that were a direct cause of death (Weber et al., 2010a). We propose 
that a contributory role of viruses to the cause of death cannot be ignored, even in the 
absence of histological evidence of infection as seen in 60.2% of our SUDI cases. 
Inflammation can be demonstrated histologically by signs of tissue infiltration of the innate 
(i.e. macrophages and neutrophils) and adaptive (i.e. lymphocytes) immune systems. In 
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order for these cells to be observed in the injured or infected tissues, the appropriate chemo-
attractant signals need to be present to facilitate migration of these cells to the tissues. The 
existence of a window period was therefore suggested during which time the molecular 
signals of inflammation may already be evident before the manifestations of inflammation 
can be observed histologically (Gotsch et al., 2007). In infancy, this window period may be 
further prolonged, because their macrophage and neutrophil cell populations are less 
sensitive to chemo-attractants (Palmeira et al., 2012). 
5.4.1 Human rhinovirus 
HRV was detected the most frequently in our cases. In all our HRV-positive cases the virus 
was detected from the trachea and in two-thirds it was detected from one or both lung 
samples as well. The presence of histological evidence of infection supported the detection 
of the virus by PCR in the majority of our cases. HRV has long been considered an 
aetiological factor for the common cold in the URT (Hendley et al., 1973; Gwaltney, 1995), 
but in a more recent study it has also been identified to cause more severe LRTI and 
wheezing (Louie et al., 2009). In addition, Miller et al. (2012) confirmed HRV as the 
predominant pathogen in premature infants, which is already a recognised risk factor for 
SUDI. 
HRV has not been investigated in SUDI in recent studies, but Patrick et al. (1989) detected 
the virus in only 16% of viral-positive SIDS cases which is much lower than the prevalence 
found in our study. When such discrepancies arise, it could be attributed to differences in the 
study populations and/or detection techniques, which most probably played a major role in 
this instance, as molecular techniques were not readily available in 1989. Recent studies 
demonstrated higher HRV detection rates in living paediatric patients with clinical symptoms 
of infection and wheezing (Piotrowska et al., 2009; Smuts et al., 2011). These results were 
comparable to the number of HRV-positive cases we found in the comparison group of 
hospitalised infants in our study, suggesting that HRV rarely seem to occur in asymptomatic 
patients. In our study HRV was co-detected in a low number of cases with RSV, HCoV, 
human enterovirus, HPIV, HMPV and influenza A. Smuts et al. (2011) also co-detected HRV 
with very low frequency with HMPV, HBoV and HCoV. Thus similar to our findings, a low co-
detection rate occurs, with the majority of PCR-positive results yielding HRV as the sole 
pathogen. 
Our HRV-positive results need to be carefully interpreted. Although more than half of the 
cases showed histological evidence of infection, HRV has been known to result in prolonged 
viral shedding after the initial establishment of infection (Hendley et al., 1973; Gwaltney, 
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1995). The actual contribution of the virus to the infant‟s demise is questionable in such 
cases, especially when HRV was found in the trachea alone in about a third of our cases. 
The majority of the cases had the virus in both the trachea and the lungs. Almost half of the 
HRV-positive cases in our study were assigned a Cause of Death Classification – Infection, 
with much less in the SIDS and only a few cases in the Other categories. We detected HRV 
in case 046 with a Cause of Death Classification – Other, but this infant was said to have 
died from a pulmonary embolism. Pulmonary embolisms are considered very rare in infants 
(Byard & Cutz, 1990), but a case report has shown that it can be a possible cause for sudden 
infant death (de la Grandmaison & Durigon 2002). The contribution of HRV to death in this 
case seems unlikely in the absence of histology signs of infection. 
5.4.2 Respiratory syncytial virus A and B 
RSV A and B were only detected in a few cases in our study, predominantly from the lungs. 
RSV A seemed to be accompanied by histological evidence of infection in the majority of 
cases, while RSV B was not. We could not demonstrate a correlation between the presence 
of RSV and Cause of Death Classification. Our findings seem to be in agreement with the 
literature where very low prevalence rates of RSV had been described in SUDI cases (Weber 
et al., 2010a), as well as premature infants with ARIs (Miller et al., 2012). We also found a 
higher prevalence of RSV A than RSV B in the hospitalised infants, which agrees with the 
findings of Miller et al. (2012). In contrast to Miller et al. (2012) and da Silva et al. (2013) 
where more RSV was detected in living infants in Brazil, we found more HRV than RSV in 
both our SUDI cases and hospitalised infants.  
None of our cases with RSV A and a Cause of Death Classification – Other showed 
significant histological evidence of infection and their deaths were ascribed to congenital 
cardiac abnormalities, aspiration of foreign material and congenital endocardial 
fibroelastosis. In a review by Ogra (2004) it was indicated that congenital cardiac disease is a 
well-established risk factor for developing severe infection with RSV, as it is associated with 
the need for increased ventilator support and requires more periods of intensive care 
compared to infants who do not have congenital cardiac disease.  
RSV is recognised as the most significant cause of LRTI in early childhood (Ong et al., 
1982). Therefore the presence of RSV should at least be considered as playing an important 
contributory role to infant death in our study, even if not a direct cause. 
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5.4.3 Human coronavirus 
We detected HCoV in a small percentage of cases, but the majority also showed histological 
evidence of infection. We confirmed co-detection with HCoV OC43/HKU1 and HCoV 
229E/NL63 in a few cases but could not identify a trend towards an anatomical site because 
the virus was detected from the trachea alone, from lungs alone and from both sites. No 
association with the Cause of Death Classification could be found either. Kuypers et al. 
(2007) and Smuts et al. (2011) found a low prevalence in paediatric patients, either 
associated with severe LRTI or co-infections with other respiratory viruses. In other studies 
investigating respiratory viruses in SIDS cases, HCoV was not investigated (Patrick et al., 
1989; Weber et al., 2010a) 
5.4.4 Human enterovirus 
Human enterovirus was found in only a small percentage of our cases from the trachea and 
lungs, either in isolation or in combination with HRV. Human enterovirus provided the lowest 
level of agreement with histological evidence of infection. We found more cases with human 
enterovirus than Weber et al. (2010a), but due to the low numbers, no significant conclusions 
can be drawn from this. The detection of the virus in the absence of histological evidence of 
infection could possibly be linked to oral polio vaccine antigen shedding (Buonagurio et al., 
1999). 
5.4.5 Human metapneumovirus 
HMPV was detected from trachea and lung samples of our cases, but at a very low 
prevalence. We found histological evidence of infection in the majority of positive cases, 
including bronchopneumonia and IP grade 2-3. Despite the very low prevalence, all cases 
were assigned to the Cause of Death Classification – Infection group. HMPV was co-
detected with HRV and RSV A, but the numbers were inadequate to draw any conclusion 
from this. We cannot compare the prevalence of HMPV in our cases to those of other studies 
because this virus does not seem to be included when investigating respiratory viruses in 
SIDS (Patrick et al., 1989; Weber et al., 2010a). 
5.4.6 Human parainfluenza virus 
HPIV 2 was detected in one SIDS case in a study from the UK by Ann et al. (1993) at a 
prevalence of 2.2% which is similar to our four cases (2.7%) of HPIV 3 detected in the 
trachea and lung samples. We did not detect HPIV 1, 2 or 4. Histological evidence was 
present in most of the cases and included bronchopneumonia, bronchiolitis, and IP grade 2-
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3. Co-detections with other PCR viruses occurred in all the cases, but the significance is 
unclear due to the limited numbers.  
5.4.7 Influenza A and B 
Influenza A had been reported in the literature at a very low prevalence (Patrick et al., 1989; 
Weber et al., 2010a). Our study also detected Influenza A and B in a very small percentage 
from trachea and lung samples. We did not find associations with regard to histological 
evidence of infection, co-infection with other viruses or Cause of Death Category. 
5.4.8 Human adenovirus 
We did not expect to detect HAdV in our study, but a few cases were PCR-positive for HAdV. 
Although the multiplex PCR included primers for this virus, we used an RNA extraction kit 
and did not expect DNA to be present in the sample after extraction. After we validated the 
extraction procedures with a confirmed positive HAdV sample, it seemed as if DNA was 
indeed preserved during the RNA extraction procedures with the QIAGEN RNeasy Plus 
Micro Kit. We thus kept these unexpected results separate from the other virology results. 
5.5 The value of polymerase chain reaction viruses detected 
The PMI did not seem to influence whether or not respiratory viruses were detected by PCR. 
Viruses detected by the RV15 Seeplex® PCR from hospitalised infants during our study were 
similar to those detected from our SUDI cases, although at a lower prevalence. There did not 
seem to be a link between the HPIV strains circulating in the hospital and those we found in 
SUDI cases during the same period. The first most noticeable difference between the viruses 
confirmed in living infants and our SUDI cases was HPIV, where only HPIV 3 was detected 
from SUDI cases, and only HPIV 1, 2 and 4 from the hospitalised infants at Tygerberg 
Hospital. HPIV 1, 2 and 4 were circulating in the hospital setting at Tygerberg, but did not 
seem to be contributing to SUDI cases in our small study. The second difference was the 
detection of HBoV, which is a DNA virus, and was detected the third most frequently from 
hospitalised infants, but not present in our SUDI cases. This is partly because we used 
extracted RNA and not DNA. Although the PCR method picked up HAdV in some of the 
samples, it is possible that the HBoV DNA was eliminated during RNA extraction by the 
genomic DNA eliminator spin column. If this is the case, HBoV may have been present in 
some of our SUDI cases, but remained undetected because we specifically used an RNA 
extraction procedure that eliminated some, if not all, HBoV DNA. The PCR-positive HAdV 
cases we detected still needs to be clarified. HBoV might actually not have been present in 
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the SUDI cases in our study, but at present the reason for the absence of HBoV remains 
unanswered. 
The majority of our cases in the Cause of Death Classification – Infection group were PCR-
positive and this association was significant. Thus, even without the PCR results, the routine 
laboratory tests and histology were able to assist the pathologist with determining the final 
cause of death. The PCR test is still important, as this can identify an aetiological agent, 
because most of the cases classified as infection are not specific for an aetiological agent. In 
the Cause of Death Classification – SIDS group, the PCR results could assist with 
determining a possible cause of death in 50% of our cases. It may also be relevant in cases 
where histology does point to a clear infectious cause of death, especially when routine 
culture does not reveal any aetiological agents. In 39.8% of our SUDI cases that were PCR-
positive, histological evidence of infection severe enough to cause death was not noted. This 
percentage of cases seems too high to indicate asymptomatic carriage, a past viral infection 
or just an incidental finding. It also questions how good a predictor of viral infections the H&E 
lung histology analysis really is. Viral infections are frequently detected from children that 
died of causes other than infections, therefore Samuels (2003) stated that it does not imply 
that the viral infections resulted in death. The detection of a pathogen must be substantiated 
with pathology changes indicative of infections, otherwise a cause of infection cannot be 
supported (Fernández-Rodríguez et al., 2006; Weber et al., 2010a). 
To evaluate the significance of PCR in detecting viruses and their possible contributions to 
SUDI, especially in the absence of histological evidence of infection, additional research is 
required. The specific viral immune response needs to be characterised in SUDI cases, both 
in terms of the histological picture, but also the serum antibody levels. If the systemic 
response to specific viruses could be further investigated in our SUDI cases, it may help to 
assist in determining the significance of viruses in causing active infection severe enough to 
contribute to death. For instance, primary infection with RSV leads to elevated levels of IgM 
which remains detectable one to three months after initial infection. The IgG levels increase 
from initial onset of symptoms to maximum serum levels in about 20-30 days and thereafter 
serum levels decrease and remain at low levels after a year. After re-exposure or re-infection 
IgG levels rise and can be detected at high serum levels within five to seven days after 
antigen stimulation (Ogra, 2004). Thus, IgM levels indicate recent infection and possible 
active infection which could be a valuable tool to corroborate viral PCR results. IgG levels are 
more difficult to interpret, because it can indicate primary infection, past infection or even a 
re-infection/re-exposure where the latter would result in a less severe infection than primary 
infection. 
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Fernández-Rodríguez et al. (2006) detected IgM and IgG levels against EBV, CMV, RSV, 
influenza A and HHV-6 from sudden death in children using serology. In a two-year-old child, 
HAdV was detected with viral culture, but serology was negative and they suggested that this 
was because the onset of the illness was too rapid for the immune response to become 
detectable. High RSV-specific antibody levels determined by complement fixation were 
regarded as indicative of recent infection in light of pathology findings indicating epiglottitis 
and laryngitis. They considered high HHV-6 specific IgM levels to indicate a recent infection 
in a three-year-old child, but a positive serology result for influenza A antibodies in a new-
born was interpreted as maternal antibody levels that had been transferred across the 
placenta to the infant. The same group acknowledged the limitations of serology, especially 
in the case of children younger than three years, where the immune response to infections 
take time to develop and could thus be delayed. Also, careful interpretation is required to 
distinguish between recent and past infections, including maternal antibodies in the infant‟s 
circulation. 
Another approach is to investigate the cellular immune response in SUDI cases. Howat et al. 
(1994) detected increased eosinophils and T and B lymphocytes in the lungs of SIDS cases 
compared to controls using immunocytochemistry when autopsies were performed within 72 
hours after death. They provided evidence of inflammation characterised by abnormal T 
lymphocyte responses in the lungs of SIDS cases and further suggested that the products 
from degranulation of eosinophils could lead to airway obstruction and hypoxia (Howat et al., 
1994). Gaaloul et al. (2012) used paraffin tissue blocks from the myocardium of sudden 
unexpected death cases (18-42 years of age) with suspected inflammatory heart disease 
and detected significant CD3 T cells and CD19 B cells considered as markers of 
inflammation, compared to control cases that died from traffic accidents. CD4+ and CD8+ T 
cells play a major role in viral clearance during infections and the antigen-specific CD4+ T cell 
response and the RSV-specific CD8+ T cell responses had been investigated by Arnold et al. 
(2002) and Heidema et al. (2004). It may therefore be worthwhile to also investigate the viral 
specific cellular immune responses in SUDI cases. 
In our study 58.3% of PCR-negative SUDI cases presented with histological evidence of 
infection. Although some of these were positive for routine culture tests, we cannot exclude 
the possibility of other undetected pathogens contributing to the observed histology. Other 
viruses that were not included in this study, but that had been implicated in SUDI and SIDS 
must also be considered, such as VZV (Desmons et al., 2013), rotavirus and echovirus 
(Patrick et al., 1989), EBV (Álvarez-Lafuente et al., 2008), CMV, HSV (Weber et al., 2010a) 
and Ljungan virus (Niklasson et al., 2009). These viruses require further investigation. It is 
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possible we may be underreporting the prevalence of respiratory viruses from our SUDI 
cases as we did not look for DNA viruses and we also did not investigate viruses from liver or 
heart tissue, post-nasal swabs, bowel, recto-sigmoid loop or suprarenal fat specimens. 
We also cannot exclude the possibility that the microscopical picture for the PCR-positive 
cases with histological evidence of infection, may have been caused by other unknown 
events, since histological signs of inflammation have been detected from cases dying from 
unnatural causes and in cases where no specific infectious aetiology could be identified 
(Krous et al., 2003). 
5.6 Cases with a Cause of Death Classification - SIDS 
We detected HRV, RSV A and B, HCoV (OC43/HKU1 and 229E/NL), influenza B and HPIV 
from half of our cases SIDS. 
5.6.1 Human rhinovirus-positive SIDS cases 
5.6.1.1 Cases 029 and 139 
Two of our cases had HRV as the only aetiological agent detected from both trachea and 
lung specimens. Case 029 had histological evidence of IP grade 4, and case 139 had 
histological evidence of IP grade 2 together with a medical history of slight cold symptoms 
prior to death. In light of the histological evidence of infection, a specific aetiological agent 
identified from the URT and LRT tract and a medical history of cold symptoms indicates that 
this virus should be considered a significant finding, which in turn could alter the diagnostic 
category of death from SIDS to infection. A diagnosis of SIDS is only valid when all the 
evidence excludes any possible cause of death. In these cases, although HRV might not 
have been the definite cause of death, it may still have contributed to it. 
5.6.1.2 Cases 045, 051, 062, 069, 085, 102 and 083 
In six cases HRV was detected in combination with positive routine bacterial culture results. 
In case 045 Staphylococcus aureus and Klebsiella pneumonia were cultured, in case 051 
Leuconostoc citreum was cultured and in case 102 Klebsiella pneumonia was cultured, but 
no histological evidence of infection or a medical history was noted. Case 062 had a medical 
history of coughing prior to death and a positive bacterial culture for Klebsiella pneumonia 
and case 085 had a medical history of throat infection and was on antibiotics for seven days 
prior to death, but histological evidence of infection was not observed in either of the two 
cases. In case 069 Klebsiella oxytoca was cultured and histology showed signs of IP grade 
1. Only one case showed mild histology indicative of an IP grade 1, which complicates 
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interpretation of results in favour of a possible infection from HRV or the bacteria that were 
co-detected. The last case (083) was HAdV-positive by routine SVC and histology showed IP 
grade 2. HRV was only present in the trachea of this case and HAdV was detected from the 
liver. This case was further complicated because the aetiological agents were not detected in 
the lungs where the IP was observed. In this case and the ones above, the PCR result would 
not have altered the final diagnostic category. 
5.6.2 Viruses in the other SIDS cases 
Case 009 was positive for three PCR viruses, i.e. HRV, RSV B and HCoV OC43/HKU1 from 
tracheal and lung specimens. The histology picture showed evidence of viral inclusion 
bodies, and a medical history of a stomach virus and a cold prior to death were noted. Da 
Silva et al. (2013) speculated that co-detection of HRV and RSV could result in an additive 
effect leading to more severe infection in infancy. In this case the PCR results may alter the 
final Cause of Death Classification from SIDS to Infection. Case 039 had co-detections with 
HRV and RSV A, and was culture positive for Escherichia coli, Pseudomonas species, 
Serratia liquefaciens and Lactococcus garvieae. A history of coughing and fever prior to 
death were noted, and an IP grade 2 was seen from the histology. In Case 145 HRV was 
detected from the trachea and HCoV 229E/NL from the lungs, along with histology signs of 
IP grade 2. Although HRV was not the sole pathogen in all HRV-positive SIDS cases, its 
possible contribution to death cannot be excluded in at least five SIDS cases in light of the 
histological evidence of infection, co-detection with other viruses and presence of the virus in 
the LRT, especially since Louie et al. (2009) and Miller et al. (2012) have associated this 
virus with more severe disease than previously thought. 
In case 023 HCoV OC43/HKU1 was detected as the sole pathogen in the absence of other 
signs of infection and in 147 HCoV OC43/HKU1 and HCoV 229E/NL 63 were detected as the 
sole pathogens in the trachea and lungs with histological evidence of IP grade 3. The 
detection of HCoV in the latter case should be considered significant in light of the histology 
picture. 
In case 104 HPIV 3 and HCoV OC43/HKU1 were detected with a histology picture of 
bronchopneumonia and bronchiolitis and a medical history of being lethargic prior to death. 
In this case the significance of HPIV 3 and HCoV possibly contributing to death requires 
further investigation, but the detection of bronchopneumonia may indicate an underlying 
infection or inflammatory response. This case therefore did not fit the normal definitional 
criteria for SIDS.  
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Influenza B was detected as the sole virus along with Klebsiella pneumonia in case 053 with 
a history of flu-like symptoms, but no histology signs of infection were observed. In this case, 
the medical history may be significant in light of the PCR result in the events that lead to the 
sudden death. 
RSV A was detected in case 072 along with Escherichia coli and the histology picture 
showed signs of IP grade 2 and bronchiolitis. In light of the histology findings RSV should be 
considered significant in the infant‟s death. 
HRV has been detected repeatedly from children with wheezing and LRT infection (Louie et 
al. 2009; Smuts et al., 2011). RSV has also been associated with bronchiolitis, wheezing and 
reduced lung function in hospitalised children (Zomer-Kooijker et al. 2014). Asthma has been 
known to result from respiratory viral bronchiolitis in paediatric populations (Tregonong & 
Schwarze 2010). Asthma is characterised by inflammation in the respiratory tract, contraction 
of bronchioles and airway remodelling and symptoms include shortness of breath and 
wheezing (Dhariwal et al. 2013). We detected HRV, RSV and HCoV the most frequently from 
our SUDI cases, with most of the lung and tracheal samples positive for these three viruses 
and the majority showing histology signs of inflammation was observed in more than half of 
all HRV, RSV and HCoV SUDI cases. Detecting these viruses in the LRT along with 
histology evidence of infection strongly suggest that these viruses played a role in the 
infectious events leading to death. Inflammation can also lead to the obstruction of 
bronchioles which can impair breathing (Gotsch et al., 2007; Openshaw, 2005) and thus the 
role of these viruses in asthma exacerbation may contribute to SUDI in some cases who 
were predisposed to asthma or who had reduced lung function. 
5.7 The routine diagnostic tests used for SUDI investigations at Tygerberg  
5.7.1 Rapid third generation VISITECT® HIV1/2 test 
During routine autopsies on SUDI cases at Tygerberg FPS Mortuary heart blood is collected 
and sent for HIV testing. We found 29.6% of the blood specimens to be reactive with the 
HIV1/2 specific recombinant antigens used in the rapid third generation VISITECT® HIV1/2 
test. Little value is placed on this test when pathologists review all the laboratory evidence to 
determine a final cause of death, but it is still part of the facility protocol for SUDI 
investigations at Tygerberg. Firstly, it is not a PCR test and does not detected HIV antigens, 
but rather HIV1/2 specific antibodies. Within the first 12-18 months of infancy it is thus not 
possible to distinguish between vertical transmission of HIV-specific maternal antibodies or 
the infant‟s own HIV1/2 specific antibodies (Graham & Gibb, 2002). Secondly, infants 
infected with HIV often experience secondary respiratory infections and thus HIV in itself is 
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not responsible for increased mortality in HIV infected populations. HIV is therefore not 
regarded as the aetiological agent responsible for death. 
5.7.2 Routine shell vial culture  
At the Tygerberg FPS Mortuary lung and liver specimens from every SUDI case are sent for 
routine SVC to screen for HAdV, influenza A and B, HPIV 1-3, RSV, CMV and HMPV. We 
only detected viruses using SVC in 9.5% of the cases. We detected HAdV in only one case 
and CMV in 13 cases. We know that some of the viruses included in the SVC method, such 
as influenza A and B, HPIV 3, RSV and HMPV, are indeed much more prevalent in our SUDI 
cases, because we detected these viruses along with others using the multiplex PCR. This 
questions whether some of the viruses we detected with the PCR may be false positive 
results. A high rate of false positivity is unlikely, given that the Seeplex® RV15 Ace detection 
assay is SANAS accredited for routine diagnostic practise and has a sensitivity of 
100 copies/3 μl cDNA. A more likely explanation may be the integrity of autopsy specimens 
and possible viral loads too low for SVC detection and the delay between taking the sample 
and getting the specimens to the lab, as well as the PMI and adequate refrigeration of the 
body. 
Through data mining we acquired the SVC results from 88 specimens sent from living infants 
admitted at Tygerberg Hospital during our study period. Of these 21.6% (19/88) were positive 
for viruses that included RSV, CMV, influenza A, HPIV 1 and 3 and HAdV. This questions 
why we did not detected any viruses other than CMV and HAdV from SVC conducted 
routinely on all SUDI cases. This also may point back to sample integrity. Specimens at 
Tygerberg Hospital are often taken upon admittance and transported to the lab where testing 
begins immediately. SVC may thus not be adequate to detect sufficient respiratory viruses 
from autopsy specimens, while there are time delays between specimen collection and 
testing. In our study we showed that all the viruses we detected using the Seeplex® RV15 
Ace detection assay were missed with the SVC method. While only this method is used, we 
may be missing important infections that could contribute to SUDI and could lead to an 
inaccurate diagnosis of SIDS in some cases at the Tygerberg FPS Mortuary. 
One could still argue that SVC is important because we detected HAdV from liver tissue in a 
case that was PCR-negative for this virus. Liver tissue was not collected for PCR and thus 
the fact that we missed HAdV from one case could be ascribed to specimen type, rather than 
an inability of the PCR to detected HAdV. In addition, SVC was not directly matched to the 
Seeplex® RV15 Ace detection assay because SVC does not include screening for HRV and 
HCoV, the most frequent and third most frequent viruses detected in our study, respectively. 
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Although we acknowledge that sample integrity must play a role in the differences in SVC 
viruses detected from hospitalised infants and the SUDI cases at Tygerberg during our study 
period, the SUDI cases that were SVC positive had a significantly higher PMI than the SVC-
negative cases. Despite this higher PMI in SVC-positive cases, the viruses detected on SVC 
from our cases were DNA viruses (CMV and HAdV) which are considered more stable than 
RNA viruses and may thus have been less likely to undergo degradation of nucleic acids and 
thus viral viability might have been preserved. In addition, the significance of the association 
between the SVC-positive cases and a longer PMI is underpowered, because the sample 
size for the positive cases is so small. More research on bigger study groups is necessary to 
elucidate this finding. 
5.7.3 Routine Bacterial Culture 
Although the focus of this study was not the detection of bacterial pathogens, it forms an 
integral part of the routine laboratory investigations in SUDI cases at Tygerberg FPS 
Mortuary. Bacterial pathogens have also frequently been detected and considered to 
contribute to SIDS (Pryce et al., 2011). We detected potential bacterial pathogens in 56.8% 
of our SUDI cases. Histology correlated with the detection of bacteria in 60.7% of the cases. 
In a review Goldwater (2004) described that viral co-infections could increase bacterial toxin 
production and lethality and thus pose a true risk for SIDS. We found that 57.1% of our cases 
were co-infected with viruses and bacteria, with 58.3% of these showing histological 
evidence of infection. 
In the literature emphasis has been placed on the PMI and how it could affect the validity of 
culture results. As part of the natural process of putrefaction the body‟s epithelial barriers 
lose integrity, which causes migration of bacteria (Tuomisto et al., 2013). Organs that 
possibly were sterile in life may become colonised with bacteria after death. The isolation of 
mixed bacterial species are considered post-mortem contaminants or post-mortem flora 
(Tuomisto et al., 2013) and therefore should have no bearing on the cause of death (Krous et 
al., 2003), as is the case at Tygerberg FPS Mortuary. The routine culture test results from the 
laboratory would not even identify the pathogens and only state post-mortem contaminants 
or post-mortem flora on the test result. In our study we did not find a significant association 
between the PMI of cases in which post-mortem flora was identified compared to cases 
where bacterial species were isolated and identified. Weber et al. (2010b) found that a longer 
PMI of up to five or more days caused a reduction in the amount of positive bacterial 
samples. In contrast, Tuomisto et al. (2013) found that a longer PMI caused liver specimens 
to be positive for bacteria more often, possibly representing bacterial migration or post-
mortem contamination. 
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5.8 Strengths 
To our knowledge, this is the first study that investigated 13 RNA respiratory viruses in SUDI 
cases in South Africa, a country where research into SIDS seems to be limited. In our study 
we were able to characterise the prevalence of RNA viruses in SUDI cases at Tygerberg 
FPS Mortuary over a one year period and included all four consecutive seasons. We also 
used a superior detection method to SVC. The PCR is more sensitive in detecting viruses 
from lung tissue in our SUDI cases and does not seem to be affected by the PMI. 
5.9 Limitations and future research 
One of the limitations to our study was the use of a qualitative assay and thus the inability to 
determine the viral load in our samples. Viral load is important to predict disease severity, 
and especially in the case of viruses with latent life cycles, such as CMV, a high viral load 
could distinguish active from infection when viral loads are low. Very low viral loads, 
especially in the case of HRV, could merely present past infections and viral shedding. Thus, 
if we were able to determine viral load in our study, we might have had a better idea of how 
important a role the viruses played in the events leading to these sudden deaths. 
A second limitation to our study, which is very common, is the lack of a suitable control 
group. Ethical approval for specimen collection from infants who died of unnatural causes is 
very hard to acquire. If we had a control group we could have compared the PCR viruses in 
that group to our SUDI cases, to determine whether the viruses and histological evidence of 
infection are also present in infants dying from causes other than infections. We used the 
laboratory results from living hospitalised infants during the same period to compare our 
results to and although the optimal control group would have been infants who died from 
unnatural causes, we feel that the information collected from the living infants is valuable in 
describing viral prevalence rates in this vulnerable population. 
A third limitation to our study is that we only included cases during one study year. If we 
collected data over a longer period, epidemiological risk factors might have emerged more 
significantly and a larger sample size over consecutive seasons could provide a better profile 
of respiratory viruses with seasonal variation in our setting and aid in determining patterns 
between viruses circulating in hospitalised infants and those in SUDI cases. 
A fourth limitation is that only the left and right lower lung lobes were assessed for histology 
signs of infection. If more representative histology sampling was conducted which included 
the upper and lower left lung lobes and the upper, middle and lower right lung lobes, it could 
ensure that underlying disease processes were not missed. 
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Lastly, no immunological data was collected that could shed light on specific viral immune 
responses in the form of virus specific IgG or IgM antibodies, nor about the cellular immune 
response and thus we had to rely on general infectious histology signs in the lungs to 
interpret our findings.  
The indicated limitations warrant additional inspection and should be further investigated in a 
much larger study. 
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CHAPTER SIX 
CONCLUSION 
We aimed to determine the prevalence of 13 RNA respiratory viruses from SUDI cases at 
Tygerberg FPS Mortuary during a one year period in order to investigate possible infectious 
causes of death. To determine the significance of viruses in our cases, we assessed different 
signs of infection present in the respiratory tract. 
We found that more than half of the SUDI cases were PCR-positive for one or more 
respiratory viruses. Many of the viruses we detected are included in the routine SVC test that 
forms part of the medico-legal laboratory investigation for all SUDI cases at Tygerberg FPS 
Mortuary. None of the viruses we detected using PCR were ever cultured using the routine 
SVC test. Factors including autopsy sample integrity, the PMI, and viral viability and viral 
load most probably played a big role in the failure to culture viruses, especially since SVC 
was able to detect many different viruses in paediatric hospital patients at Tygerberg Hospital 
during the same study period. This indicates that the SVC method is suboptimal at 
determining respiratory viral prevalence in the post-mortem setting. We showed that SVC is 
potentially missing many respiratory viruses that could contribute to death in some of the 
SUDI cases at Tygerberg FPS Mortuary. In some cases that were classified as SIDS, the 
PCR results cannot be ignored, especially when it is supported by histological evidence of 
infection. We thus propose that the use of PCR could have altered a Cause of Death 
Classification from SIDS to Infection in some of these cases.  
Further research is needed to determine the importance of detecting viruses from SUDI 
cases where no significant histological evidence of infection was observed. This questions 
whether PCR may be too sensitive and is detecting past and latent viral infections that do not 
play any role in the cause of death. The histological picture also requires further 
characterisation to determine if it accurately predicts infections or lethal events and can truly 
support virology findings, especially in young infants whose immune systems are still 
maturing. 
In line with the aims and objectives of our study we showed that a substantial proportion of 
SUDI cases were PCR-positive for respiratory viruses, but the true clinical significance of 
detecting these viruses could not be determined within the scope of this study due to the 
absence of information regarding a viral-specific immune response. SVC routinely included in 
the SUDI investigations at Tygerberg FPS Mortuary is missing PCR-positive cases and is 
thus insufficient for autopsy samples in a post-mortem setting. Before the significance of 
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respiratory viruses can adequately be determined in the context of SUDI and SIDS, protocols 
need to include sufficient anatomical sampling sites and sufficient laboratory techniques to 
shed light on the prevalence of viruses. In addition, viral specific immune response needs to 
be further characterised. Without determining the true prevalence of viruses in SUDI cases 
and the viral-specific immune response, the contribution of virus-specific infections to this 
syndrome will remain largely undetermined. 
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Addendum 3 
Details of PCR-positive cases (n=88) 
Case 
Number 
Virus Detected Histological Signs of 
Infection 
Medical History  Cause of Death 
Classification 
Routine Culture 
Results 
002 HRV Congestion, 
bronchopneumonia, 
focal collapse, 
alveolar haemorrhage 
Feverish day 
before death and 
two weeks prior to 
death 
Infection  
003 Human enterovirus Congestion, focal 
collapse, pigment 
iron/formalin 
   
005 RSV A Oedema, congestion, 
focal collapse,  
pigment iron/formalin, 
alveolar debris 
Yes Congenital 
cardiac 
abnormalities  
 
006 HCoV OC43/HKU1 Congestion, focal 
collapse 
 Infection Enterobacter 
aerogenes 
007 HRV 
RSV B 
Oedema, focal 
collapse 
 Infection Klebsiella 
pneumoniae 
009 HRV 
RSV B 
HCoV OC43/HKU1 
Query RSV Stomach virus 
and cold 
1 week prior 
SIDS  
011 HRV Oedema, IP grade 1, 
focal collapse,  
pigment iron/formalin, 
alveolar debris 
 Infection  
013 HCoV OC43/HKU1 
RSV A 
Congestion, alveolar  
haemorrhage 
 Aspiration of 
foreign material 
or gastric 
contents  
 
014 HRV Oedema   Raoultella 
ornithinolytica 
015 RSV A Focal collapse, 
alveolar debris 
was not breathing 
right 
Congenital 
cardiac 
abnormalities  
 
017 HCoV OC43/HKU1 
HCoV 229E/NL63 
RSV A 
Oedema, 
bronchopneumonia, 
focal collapse,  
pigment iron/formalin, 
alveolar debris 
 Infection Klebsiella oxytoca 
019 HRV Focal collapse, 
alveolar debris, query 
 Infection Escherichia coli  
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RSV 
023 HCoV OC43/HKU1 Focal collapse  SIDS  
026 HRV Bronchopneumonia Coughing Infection Beta-haemolytic 
strep. Group B 
027 HRV Bronchopneumonia  Infection  
029 HRV Congestion, IP grade 
4, alveolar 
haemorrhage 
 SIDS  
030 HRV Oedema, IP grade 1, 
bronchopneumonia 
   
032 HRV Oedema, IP grade 2  Infection Escherichia coli 
034 HRV Unremarkable   Raoultella 
planticola 
037 HRV 
RSV A 
PIV 3 
Unremarkable    
038 HMPV Unremarkable  Infection Escherichia coli 
Enterococcus 
species 
039 HRV 
RSV A 
IP grade 1, focal 
collapse 
Coughing and 
fever 
SIDS Escherichia coli  
Pseudomonas 
species 
Serratia 
liquefaciens 
Lactococcus 
garvieae 
040 HRV 
Human enterovirus 
Unremarkable  Infection  
043 HRV Oedema, congestion, 
IP grade 1, focal 
collapse,  
pigment iron/formalin 
 Unable to exclude 
accidental 
suffocation  
 
044 HRV 
Human enterovirus 
Congestion Breathing 
difficulties and  
received 
antibiotics a week  
prior to demise 
Infection CMV 
Staphylococcus 
aureus 
045 HRV Congestion, focal 
collapse, alveolar 
debris 
 SIDS Staphylococcus 
aureus 
Klebsiella 
pneumoniae  
046 Influenza A Oedema   Escherichia coli 
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047 HRV 
RSV A 
Oedema, congestion, 
bronchiolitis 
   
048 HRV Focal collapse cold/runny nose, 
diarrhoea 
 and fever 24 hrs 
before 
Infection  
051 HRV Unremarkable  SIDS Leuconostoc 
citreum 
052 HRV Oedema, IP grade 2-3   Staphylococcus 
aureus  
053 Influenza B Oedema, congestion, 
focal collapse 
Flu-like symptoms 
prior to 
death 
SIDS Klebsiella 
pneumoniae  
057 HRV 
Influenza A 
IP grade 1, focal 
collapse 
Sick for one week 
with fever  
and coughing 
Infection  
058 HRV Unremarkable   Raoultelle 
planticola 
062 HRV Unremarkable Sick with 
coughing one day  
prior to death 
SIDS Klebsiella 
pneumoniae 
063 Influenza A Pigment iron/formalin, 
alveolar haemorrhage 
   Beta-haemolytic 
strep. Group B 
064 HRV Oedema, congestion, 
bronchiolitis, alveolar 
debris,  
alveolar 
haemorrhage, query 
RSV 
 Congenital 
cardiac 
abnormalities  
 
067 HRV IP grade 1, focal 
collapse 
  Klebsiella 
pneumoniae 
068 HMPV IP grade 2, alveolar 
haemorrhage 
  CMV 
Klebsiella 
pneumoniae 
Streptococcus 
pneumoniae 
069 HRV IP grade 1, focal 
collapse, alveolar 
debris, alveolar 
haemorrhage 
 SIDS Klebsiella oxytoca 
070 RSV A 
HCoV OC43/HKU1 
Congestion, 
bronchopneumonia, 
focal collapse 
 Infection Escherichia coli 
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071 HRV 
RSV A 
HMPV 
Oedema, IP grade 2, 
query RSV/virus 
 Infection Klebsiella 
pneumoniae 
072 RSV A Oedema, congestion, 
IP grade 2, focal 
collapse,  
alveolar 
haemorrhage, 
bronchiolitis, query 
virus 
 SIDS Escherichia coli 
073 HRV Oedema, IP grade 2, 
alveolar debris, 
alveolar 
haemorrhage, query 
RSV/HAdV 
 Aspiration of 
foreign material 
or gastric 
contents  
Klebsiella 
pneumoniae 
077 HCoV OC43/HKU1 
HRV 
Oedema, congestion, 
IP grade 1, 
bronchopneumonia, 
focal collapse, 
alveolar debris, 
alveolar 
haemorrhage 
  Streptococcus 
pneumoniae 
078 HRV IP grade 2, focal 
collapse, alveolar 
haemorrhage 
  Raoultella 
planticola  
080 HRV 
HPIV 3 
Oedema, congestion, 
IP grade 2-3, focal 
collapse, alveolar 
debris 
  Klebsiella 
081 HRV 
HPIV 3 
Oedema, IP grade 2, 
alveolar debris 
   
082 HRV IP grade 2, focal 
collapse, alveolar 
debris, alveolar 
haemorrhage 
Fever on day of 
death 
Infection  
083 HRV Oedema, IP grade 2, 
alveolar debris 
 SIDS HAdV 
084 HRV Oedema, IP grade 1-
2, bronchitis 
Ill with vomiting 24 
hours prior to 
death 
Infection Enterobacter 
cloacae 
085 HRV Oedema, congestion Throat infection  
(7 days on 
antibiotics) 
SIDS Haemophilus 
influenzae 
086 HRV 
Human enterovirus 
Oedema, alveolar 
haemorrhage 
  Escherichia coli 
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087 HMPV Oedema, 
bronchopneumonia, 
alveolar haemorrhage 
  Klebsiella 
pneumoniae  
089 HRV Congestion, IP grade 
4, alveolar debris, 
alveolar 
haemorrhage, query 
virus 
 Infection Escherichia coli 
090 HRV Congestion, IP grade 
3, alveolar 
haemorrhage 
 Infection CMV 
Haemophilus 
influenzae 
091 HRV 
HMPV 
IP grade 3  Infection Klebsiella 
Pneumoniae  
092 HRV Oedema, congestion, 
IP grade 1, alveolar 
debris 
 Infection Klebsiella 
Pneumoniae 
Salmonella group 
D 
093 HRV Oedema, focal 
collapse 
 Infection  
094 HRV 
Human enterovirus 
Oedema  Infection Enterococcus 
faecalis 
Klebsiella 
Pneumoniae  
095 HRV Congestion, focal 
collapse, alveolar 
debris 
 Infection  
102 HRV Oedema  SIDS Klebsiella 
pneumoniae 
103 HRV Oedema, focal 
collapse 
 Infection  
104 HCoV OC43/HKU1 
HPIV 3 
Oedema, 
bronchopneumonia,  
alveolar debris,  
Bronchiolitis 
Lethargic at 
crèche 
SIDS  
105 Human enterovirus Oedema, congestion, 
bronchopneumonia 
  CMV 
Staphylococcus 
aureus  
106 HRV Congestion, alveolar 
haemorrhage 
 Infection CMV 
108 HRV Oedema, focal 
collapse 
   
110 HRV Oedema, focal 
collapse, alveolar 
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debris 
111 HRV Bronchopneumonia Breathing 
problems and  
diarrhoea 
Infection Candida albicans 
112 HRV Oedema, IP grade 2, 
alveolar debris 
 Infection Candida albicans 
113 HRV Congestion, IP grade 
1, focal collapse 
 Infection Klebsiella 
pneumoniae 
115 HRV Oedema, alveolar 
debris, bronchiolitis, 
bronchitis 
   
118 RSV A Congestion,  IP grade 
1, bronchopneumonia 
  Haemophilus 
influenza 
119 HRV Oedema, congestion, 
IP grade 1-2 
 Infection  
120 RSV A 
HRV 
Congestion, IP grade 
1, alveolar debris, 
alveolar haemorrhage 
  Escherichia coli  
122 HRV Oedema,  IP grade 2, 
bronchopneumonia 
Diarrhoea, 
vomiting and   
listlessness for a 
week 
Infection Klebsiella 
pneumoniae  
128 HRV Oedema, congestion, 
IP grade 1 
   
129 HRV 
HCoV 229E/NL63 
Oedema, congestion, 
IP grade 1, alveolar 
debris 
  CMV 
131 HRV Oedema, congestion  Infection  
132 HRV Oedema  Infection Escherichia coli 
135 HRV 
RSV A 
Alveolar debris, 
bronchitis 
 Infection  
137 HRV Oedema, alveolar 
haemorrhage 
  CMV 
139 HRV IP Grade 2 Slight cold 
symptoms 
SIDS  
142 RSV A Oedema, congestion, 
IP grade 2-3, alveolar 
debris,  
bronchiolitis, query 
RSV 
   
144 HRV IP grade 1, alveolar 
haemorrhage, 
 Infection  
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bronchitis 
145 HRV 
HCoV 229E/NL63 
Oedema, IP grade 2  SIDS  
147 HCoV 229E/NL63 Oedema, IP grade 3, 
alveolar debris 
 SIDS  
148 HRV IP grade 1, alveolar 
haemorrhage 
 Infection CMV 
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